
<html lang="en"     class="pb-page"  data-request-id="61202b5b-9935-4d06-880b-cc1b13e3d8f7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2020.63.issue-3;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.9b01338"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Development of Novel N-hydroxypyridone Derivatives as Potential Anti-Ischemic Stroke Agents" /></meta><meta name="dc.Creator" content="Linghao  Hu" /></meta><meta name="dc.Creator" content="Hongxuan  Feng" /></meta><meta name="dc.Creator" content="Hongguang  Zhang" /></meta><meta name="dc.Creator" content="Songda  Yu" /></meta><meta name="dc.Creator" content="Qinyuan  Zhao" /></meta><meta name="dc.Creator" content="Wei  Wang" /></meta><meta name="dc.Creator" content="Fengxia  Bao" /></meta><meta name="dc.Creator" content="Xun  Ding" /></meta><meta name="dc.Creator" content="Jiajing  Hu" /></meta><meta name="dc.Creator" content="Manjiong  Wang" /></meta><meta name="dc.Creator" content="Yixiang  Xu" /></meta><meta name="dc.Creator" content="Zengrui  Wu" /></meta><meta name="dc.Creator" content="Xiaokang  Li" /></meta><meta name="dc.Creator" content="Yun  Tang" /></meta><meta name="dc.Creator" content="Fei  Mao" /></meta><meta name="dc.Creator" content="Xiaoyan  Chen" /></meta><meta name="dc.Creator" content="Haiyan  Zhang" /></meta><meta name="dc.Creator" content="Jian  Li" /></meta><meta name="dc.Description" content="Our previous study had identified ciclopirox (CPX) as a promising lead compound for treatment of ischemic stroke. To find better neuroprotective agents, a series of N-hydroxypyridone derivatives ba..." /></meta><meta name="Description" content="Our previous study had identified ciclopirox (CPX) as a promising lead compound for treatment of ischemic stroke. To find better neuroprotective agents, a series of N-hydroxypyridone derivatives ba..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 7, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01338" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01338" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01338" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01338" /></link>
        
    
    

<title>Development of Novel N-hydroxypyridone Derivatives as Potential Anti-Ischemic Stroke Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01338" /></meta><meta property="og:title" content="Development of Novel N-hydroxypyridone Derivatives as Potential Anti-Ischemic Stroke Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0017.jpeg" /></meta><meta property="og:description" content="Our previous study had identified ciclopirox (CPX) as a promising lead compound for treatment of ischemic stroke. To find better neuroprotective agents, a series of N-hydroxypyridone derivatives based on CPX were designed, synthesized, and evaluated in this study. Among these derivatives, compound 11 exhibits significant neuroprotection against oxygen glucose deprivation and oxidative stress-induced injuries in neuronal cells. Moreover, compound 11 possesses good blood–brain barrier permeability and superior antioxidant capability. In addition, a complex of compound 11 with olamine—11·Ola possesses good water solubility, negligible hERG inhibition, and superior metabolic stability. The in vivo experiment demonstrates that 11·Ola significantly reduces brain infarction and alleviates neurological deficits in middle cerebral artery occlusion rats. Hence, compound 11·Ola is identified in our research as a prospective prototype in the innovation of stroke treatment." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01338"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01338">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01338&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01338&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01338&amp;href=/doi/10.1021/acs.jmedchem.9b01338" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1051-1067</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01218" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01398" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of Novel <i>N</i>-hydroxypyridone Derivatives as Potential Anti-Ischemic Stroke Agents</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Linghao Hu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Linghao Hu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</div><div class="loa-info-affiliations-info">Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Linghao++Hu">Linghao Hu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hongxuan Feng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hongxuan Feng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, Beijing 100049, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hongxuan++Feng">Hongxuan Feng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hongguang Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hongguang Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hongguang++Zhang">Hongguang Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Songda Yu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Songda Yu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Songda++Yu">Songda Yu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qinyuan Zhao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qinyuan Zhao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, Beijing 100049, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qinyuan++Zhao">Qinyuan Zhao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wei Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wei Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Wang">Wei Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fengxia Bao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fengxia Bao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fengxia++Bao">Fengxia Bao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xun Ding</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xun Ding</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, Beijing 100049, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xun++Ding">Xun Ding</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jiajing Hu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jiajing Hu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jiajing++Hu">Jiajing Hu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Manjiong Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Manjiong Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</div><div class="loa-info-affiliations-info">Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Manjiong++Wang">Manjiong Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yixiang Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yixiang Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</div><div class="loa-info-affiliations-info">Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yixiang++Xu">Yixiang Xu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zengrui Wu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zengrui Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zengrui++Wu">Zengrui Wu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiaokang Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaokang Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</div><div class="loa-info-affiliations-info">Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaokang++Li">Xiaokang Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yun Tang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yun Tang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yun++Tang">Yun Tang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2340-1109" title="Orcid link">http://orcid.org/0000-0003-2340-1109</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fei Mao</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fei Mao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</div><div class="loa-info-affiliations-info">Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#6409050b02010d2401071117104a0100114a070a"><span class="__cf_email__" data-cfemail="82efe3ede4e7ebc2e7e1f7f1f6ace7e6f7ace1ec">[email protected]</span></a>. Phone: +86-21-64252584 (F.M.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fei++Mao">Fei Mao</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5871-6878" title="Orcid link">http://orcid.org/0000-0001-5871-6878</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiaoyan Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaoyan Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoyan++Chen">Xiaoyan Chen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6559-8627" title="Orcid link">http://orcid.org/0000-0002-6559-8627</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Haiyan Zhang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Haiyan Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, Beijing 100049, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#3951435158575e794a50545417585a175a57"><span class="__cf_email__" data-cfemail="e0889a88818e87a093898d8dce8183ce838e">[email protected]</span></a>. Phone: +86-21-50806710 (H.Z.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Haiyan++Zhang">Haiyan Zhang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2877-2040" title="Orcid link">http://orcid.org/0000-0002-2877-2040</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jian Li</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jian Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</div><div class="loa-info-affiliations-info">Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#157f7c747b797c5570766066613b7071603b767b"><span class="__cf_email__" data-cfemail="2a40434b4446436a4f495f595e044f4e5f044944">[email protected]</span></a>. Phone: +86-21-64252584. Fax: +86-21-64252584 (J.L.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Li">Jian Li</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7521-8798" title="Orcid link">http://orcid.org/0000-0002-7521-8798</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01338&amp;href=/doi/10.1021%2Facs.jmedchem.9b01338" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1051–1067</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 7, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 August 2019</li><li><span class="item_label"><b>Published</b> online</span>7 January 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 February 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01338" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01338</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1051%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLinghao%2BHu%252C%2BHongxuan%2BFeng%252C%2BHongguang%2BZhang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D3%26contentID%3Dacs.jmedchem.9b01338%26title%3DDevelopment%2Bof%2BNovel%2BN-hydroxypyridone%2BDerivatives%2Bas%2BPotential%2BAnti-Ischemic%2BStroke%2BAgents%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1067%26publicationDate%3DFebruary%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01338"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1513</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01338" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of Novel N-hydroxypyridone Derivatives as Potential Anti-Ischemic Stroke Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Linghao&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Hongxuan&quot;,&quot;last_name&quot;:&quot;Feng&quot;},{&quot;first_name&quot;:&quot;Hongguang&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Songda&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Qinyuan&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Fengxia&quot;,&quot;last_name&quot;:&quot;Bao&quot;},{&quot;first_name&quot;:&quot;Xun&quot;,&quot;last_name&quot;:&quot;Ding&quot;},{&quot;first_name&quot;:&quot;Jiajing&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Manjiong&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Yixiang&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Zengrui&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Xiaokang&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yun&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Fei&quot;,&quot;last_name&quot;:&quot;Mao&quot;},{&quot;first_name&quot;:&quot;Xiaoyan&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Haiyan&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Li&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;1051-1067&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01338&quot;},&quot;abstract&quot;:&quot;Our previous study had identified ciclopirox (CPX) as a promising lead compound for treatment of ischemic stroke. To find better neuroprotective agents, a series of N-hydroxypyridone derivatives based on CPX were designed, synthesized, and evaluated in this study. Among these derivatives, compound 11 exhibits significant neuroprotection against oxygen glucose deprivation and oxidative stress-induced injuries in neuronal cells. Moreover, compound 11 possesses good blood–brain barrier permeability and superior antioxidant capability. In addition, a complex of compound 11 with olamine—11·Ola possesses good water solubility, negligible hERG inhibition, and superior metabolic stability. The in vivo experiment demonstrates that 11·Ola significantly reduces brain infarction and alleviates neurological deficits in middle cerebral artery occlusion rats. Hence, compound 11·Ola is identified in our research as a prospective prototype in the innovation of stroke treatment.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01338&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01338" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01338&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01338" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01338&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01338" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01338&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01338&amp;href=/doi/10.1021/acs.jmedchem.9b01338" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01338" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01338" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01338%26sid%3Dliteratum%253Aachs%26pmid%3D31910018%26genre%3Darticle%26aulast%3DHu%26date%3D2020%26atitle%3DDevelopment%2Bof%2BNovel%2BN-hydroxypyridone%2BDerivatives%2Bas%2BPotential%2BAnti-Ischemic%2BStroke%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D3%26spage%3D1051%26epage%3D1067%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/jmcmar.2020.63.issue-3/20200213/jmcmar.2020.63.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Our previous study had identified ciclopirox (CPX) as a promising lead compound for treatment of ischemic stroke. To find better neuroprotective agents, a series of <i>N</i>-hydroxypyridone derivatives based on CPX were designed, synthesized, and evaluated in this study. Among these derivatives, compound <b>11</b> exhibits significant neuroprotection against oxygen glucose deprivation and oxidative stress-induced injuries in neuronal cells. Moreover, compound <b>11</b> possesses good blood–brain barrier permeability and superior antioxidant capability. In addition, a complex of compound <b>11</b> with olamine—<b>11·Ola</b> possesses good water solubility, negligible hERG inhibition, and superior metabolic stability. The in vivo experiment demonstrates that <b>11·Ola</b> significantly reduces brain infarction and alleviates neurological deficits in middle cerebral artery occlusion rats. Hence, compound <b>11·Ola</b> is identified in our research as a prospective prototype in the innovation of stroke treatment.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30461" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30461" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Ischemic stroke, the most common form of stroke, accounted for 2.57–2.82 million deaths per year, and it is a major cause of severe disability among adults worldwide.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> Currently, US Food and Drug Administration (FDA) approved only the recombinant tissue plasminogen activator (rtPA) for thrombolysis in the treatment of ischemic stroke. However, rtPA must be administered within 4.5 h after stroke, and because of its short therapeutic time window, only a limited number of ischemic stroke patients can receive thrombolysis.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> Furthermore, the subsequent ischemia–reperfusion (I/R) injury, which happens when returning blood flow to the ischemic brain tissue after thrombolysis, can mitigate the benefits of thrombolysis. The clinical use of neuroprotective agents, such as edaravone and NBP (racemic 3-<i>n</i>-butylphthalide, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), exerted beneficial effects on outcome in stroke patients.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> Moreover, neuroprotective agents can be administrated in a relatively wide therapeutic time window. This suggests that the neuroprotection strategy, namely, protecting the penumbra from I/R injury after thrombolysis, is an effective therapy for stroke.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Hence, in order to protect ischemic neurons and minimize I/R injury, it is urgent to develop novel neuroprotective agents with a wide therapeutic time window to provide better prognosis for ischemic stroke patients. The mechanisms and targets of reported neuroprotective agents include free radical scavenging, alleviating oxidative stress, ionotropic glutamate receptors, and anti-inflammation and antiplatelet aggregation.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13 ref14">(9−14)</a> Among these neuroprotective agents, the well-known NXY-059, a spin-trapping free radical scavenging agent which was first reported in 1990s significantly improved the overall distribution of scores on the modified Rankin scale (indicating its potential on reducing disability) in SAINT-I (a clinical trial involving 1722 patients).<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> Although NXY-059 had not been approved at last,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> this work which demonstrated the ability of free radical scavenging agents to reduce oxidative stress-induced damage in I/R injury is still enlightening.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of NBP and edaravone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In order to find the hit compound for ischemic stroke, an FDA-approved drug library (778 drugs) was screened through the oxygen glucose deprivation (OGD)-stimulated ischemic cellular model in our previous study. Among them, the antifungal drug ciclopirox (CPX) showed significant neuroprotective effects against the ischemic injury. CPX, which was first reported as an antifungal agent in 1970,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> is used for the treatment of tinea pedis and tinea corporis caused by trichophyton rubrum. Later on, it was reported that CPX could promote the survival of neuronally differentiated PC12 cells in serum-free medium in 1998.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In our previous studies, in vivo and in vitro results had confirmed the effectiveness of CPX for ischemic brain injury. CPX treatment not only reduced the brain infarction and neurological deficits in middle cerebral artery occlusion (MCAO) rats significantly but also ameliorated the blood–brain barrier (BBB).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Moreover, the previous study proved that the neuroprotective effects of CPX were associated with the enhancement of AKT and GSK3β phosphorylation.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">In this study, CPX was selected as a lead compound for antistroke drug discovery. As the course of NBP and edaravone treatment is typically 14–20 days, a long-lasting anti-ischemic effect is vital to ischemic stroke treatment. Thus, besides neuroprotective activity, metabolic stability which contributes to long-lasting efficacy is also important for antistroke agents. CPX consists of the <i>N</i>-hydroxyl pyridone ring, methyl at position 4, and cyclohexyl at position 6 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Therefore, in order to elucidate the structure and activity relationship and improve neuroprotective activity and metabolic stability, <i>N</i>-hydroxyl pyridone derivatives were designed and synthesized by replacing the hydrogens or substituents at position 1, 3, 4, 5, and 6 with different substituents, and their neuroprotective activities were evaluated through in vitro and in vivo experiments.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of CPX and pyridone derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Among them, compound <b>11</b> showed better neuroprotective activity, good BBB permeability, and superior antioxidant capacity. Moreover, <b>11·Ola</b> (complex of <b>11</b> and olamine) showed better metabolic stability, good water solubility, safety, and better efficacy in vivo, indicating that it possesses development potential as a prospective anti-ischemic stroke agent.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66446" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66446" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design and Synthesis</h3><div class="NLM_p">To identify the pharmacophore of CPX, first, compounds <b>1–4</b> were designed and synthesized. The hydroxyl at position 1 was replaced by ethoxyl, 2-methoxy-2-oxoethoxy, and carboxymethoxy to produce compounds <b>1–3</b> (ineffective, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Compound <b>4</b> was given by replacing the pyridone of CPX with isoquinoline. After <i>N</i>-hydroxypyridone was confirmed as the pharmacophore, the methyl at position 4 was replaced by hydrogen and ethyl to produce compound <b>5</b> and compound <b>6</b>. Because of the inferior activity of compounds <b>5</b> and <b>6</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), methyl was fixed as the substituent at position 4 for compounds <b>7–31</b>. Next, to explore the ideal substituent at position 6, compounds <b>7–19</b> were produced by replacing the cyclohexyl with alkyls, cycloalkyls, norbornane, phenyl, and benzyl. Then, in order to elucidate the effects of substituents at position 3 and 5, halogen-substituted derivatives (compounds <b>20–23</b>) and formyl- or aminomethyl-substituted derivatives (compounds <b>24–31</b>) were designed and synthesized.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effect of Compounds <b>1–6</b> on SH-SY5Y Cells Exposed to OGD<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0010.gif" alt="" id="GRAPHIC-d7e574-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0011.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Cell viability was measured by MTT assay at 24 h after OGD exposure. The compounds <b>1–6</b> at concentrations of 1 or 10 μM were added to the cells immediately before OGD stimulus. The data are presented as the percentage of surviving cells relative to control cells (100%) as the mean ± SD, <i>n</i> = 3. ###<i>p</i> < 0.001 versus control, *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 versus OGD group, one-way ANOVA, Dunnett’s multiple comparison test.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">The data of compound <b>1</b> are gathered from another assay (<i>n</i> = 3) in which the cell viability of the OGD group was 49.91% of control.</p></div></div><div></div></div><div class="NLM_p">The synthetic route for the preparation of compounds <b>1–19</b> is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Reaction of CPX with iodoethane and methyl 2-bromoacetate produced compound <b>1</b> and <b>2</b>, respectively (reactions a, b, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>(I)). Compound <b>3</b> was obtained by hydrolyzing the methyl of compound <b>2</b> using lithium hydroxide (reaction c, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>(I)). Reaction of commercially available 2-iodobenzoic acid and methanol in the presence of sulfurous dichloride generated methyl 2-iodobenzoate (<b>4a</b>). Then, intermediate <b>4a</b> was used in the subsequent Sonogashira cross coupling with ethynylcyclohexane to generate <b>4b</b>, which was then refluxed in methanol with hydroxylamine hydrochloride and hydroxyl potassium to afford compound <b>4</b> [<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>(II)]. Intermediate <b>5a</b> was obtained through Kumada cross-coupling of 2-bromo-6-methoxypyridine and cyclohexylmagnesium bromide, which was oxidized by <i>m</i>CPBA to generate intermediate <b>5b</b>. Intermediate <b>5b</b> was refluxed in acetyl chloride and then in methanol to afford compound <b>5</b> [<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>(III)]. Using ethyl (<i>Z</i>)-3-methylpent-2-enoate (<b>A6</b>) and cyclohexyl chloride as the starting material, compound <b>6</b> was generated through reactions j, k, m, and n; this synthesis method is similar to that of compounds <b>7–19</b> which is described as follows: reaction of methyl 3-methylbut-2-enoate (<b>A0</b>, commercially available) with corresponding acyl chloride in the presence of aluminum trichloride provided different substituted acyl α,β-unsaturated esters, which were then heated with a mixture of sulfuric acid and acetic acid to give intermediates <b>B7–B18</b> [<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>(IV), reactions j, k]. The synthesis of <b>B19</b> is an exception. The starting materials of <b>19</b> are bromoacetyl chloride and methyl 3-methylbut-2-enoate, and the corresponding product 6-(bromomethyl)-4-methyl-2<i>H</i>-pyran-2-one was then used in the Suzuki cross-coupling with phenylboronic acid in the presence of Pd(dppf)Cl<sub>2</sub> to generate intermediate <b>B19</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>(IV), reaction l). Intermediates <b>B7–B17</b> and <b>B19</b> spontaneously formed <b>C7–C17</b> and <b>C19</b> when heated with tetraphosphorus decasulfide in toluene (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>(IV), reaction m). Compounds <b>C7–C17</b> and <b>C19</b> and hydroxylamine hydrochloride were refluxed in pyridine to afford target compounds <b>7–17</b> and <b>19</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>(IV), reaction n). Intermediate <b>B18</b> directly formed compound <b>18</b> through an adjusted reaction n; see the <a class="ref internalNav" href="#sec4" aria-label="Experiment Section">Experiment Section</a>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1–19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) iodoethane, K<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C; (b) methyl 2-bromoacetate, K<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux; (c) lithium hydroxide, water/THF, 40 °C; (d) SOCl<sub>2</sub>, then methanol and Et<sub>3</sub>N; (e) ethynylcyclohexane, Et<sub>3</sub>N, CuI, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, toluene, 4.5 h, 40 °C under Ar; (f) NH<sub>2</sub>OH, KOH, CH<sub>3</sub>OH, reflux; (g) cyclohexylmagnesium bromide, Pd(dppf)Cl<sub>2</sub>; (h) <i>m</i>CPBA, DCM, reflux; (i) acetyl chloride, reflux, then MeOH; (j) AlCl<sub>3</sub>, DCM, reflux; (k) H<sub>2</sub>SO<sub>4</sub>, acetic acid; (l) only for <b>B19</b>: phenylboronic acid, Pd(dppf)Cl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, reflux; (m) P<sub>4</sub>S<sub>10</sub>, toluene, reflux; (n) NH<sub>2</sub>OH·HCl pyridine, reflux.</p></p></figure><div class="NLM_p">The synthetic route for the preparation of compounds <b>20–31</b> is shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. CPX and <i>N</i>-halogen butanimide were refluxed in carbon tetrachloride in the presence of initiator azobisisobutyronitrile (AIBN) to afford halogen-substituted (at position 3 or 5) pyridone derivatives <b>20–23</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>(II), reaction a). The sodium salt of compound <b>20</b> (prepared by adding sodium hydride into the THF solution of compound <b>20</b>) and <i>tert</i>-butyl lithium were used in the halogen–lithium exchange reaction and then reacted with DMF to afford the aldehyde, namely, compound <b>24</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>(II), reaction b). Compound <b>25–31</b> were synthesized through reductive amination using compound <b>24</b> as the reactant (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>(II), reaction c).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>20–31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NBS/NIS/NCS, AIBN, CCl<sub>4</sub>, reflux; (b) NaH, THF, 0 °C, then <i>tert</i>-BuLi, DMF, THF, −78 °C; (c) Na(CH<sub>3</sub>COO)<sub>3</sub>BH, acetic acid, Cl(CH<sub>2</sub>)<sub>2</sub>Cl, r. t.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Pyridone Analogues Protecting SH-SY5Y Cells against OGD Damage</h3><div class="NLM_p">First, the neuroprotective effect of the compounds <b>1–31</b> was evaluated by the OGD model, which is an in vitro model for ischemic stroke, and it was widely used in the study of anti-stroke agents.<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21−23)</a> The results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<named-content content-type="anchor" rid="tbl2" type="simple"></named-content><a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Neuroprotective Effect of compounds <b>4</b>, <b>6</b>, <b>10</b>, <b>11</b>, <b>21</b>, <b>22</b>, and <b>29</b> at concentrations in the range from 0.25 μM to 4 μM on SH-SY5Y cells exposed to OGD injury. The data are presented as the percentage of surviving cells relative to control cells (100%) and as the mean ± SD, <i>n</i> = 3, ###<i>p</i> < 0.001 versus control, *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 versus OGD group, one-way ANOVA, Dunnett’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effect of Compounds 7–19 on SH-SY5Y Cells Subjected to OGD<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0012.gif" alt="" id="GRAPHIC-d7e1016-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0013.gif" alt="" id="gr11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The data are presented as the percentage of surviving cells relative to control cells and as the mean ± SD, <i>n</i> = 3. ###<i>p</i> < 0.001 versus control, *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 versus OGD group, one-way ANOVA, Dunnett’s multiple comparison test.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effect of Compounds <b>20–31</b> on SH-SY5Y Cells Exposed to OGD<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0014.gif" alt="" id="GRAPHIC-d7e1049-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0015.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The data are presented as the percentage of surviving cells relative to control cells and as the mean ± SD, <i>n</i> = 3. ###<i>p</i> < 0.001 versus control, *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 versus OGD group, one-way ANOVA, Dunnett’s multiple comparison test.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">The data of compound <b>31</b> are gathered from another assay of which the cell viability of the OGD group was 54.23 ± 4.48% of control.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">An exception, the concentration was 4 μM.</p></div></div><div></div></div><div class="NLM_p">As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, compounds <b>1–3</b> with the substituents of ethoxyl, 2-methoxy-2-oxoethoxy, and carboxymethoxy at position 1 (R<sup>1</sup>) showed no neuroprotective activity. These results indicate that hydroxyl at position 1 is necessary for the neuroprotective activity of pyridone analogues. Compound <b>4</b> which was obtained by replacing the pyridone ring of CPX with isoquinoline showed good neuroprotective activity (78.49%) at 1 μM but no activity at 10 μM. Considering the activity of compounds <b>1–4</b>, <i>N</i>-hydroxypyridone was fixed as the core of compounds <b>5–31</b>. Compound <b>5</b> with hydrogen at position 4 showed good neuroprotective activity (76.61%) at 10 μM but no activity at 1 μM. Compound <b>6</b> with the ethyl substituent at position 4 showed moderate neuroprotective activity at both 1 and 10 μM. The activities of compounds <b>5</b> and <b>6</b> are inferior to CPX. Therefore, methyl was fixed as the substituent at position 4 for compounds <b>7–31</b>.</div><div class="NLM_p">The cell viability of groups treated with compounds <b>7–11</b> demonstrated that the neuroprotective activity at 1 μM of compounds with large cycloalkyl substituents (<b>11</b>: <i>endo</i>-norbornane, <b>10</b>: cycloheptyl) at position 6 was better than that of compounds with smaller substituents (<b>7</b>: cyclopropyl, <b>8</b>: cyclobutyl). Compound <b>9</b> with the cyclopentyl substituent at position 6 showed good neuroprotective activity (70.66% at 10 μM) but no activity at 1 μM. Compound <b>10</b> with the cycloheptyl substituent at position 6 showed good neuroprotective activity (71.01% at 1 μM). It is worth noting that compound <b>11</b> (<i>endo</i>-norbornane at position 6) showed good neuroprotective activity at both 1 μM (70.62%) and 10 μM (64.46%). Compounds <b>12</b>, <b>13</b>, and <b>15–17</b> showed no neuroprotective activity (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>); revealing unbranched alkyl substitution at position 6 was adverse to neuroprotective activity, whereas compound <b>14</b> with branched alkyl substitution isobutyl (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) showed slightly better activity at 4 μM (73.30%) compared with CPX but no neuroprotective activity at 1 μM. So, alkyl substitution at position 6 is not favored compared to cycloalkyl or bicycloalkyl substitution. Compound <b>18</b> bearing a phenyl substituent at position 6 showed no neuroprotective activity. Compound <b>19</b> bearing a benzyl substituent at position 6 showed comparable activity to that of CPX at 10 μM but no neuroprotective activity at 1 μM. Generally speaking, large cycloalkyl or bicycloalkyl substitution at position 6 is better than small cycloalkyl, alkyl, phenyl, and benzyl substitution.</div><div class="NLM_p">As shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, compounds <b>20–31</b> are series of <i>N</i>-hydroxypyridone derivatives with halogen, N-substituted aminomethyl, or formyl substituents at position 3 or 5, and the substituents at position 4 and position 6 of compounds <b>20–31</b> are methyl and cyclohexyl, respectively. The introduction of bromine at position 5 (<b>21</b>) or iodine at position 3 (<b>22</b>) produced a considerable activity improvement at 1 μM. Compounds <b>20</b> (bromine at position 3), <b>23</b> (chlorine at position 3), and <b>24</b> (3-formyl derivative) showed no activity at both 1 and 10 μM. Compounds <b>25–31</b> are a series of compounds bearing N-substituted aminomethyl substitution at position 3 (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Compound <b>26</b> (<i>N</i>-propyl aminomethyl), <b>27</b> (<i>N</i>-isopropyl aminomethyl), and <b>30</b> (<i>N</i>-phenyl aminomethyl) exhibited neuroprotective activity at 10 μM, and <b>29</b> (<i>N</i>-cyclopentyl aminomethyl) showed moderate activity at 1 μM. Compound <b>31</b> showed no activity at 1 μM but good activity at 4 μM (87.18%) (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Compound <b>25</b> (<i>N</i>-methyl aminomethyl) showed moderate activity at 10 μM but no activity at 1 μM. However, compound <b>28</b> (<i>N</i>-propargyl aminomethyl) had no effects in the OGD-exposed SH-SY5Y cell. In general, the neuroprotective activity of compounds with aminomethyl substitution at position 3 did not improve compared to CPX.</div><div class="NLM_p">Among these 31 compounds, some compounds showed lower neuroprotective effects at 10 μM than that at 1 μM. To evaluate whether these compounds have a toxic effect on normal cells at higher concentration, we tested the influence of the compounds (<b>1</b>, <b>2</b>, <b>3</b>, <b>4</b>, <b>5</b>, <b>6</b>, <b>10</b>, <b>11</b>, <b>12</b>, <b>15</b>, <b>16</b>, <b>17</b>, <b>18</b>, <b>20</b>, <b>21</b>, <b>22</b>, <b>23</b>, <b>28</b>, <b>29</b>, and CPX) on the cell viability of SH-SY5Y cells without OGD insult. The results indicated that CPX, <b>10</b>, <b>11</b>, and <b>29</b> reduce the viability at a concentration of 10 μM (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01338/suppl_file/jm9b01338_si_001.pdf" class="ext-link">Table S7</a>), which might be related with their lower neuroprotective activity at a concentration of 10 μM.</div><div class="NLM_p last">In the first round of the OGD experiment, the concentrations of the tested compounds are 1 and 10 μM. Among them, seven of the tested compounds (<b>4</b>, <b>6</b>, <b>10</b>, <b>11</b>, <b>21</b>, <b>22</b>, and <b>29</b>) exerted a neuroprotective effect at 1 μM, and they were selected for further studies. Although the cell viability of SH-SY5Y cells treated with 1 μM of compound <b>16</b> was beyond 70%, there was no statistical significance. An additional experiment confirmed that it is ineffective at 1 μM (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01338/suppl_file/jm9b01338_si_001.pdf" class="ext-link">Figure S6</a>). Some of the derivatives showed an inferior neuroprotective effect at 10 μM compared to the effect at 1 μM; thus, in order to further evaluate the activity of these seven compounds, it was necessary to set more doses. Thus, we carried out another OGD experiment in which the doses of the compounds ranged from 0.25 to 4 μM (0.25, 0.5, 1, 2, 4 μM, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). There were three compounds that showed excellent neuroprotective activity (cell viability >80%): <b>10</b> (at 2 μM), <b>11</b> (at 1, 2, and 4 μM), and <b>22</b> (at 2 μM). Among them, compound <b>11</b> provided an excellent neuroprotective effect at 1, 2, and 4 μM (cell viability of these three doses are all above 80%, <i>p</i> < 0.001).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Structure and Activity Relationships</h3><div class="NLM_p last">Analysis of the data revealed the structure and activity relationship of these derivatives: (<b>I</b>) the <i>N</i>-hydroxyl is necessary for the neuroprotective activity. Replacing the <i>N</i>-hydroxyl with ethoxyl, 2-methoxy-2-oxoethoxy, and carboxymethoxy (compounds <b>1–3</b>) leads to the loss of activity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). (<b>II</b>) Methyl is the optimal substituent at positon 4. Replacing methyl with hydrogen and ethyl reduced the neuroprotective activity of compounds <b>5–6</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). (<b>III</b>) Large cycloalkyl and bicycloalkyl substituents at position 6 are better than small cycloalkyl, alkyl, phenyl, and benzyl substituents (compounds <b>10–11</b> vs <b>7–9</b>, <b>12–19</b>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). (<b>IV</b>) Halogen substituents at position 3 or 5 have no obvious influence to the neuroprotective activity (compounds <b>20–23</b>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). (<b>V</b>) The N-substituted aminomethyl at position 3 could not improve the neuroprotective activity.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Antioxidant Ability of Pyridone Analogues</h3><div class="NLM_p">In the pathological process of I/R, there are excessive free radicals including reactive oxygen species (ROS) generated within the penumbra, causing oxidative damage.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Therefore, the antioxidant property of compound is considered as an important indicator for its neuroprotective activity.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> The antioxidant activities of compounds with good neuroprotective activities in the OGD model (exhibited significant improvement in cell viability compared with OGD group at 1 μM) were evaluated by oxygen radical absorbance capacity (ORAC) assay.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In this experiment, the fluorescent probe fluorescein can react with the peroxide radical induced by AAPH, which is widely used as the free radical reaction initiator, to generate a nonfluorescent substance, and the quenching of fluorescence can be slowed by antioxidants. This process closely mimics the production and scavenging of in vivo peroxide radicals. Compared with other assays such as DPPH assay, the ORAC method combines both inhibition time and degree of inhibition into a single quantity through measuring the kinetics of the decrease in fluorescence for each sample compared to a blank and building antioxidant curves (fluorescence vs time, normalized to the curve of the blank).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In general, ORAC values were expressed as trolox equivalents which were calculated by plugging the area under the curve (AUC) into the regression equations between the net AUC and Trolox concentrations; the higher values indicated better antioxidant activity. The results in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> manifested that compound <b>11</b>, which exhibited the best neuroprotective effect in the OGD model, also demonstrated superior antioxidant activity (1.13 ± 0.19) compared to CPX (0.52 ± 0.32).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. ORAC (Trolox Equivalents) and Permeability Results (<i>P</i><sub>e</sub> × 10<sup>–6</sup> cm s<sup>–1</sup>) from the PAMPA-BBB Assay for Compounds <b>4</b>, <b>6</b>, <b>10</b>, <b>11</b>, <b>21</b>, <b>22</b>, and <b>29</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd.</th><th class="colsep0 rowsep0" align="center">ORAC<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±"><i>P</i><sub>e</sub> (10<sup>–6</sup> cm s<sup>–1</sup>)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">prediction</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CPX</td><td class="colsep0 rowsep0" align="left">0.52 ± 0.32</td><td class="colsep0 rowsep0" align="char" char="±">8.17 ± 1.43</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char="±">4.43 ± 0.72</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char="±">4.53 ± 0.34</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char="±">4.42 ± 0.57</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">1.13 ± 0.19</td><td class="colsep0 rowsep0" align="char" char="±">7.50 ± 0.33</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char="±">3.97 ± 0.25</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">0.20 ± 0.17</td><td class="colsep0 rowsep0" align="char" char="±">7.65 ± 0.52</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char="±">3.89 ± 2.01</td><td class="colsep0 rowsep0" align="left">CNS+</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Values are expressed as the mean ± SD of three independent experiments; NA means no activity. Data are expressed as μmol of Trolox equivalent/μmol of tested compounds.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Values are expressed as the mean ± SD of three independent experiments.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> BBB Permeability of Pyridone Analogues</h3><div class="NLM_p last">Good BBB penetration ability is required for central nervous system drugs. To evaluate the BBB penetration ability of pyridone analogues, the permeability (<i>P</i><sub>e</sub>) values of compounds with good neuroprotective activities in the OGD model (<b>4</b>, <b>6</b>, <b>10</b>, <b>11</b>, <b>21</b>, <b>22</b>, and <b>29</b>) were determined through the parallel artificial membrane permeation assay (PAMPA, using the lipid extract of the porcine brain-covered membrane). Thirteen marketed drugs were tested to build the standard that compounds with <i>P</i><sub>e</sub> values greater than 3.08 × 10<sup>–6</sup> cm/s could cross the BBB by passive permeation (marked CNS+). Among them, compounds <b>11</b> (7.50 × 10<sup>–6</sup> cm/s), <b>22</b> (7.65 × 10<sup>–6</sup> cm/s), and CPX (8.17 × 10<sup>–6</sup> cm/s) show good BBB permeation. In short, compound <b>11</b> demonstrated the best neuroprotective activity in the OGD model, and it also has good BBB permeability ability (7.50 × 10<sup>–6</sup> cm/s) and better antioxidant capability (1.13 ± 0.19) compared to the lead compound CPX (0.52 ± 0.32). Thus, compound <b>11</b> was selected for further studies.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Water Solubility of Compounds <b>11</b> and <b>11·Ola</b></h3><div class="NLM_p">Because marketed anti-stroke drugs include butylphthalide and edaravone administered through injection, the water solubility is important for anti-stroke agents. Therefore, the solubility of <b>11</b> and its complex with olamine in normal saline (0.9% for intravenous injection) were calculated by comparing the HPLC peak area to the calibration curves which were plotted as peak areas versus concentrations. However, compound <b>11</b> shows poor water solubility (1.22 mg/mL). Ciclopirox olamine is the complex which consists of ciclopirox and 2-aminoethan-1-ol (olamine is USAN-approved contraction for ethanolamine); it is water-soluble and widely used in external medicament. Olamine is not only used in external medicament but also used in oral medicaments such as eltrombopag olamine, and it is considered a low toxic compound. Thus, the complex of compound <b>11</b> and olamine (named <b>11·Ola</b> for short) was synthesized and it processed good water solubility (10.90 mg/mL), as shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>. Compound <b>11·Ola</b> was an ideal form for intravenous administration in the in vivo experiment.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Water Solubility of Compounds <b>11</b> and <b>11·Ola</b> (<i>n</i> = 3, Mean ± SD)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0016.gif" alt="" id="GRAPHIC-d7e1762-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd.</th><th class="colsep0 rowsep0" align="center" char="±">water solubility (mg/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char="±">1.22 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11·Ola</b></td><td class="colsep0 rowsep0" align="char" char="±">10.90 ± 1.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CPX</td><td class="colsep0 rowsep0" align="char" char="±">1.43 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CPX olamine</td><td class="colsep0 rowsep0" align="char" char="±">6.82 ± 0.45</td></tr></tbody></table></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Anti-Apoptotic Effect of Compound <b>11·Ola</b> on OGD-Exposed SH-SY5Y Cells</h3><div class="NLM_p">Considering that inflammation and oxidative damage caused by the I/R injury can lead to neuronal apoptosis which results in neuron death in the penumbra, reduction of the apoptotic rate is another important indicator of neuroprotective capability.<a onclick="showRef(event, 'ref21 ref26'); return false;" href="javascript:void(0);" class="ref ref21 ref26">(21,26)</a> Thus, Annexin-V-FITC and propidium iodide (PI) staining was performed to examine whether the neuroprotective effects of compound <b>11·Ola</b> on SH-SY5Y cells correlated with reduced apoptosis. The distribution of SH-SY5Y cells to the lower left quadrant indicated that these cells were viable and without measurable apoptosis. OGD insults induced obvious increases in cell numbers in the lower and upper right quadrants, which indicated that these SH-SY5Y cells underwent early and late apoptosis (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). The percentage of SH-SY5Y cells at early and late stages of apoptosis increased from 15.88 to 40.98% in the OGD group compared to the control group (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). Treatment with compound <b>11·Ola</b> at 4 μM significantly reduced the apoptotic ratio to 25.91% (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). Moreover, the OGD treatment induced obvious morphological changes of SH-SY5Y cells, including neurite disappearance, bright and shrinking cell body, and reduced cell number. <b>11·Ola</b> treatment remarkably attenuated the cell morphological changes (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). The results mentioned above indicated that treatment with <b>11·Ola</b> not only reduces the cell apoptosis but also protects the cell morphology against OGD injury.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>11·Ola</b> decreases OGD-induced apoptosis in SH-SY5Y cells. (A) Representative plot of Annexin V-FITC/PI staining; (B) statistical results of the apoptotic rate (<i>n</i> = 4, error bars represent standard error of the mean (SEM), ###<i>p</i> < 0.001 vs control, ***<i>p</i> < 0.001 vs OGD group, <i>t</i>-test); (C) photomicrographs of cell morphology (scale bar = 100 μm).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Neuroprotective Effect of Compound <b>11·Ola</b> on Glutamate-Exposed HT22 Cells and H<sub>2</sub>O<sub>2</sub>-Exposed SH-SY5Y Cells</h3><div class="NLM_p">In the process of I/R injury, the release of glutamate activates ionotropic glutamate receptors and causes excitotoxicity which can result in neuronal death. In addition, the consequent ROS are also accountable for neuronal death in the ischemic penumbra. Therefore, in vitro models using glutamate and H<sub>2</sub>O<sub>2</sub> stimulus are widely used for the mimic ischemic stroke injury.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30">(27−30)</a> In the present study, we further evaluated the neuroprotection of optimal compound <b>11·Ola</b> on glutamate and H<sub>2</sub>O<sub>2</sub>-stimulated cellular models. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A, excessive glutamate exposure significantly reduced the cell viability of HT22 cells to 28.53% of the control, but incubation with <b>11·Ola</b> at concentrations of 0.5, 1, 2, and 4 μM significantly protected the cells against the glutamate insult, and the protective effect is similar to that of ciclopirox olamine. Moreover, as shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B, 100 μM H<sub>2</sub>O<sub>2</sub> reduced cell viability to 45.73% of the control. Compound <b>11·Ola</b> at 1, 2, and 4 μM promoted cell viability up to 80%, which is also similar to that of ciclopirox olamine. These results suggested that compound <b>11·Ola</b> could attenuate oxidative damage in SH-SY5Y cells and glutamate-induced toxicity in HT22 cells.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Neuroprotective Effect of compound <b>11·Ola</b> on HT22 cells subjected to glutamate stimulus (A) and SH-SY5Y cells exposed to H<sub>2</sub>O<sub>2</sub> injury (B). The data are presented as the percentage of surviving cells relative to control cells (100%) and as the mean ± SD, <i>n</i> = 3 for (A), <i>n</i> = 4 for (B). ###<i>p</i> < 0.001 vs control, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 vs glutamate group or H<sub>2</sub>O<sub>2</sub> group, one-way ANOVA, Dunnett’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Iron Chelation and bSDTNBI Prediction Results</h3><div class="NLM_p">The hypoxia-inducible factor (HIF)-1α plays an important role in the regulation of gene expression in response to hypoxia and ischemia. It induces transcription of genes involved in energy metabolism, angiogenesis, and erythropoiesis which promotes the neuronal survival under ischemic conditions.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> HIF-1α is regulated by HIF-prolyl hydroxylases (PHDs); in other words, hydroxylation of the proline residue leads to the degradation of HIF-1α. Iron ion which is utilized as a cofactor in the hydroxylation process is necessary for the activity of PHDs. Moreover, it was reported that stabilizing HIF-1α through the inhibition of PHDs significantly reduced the infarct volumes and improved behavior after MCAO.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> A previous study had confirmed that ciclopirox could induce HIF-1α stability through iron chelating.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> In this study, in silico bSDTNBI (balanced substructure–drug–target network-based inference) prediction also suggested the strong correlation between HIF1A gene (encoded HIF-1α) and the neuroprotective activity of CPX and compound <b>11</b> (CPX: HIF1A ranked 4th, <b>11</b>: HIF1A ranked 5th, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The bSDTNBI is a network-based method which can identify new drug–target interactions for further understanding the mechanism of action. Derived from recommendation algorithms for networks, it uses resource diffusion processes to predict potential targets for both known drugs and new chemical entities and does not rely on either three-dimensional structures of target proteins or negative samples. Furthermore, it can predict potential ligands for targets for the development of potential targeted therapies (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01338/suppl_file/jm9b01338_si_001.pdf" class="ext-link">Figure S2</a> Schematic diagram of bSDTNBI). Here, iron-chelating experiments was performed to clarify the relationship between the iron chelation and neuroprotective activity of <b>11</b>, CPX and <b>1</b>, and the ion-chelating ability was determined by UV–visual spectroscopy. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, both CPX olamine and <b>11·Ola</b> exerted good neuroprotective activity, and compound <b>1</b> showed no activity. As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B,C, the absorption between 350 and 500 nm increased after the addition of ammonium iron(III) citrate and FeSO<sub>4</sub> to both <b>11</b> solutions and the CPX solutions. The change of the absorption curves of <b>11</b> and CPX demonstrated the production of the iron chelating complex. In addition, the color charge of these solutions also corresponded with the curve change (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01338/suppl_file/jm9b01338_si_001.pdf" class="ext-link">Figure S3</a> photographs). The addition of the other three iron salts [ammonium iron(III) sulfate, ammonium iron(II) sulfate, FeCl<sub>3</sub>] led to similar changes in the absorption curve of the solutions, which indicated that these changes result from the iron ion, not the anion (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01338/suppl_file/jm9b01338_si_001.pdf" class="ext-link">Figure S4</a>). On the contrary, the curve of compound <b>1</b> was almost unchanged when FeSO<sub>4</sub> and ammonium iron(III) citrate were added into the solutions (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D); this indicated that compound <b>1</b> (no neuroprotection) did not chelate the iron ion. These findings suggested that the neuroprotective activity of <b>11</b> and CPX might correlate with iron chelation and stabilization of HIF1-α.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. bSDTNBI prediction (A), absorption spectra of CPX, <b>11</b>, and <b>1</b> (60 μM) alone and in the presence of FeSO<sub>4</sub>, ammonium iron(III) citrate (120 μM) (B–D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Compound <b>11·Ola</b> Attenuated Brain Injury of MCAO Rats</h3><div class="NLM_p">In view of compound <b>11·Ola</b> possesses superior neuroprotective ability, good antioxidant ability, BBB permeability, and water solubility in vitro; its in vivo neuroprotective effect was further evaluated through a widely-used MCAO model for the ischemic stroke study.<a onclick="showRef(event, 'ref28 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref28 ref35 ref36">(28,35,36)</a> In our previous studies, the dose for CPX olamine in rats which afforded the best efficacy was 3 mg/kg (iv); hence, this dose was used in our experiment for comparison.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Because the minimum effective dose of compound <b>11</b> is much lower than CPX (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), two experimental groups treated with 0.3 mg/kg (iv) and 1 mg/kg (iv) of compound <b>11·Ola</b> were set, respectively. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A,B, an obvious infarction (39%) was induced by MCAO insult, which displayed as the white region of brain sections. Treatment with 1 mg/kg of compound <b>11·Ola</b> significantly reduced the infarct volume to 23% (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A,B, <i>p</i> < 0.01 vs MCAO group) and decreased the neurological severity scores to 5 (<i>p</i> < 0.01 vs MCAO group, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C), and 0.3 mg/kg dose of compound <b>11·Ola</b> reduced the infarct volume to 25% (<i>p</i> < 0.05 vs MCAO group, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). As a comparison, treatment with 3 mg/kg of CPX olamine reduced the infarcted volume by 26% (<i>p</i> < 0.01 vs MCAO group) and decreased the neurological severity scores to 6 (<i>p</i> < 0.05 vs MCAO group). Abovementioned experiments indicated that compound <b>11·Ola</b> can significantly protect the brain and attenuated neurological deficits after I/R injury in vivo and its initial dose of efficacy is lower than that of CPX olamine. The protective effects of <b>11·Ola</b> at a dose of 1 mg/kg were comparable to that of CPX olamine at 3 mg/kg, and taken together the similar cytotoxicity of <b>11·Ola</b> and CPX olamine (see below <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>), suggesting that <b>11·Ola</b> possesses superior safety window compared to CPX olamine.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of Compound <b>11·Ola</b> on infarct area and neurological function after 2 h of MCAO and 24 h of reperfusion. (A) Representative picture of TTC staining, (B) quantification of infarct volumes, (C) neurological severity scores. (<i>n</i> = 15–18, data are presented as mean ± SEM, ###<i>p</i> < 0.001 vs sham group, *<i>p</i> < 0.05, **<i>p</i> < 0.01, vs vehicle-treated MCAO group, one-way ANOVA, Dunnett’s multiple comparison test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. hERG Potassium Channel Inhibition, Cytotoxicity, and Metabolic Stability of Compound <b>11·Ola</b> and CPX Olamine</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd.</th><th class="colsep0 rowsep0" align="center">hERG IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">SH-SY5Y, 24 h</th><th class="colsep0 rowsep0" align="center" char="±">MRC-5, 72 h</th><th class="colsep0 rowsep0" align="center" char=".">dose in rat (reduce infarct volume to <26%) mg/kg</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> in mouse microsomes (min)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11·Ola</b></td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="char" char="±">23.60 ± 1.15</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">91.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CPX olamine</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="char" char="±">23.47 ± 4.19</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">53.14</td></tr></tbody></table></div></div></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> The hERG Potassium Channels Inhibition, Cytotoxicity, and Metabolic Stability of Compound <b>11·Ola</b> and CPX Olamine</h3><div class="NLM_p">Safety is important for drug candidates, so we further evaluated the optimal compound <b>11·Ola</b> through hERG potassium channel inhibition assay and cytotoxicity assay. The hERG potassium channels inhibition can lead to the prolongation of Q–T interval; therefore, it is an important indicator of cardiotoxicity. The hERG IC<sub>50</sub> value of compound <b>11·Ola</b> and CPX olamine is assessed through automated patch-clamp assay,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and the results in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a> shows that the hERG inhibition of compound <b>11·Ola</b> and CPX olamine is negligible (IC<sub>50</sub> values of them are above 40 μM, <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). This suggests that these two compounds are unlikely to cause cardiovascular safety risk arising from hERG inhibition.</div><div class="NLM_p">MRC-5 is a human cell line composed of fibroblasts which were derived from the embryonal lung tissue, and it is widely used in the evaluation of the toxicity in medicinal chemistry research.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> The IC<sub>50</sub> values in the SH-SY5Y cell line were assessed as the indicator of neurotoxicity. Therefore, we assessed the cytotoxicity of <b>11·Ola</b> and CPX olamine against MRC-5 and SH-SY5Y as indicators of the safety of these two compounds. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>, the IC<sub>50</sub> of both <b>11·Ola</b> and CPX olamine are all above 100 μM. So, these two compounds are safe for neurons at their therapeutic doses. Considering that neuroprotective agents are administered continuously during the middle and late stages, we prolonged the incubating time to 72 h for MRC-5, and the IC<sub>50</sub> values of <b>11·Ola</b> and CPX olamine in MRC-5 cell line at 72 h are 23.60 ± 1.15 and 23.47 ± 4.19 μM, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). To compare the activity of <b>11·Ola</b> and CPX olamine, we selected the dose which reduced the infarct volume to about 25% (control = 38.68%) in the MCAO experiments as an indicator to present their activity. The dose of <b>11·Ola</b> is 0.3 mg/kg, and that of CPX olamine is 3 mg/kg (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Considering that the cytotoxicity of compound <b>11·Ola</b> and CPX olamine is at the same level, the treatment with lower doses of <b>11·Ola</b> possesses a superior safety window compared to CPX olamine.</div><div class="NLM_p last">The metabolic stability of compound <b>11·Ola</b> and CPX olamine was evaluated through in vitro mouse liver microsome experiments. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>, compound <b>11·Ola</b> (<i>T</i><sub>1/2</sub> = 91.63 min) showed superior metabolic stability compared to CPX olamine (<i>T</i><sub>1/2</sub> = 53.14 min), which is conducive to the improvement of long-term efficacy. We further evaluated the in vivo blood plasma concentrations of <b>11·Ola</b> and CPX olamine after intravenous administration in rats. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01338/suppl_file/jm9b01338_si_001.pdf" class="ext-link">Figure S68</a>, both of them were rapidly cleared in rats’ plasma, but the group treated with <b>11·Ola</b> maintained a higher plasma concentration compared with the group treated with CPX olamine. In general, <b>11·Ola</b> was metabolized more slowly compared with CPX olamine.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14783" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14783" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In order to find potential anti-ischemic stroke agents, we designed and synthesized 31 <i>N</i>-hydroxypyridone derivatives based on the structure of CPX which was identified as a lead compound in our previous study. Then, the neuroprotective effect of these compounds at 1 and 10 μM was evaluated by the OGD model. Among these derivatives, seven compounds (<b>4</b>, <b>6</b>, <b>10</b>, <b>11</b>, <b>21</b>, <b>22</b>, and <b>29</b>) which exhibited a potent neuroprotective effect at 1 μM were selected for the second-round screening with more concentrations ranging from 0.25 to 4 μM (0.25, 0.5, 1, 2, and 4 μM, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Among them, compound <b>11</b> exhibited significant neuroprotective effects (cell viability >80% at 1, 2, 4 μM) against OGD-induced neuronal damage in SH-SY5Y cells compared to CPX (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Moreover, optimal compound <b>11</b> possessed good BBB permeability (7.50 × 10<sup>–6</sup> cm/s, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) and better antioxidant capability (1.13 ± 0.19 vs CPX, 0.52 ± 0.32, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). In addition, complex of compound <b>11</b> and olamine—<b>11·Ola</b> possessed good water solubility.</div><div class="NLM_p">Treatment with compound <b>11·Ola</b> at 4 μM significantly suppressed the apoptotic ratio in SH-SY5Y cells after OGD exposure (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Besides, treatment with compound <b>11·Ola</b> at 0.5, 1, 2, and 4 μM significantly attenuated glutamate-induced HT22 cell damage and H<sub>2</sub>O<sub>2</sub>-induced SH-SY5Y cell damage (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). These results further verify the neuroprotective activity of compound <b>11·Ola</b> and also indicated that it might exhibit neuroprotective effects through anti-apoptosis and attenuating oxidative damage and oxidative glutamate toxicity. The safety of <b>11·Ola</b> was evaluated through hERG inhibition assay and cytotoxicity assay. As the hERG inhibition IC<sub>50</sub> values of both <b>11·Ola</b> and CPX olamine are all above 40 μM, these two compounds are unlikely to cause hERG inhibition at the therapeutic dose. The IC<sub>50</sub> values in the MRC-5 cell line of <b>11·Ola</b> and CPX olamine are all around 23 μM (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>), and the IC<sub>50</sub> values of them in SH-SY5Y cell line are above 100 μM (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). In the in vivo experiment (MCAO rats, 24 h after the reperfusion), compound <b>11·Ola</b> exhibited a marked neuroprotective effect at lower doses (0.3 and 1 mg/kg for <b>11·Ola</b> vs 3 mg/kg for CPX olamine). Treatment with 0.3 and 1 mg/kg of compound <b>11·Ola</b> significantly reduced brain infarct volume. Besides, the treatment with 1 mg/kg of compound <b>11·Ola</b> significantly reduced the neurological score (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Considering that compound <b>11·Ola</b> and CPX olamine have similar cytotoxicity, and <b>11·Ola</b> has lower effective doses, compound <b>11·Ola</b> possesses superior safety window compared with CPX olamine. Moreover, compound <b>11·Ola</b> (<i>T</i><sub>1/2</sub> = 91.63 min) showed superior metabolic stability compared to CPX olamine (<i>T</i><sub>1/2</sub> = 53.14 min) in the mouse liver microsome experiments.</div><div class="NLM_p last">To conclude, among these derivatives investigated, the BBB-permeable and water-soluble compound <b>11·Ola</b> showed superior neuroprotective activity, good safety, and metabolic stability in vitro and lower effective dose in vivo compared to CPX olamine. Compound <b>11·Ola</b> could be a promising drug candidate for the treatment of ischemic stroke.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61708" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61708" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Chemistry</h3><div class="NLM_p last">Reagents and solvents were purchased from Adamas-Beta, J&K, Energy Chemical, TCI, Alfa Aesar, and Bide Pharmatech; they were used without further purification. Analytical thin-layer chromatography (TLC) was performed using HSGF 254 (0.2 mm thickness; Yantai Huiyou Co., China), and spots were visualized with UV light. Yields were not optimized. Melting points were measured in capillary tubes on a SGW X-4 melting point apparatus without correction. <sup>1</sup>H and <sup>13</sup>C nuclear magnetic resonance (NMR) spectroscopy was performed on a Bruker AMX-400 MHz NMR and Ascend 600 MHz NMR (IS as TMS). Chemical shifts were reported in parts per million (ppm, δ) downfield from tetramethylsilane. Proton coupling patterns were described as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), and broad (br). High-resolution mass spectra (HRMS) were obtained by electric ionization (EI) and electrospray ionization using a Waters GCT Premier and Waters LCT. HPLC data analysis of compounds <b>1–31</b> was performed on Agilent 1100 with a quaternary pump and diode-array detector (DAD). The peak purity was verified by UV spectra. All analogues were confirmed to be ≥95% pure (Table S1, <a href="/doi/suppl/10.1021/acs.jmedchem.9b01338/suppl_file/jm9b01338_si_001.pdf" class="ext-link">Supporting Information</a>). The NMR spectroscopy and synthetic methods of intermediates are given in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01338/suppl_file/jm9b01338_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Method A (Reactions j, k, m, and n in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for Compounds <b>6–19</b></h3><div class="NLM_p">This synthetic route was modified from several reported methods.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a></div><div class="NLM_p">Reaction j in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>: to a vigorously stirred solution of AlCl<sub>3</sub> (3.99 g, 30 mmol) in dichloromethane (10 mL) at 0 °C, a mix of methyl 3-methylbut-2-enoate (<b>A0</b> for compounds <b>7–19</b>, purchased from Energy Chemical)/<b>A6</b> (methyl (<i>Z</i>)-3-methylpent-2-enoate, for compound <b>6</b>) (10 mmol) and corresponding carboxyl acid chloride (10 mmol) in dichloromethane (5 mL) was added dropwise. The reaction was refluxed until the emission of HCl gas ceased (typically 3.5 h). The mixture was then cooled to room temperature and quenched with 20 mL 6 N HCl (aq). The organic phase was separated, and the aqueous phase was extracted with dichloromethane (20 mL × 3). The combined dichloromethane solution was washed with saturated NaHCO<sub>3</sub> water solution, dried by Mg<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to provide the crude γ-acyl substituted α,β-unsaturated ester which was used in the next step without further purification. The yield for this step range from 55 to 85%.</div><div class="NLM_p">Reaction k in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>: the crude γ-acyl substituted α,β-unsaturated ester was dissolved in acetic acid (1 mL/1 mmol) and then concentrated H<sub>2</sub>SO<sub>4</sub> (0.3 mL/1 mmol) was added. After 4.5 h stirring at 105 °C, the reaction mixture was cooled to room temperature and quenched with saturated NaHCO<sub>3</sub> water solution carefully. The resulting mixture was extracted with ethyl acetate. The ethyl acetate solution was washed by brine, dried by NaSO<sub>4</sub>, and concentrated under reduced pressure to give the crude product. The crude product was purified by column chromatography (silica gel, ethyl acetate/hexane, 1:10) to provide <b>B6–B18</b>. (<b>B19</b> was synthesized through an additional step reaction l using 6-(bromomethyl)-4-methyl-2<i>H</i>-pyran-2-one and phenylboronic acid as reactants). The yield for this step ranges from 15 to 35%.</div><div class="NLM_p">Reaction m in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>: compounds <b>C6–C17</b> and <b>C19</b> were synthesized through reaction m using compounds <b>B6–B17</b> and <b>B19</b> as reactants. The pyrone (referred to one of compounds <b>B6–B17</b> and <b>B19</b>) and P<sub>4</sub>S<sub>10</sub> (2.5 equiv) were refluxed in toluene (8 mL/1 mmol) for 6 h. The resulting mixture was filtered, and the filtrate was concentrated under reduced pressure to give the crude product. [The stinky filter cake was destroyed by NaClO (aq)]. The crude product was purified by column chromatography (silica gel, ethyl acetate/hexane, 1:10) to provide compounds <b>C6–17</b> and <b>C19</b>. The yield for this step ranges from 55 to 80%. To avoid the unpleasant smell, the instrument used in this reaction must be washed by NaClO (aq).</div><div class="NLM_p last">Reaction n in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>: compounds <b>C6–C17</b> and <b>C19</b> and hydroxyamine hydrochloride (5 equiv) were refluxed in pyridine (10 mL/1 mmol) for 6 h. The reaction mixture was concentrated under reduced pressure, and the crude product was then purified by column chromatography (SiO<sub>2</sub>, methanol/dichloromethane, from 1:40 to 1:15) to provide compounds <b>6–19</b>. The yield for this step ranges from 30 to 50%. For the synthesis of compound <b>18</b>, the method is adjusted: compound <b>B18</b> (372 mg, 2 mmol) and hydroxylamine hydrochloride (2.45 g, 35 equiv) were refluxed in pyridine (10 mL) for 18 h; the reaction mixture was concentrated under reduced pressure and purified by the same method (see above) to give compound <b>18</b> (150 mg, yield 37%).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Method B (Reaction a in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) for Compounds <b>20–23</b></h3><div class="NLM_p last">CPX (purchased from Bide Pharmatech), AIBN (0.05 equiv), and NBS (for 20, 21)/NIS (for 22)/NCS (for 23) (1.05 equiv) were refluxed in CCl<sub>4</sub> for 6 h. The reaction mixture was cooled to 0 °C, and the succinimide was filtered and removed. The filtrate was concentrated in reduced pressure, and the resulting crude product was washed by hexane and purified by column chromatography (silica gel, methanol/dichloromethane, 1:20) to provide compounds <b>20</b>, <b>22</b>, and <b>23</b>. (yield: <b>20</b>: 90%, <b>22</b>: 63%, <b>23</b>: 70%) The hexane solution which was used for washing the crude compound <b>20</b> was collected. Then, the solution was cooled to −20 °C, and the resulting suspension was filtered. The filtrate was concentrated under reduced pressure, and the crude product was purified by column chromatography (silica gel, methanol/dichloromethane, 1:30) to provide compounds <b>21</b>. (yield = 5%)</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Method C (Reaction c in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) for Compounds <b>25–31</b></h3><div class="NLM_p">Compound <b>25</b> and the corresponding amine (2 equiv) were stirred at room temperature in 1, 2-dichloroethane (10 mL/1 mmol) for 30 min. Then, sodium triacetoxyborohydride (2 equiv) was added. After stirring overnight, the reaction mixture was quenched by water, and the organic phase was separated. The aqueous phase was extracted with dichloromethane twice, and the combined organic phase was washed by brine and dried by Na<sub>2</sub>SO<sub>4</sub>. It was then concentrated under reduced pressure, and the crude product was purified by column chromatography (silica gel, methanol/dichloromethane, 1:15) to provide compounds <b>25–31</b>.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 6-Cyclohexyl-1-ethoxy-4-methylpyridin-2(1<i>H</i>)-one (<b>1</b>)</h4><div class="NLM_p last">Ciclopirox (414 mg) was dissolved in 5 mL of DMF. Then, 160 μL of iodoethane and 300 mg of K<sub>2</sub>CO<sub>3</sub> were added. The mixture was heated to 60 °C. The reaction was quenched with 50 mL Li<sub>2</sub>CO<sub>3</sub> water solution (4 mol/L) at 0 °C when TLC indicated the reaction to be completed. The resulting solution was extracted with DCM (50 mL × 3). At last, the combined organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo to afford 350 mg compound <b>1</b>, white solid, mp 68–72 °C, yield = 74%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 6.32 (s, 1H), 5.79 (s, 1H), 4.27 (q, <i>J</i> = 7.1 Hz, 2H), 2.82–2.72 (m, 1H), 2.15 (s, 3H), 2.02–1.92 (m, 2H), 1.91–1.83 (m, 2H), 1.82–1.72 (m, 1H), 1.51–1.14 (m, 8H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 159.53, 153.15, 149.76, 117.55, 104.48, 72.16, 38.43, 32.57, 26.57, 25.96, 21.46. HRMS (ES) <i>m</i>/<i>z</i>: calcd for C<sub>14</sub>H<sub>21</sub>NO<sub>2</sub> [M + H]<sup>+</sup>, 236.1650; found, 236.1652.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Methyl 2-((6-Cyclohexyl-4-methyl-2-oxopyridin-1(2<i>H</i>)-yl)oxy)acetate (<b>2</b>)</h4><div class="NLM_p last">Methyl 2-bromoacetate (352 mg) and K<sub>2</sub>CO<sub>3</sub> (400 mg) were added in a 8 mL acetonitrile solution of ciclopirox (414 mg). The reaction was refluxed overnight. Then, the mixture was diluted in 100 mL of ethyl acetate and ethyl acetate solution was washed with saturated NaHCO<sub>3</sub> water solution. The organic phase was dried and concentrated to afford 468 mg of compound <b>2</b>, pale-yellow oil, yield = 80%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 6.28 (s, 1H), 5.82 (s, 1H), 4.95 (s, 2H), 3.80 (s, 3H), 3.15–3.00 (m, 1H), 2.15 (s, 3H), 2.04–1.92 (m, 2H), 1.90–1.82 (m, 2H), 1.80–1.72 (m, 1H), 1.55–1.10 (m, 5H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 168.77, 160.26, 153.09, 152.72, 116.58, 107.28, 78.22, 38.50, 32.57, 26.36, 25.72, 21.71. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>15</sub>H<sub>21</sub>NO<sub>4</sub> M<sup>+</sup>, 279.1471; found, 279.1472.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-((6-Cyclohexyl-4-methyl-2-oxopyridin-1(2<i>H</i>)-yl)oxy)acetic Acid (<b>3</b>)</h4><div class="NLM_p last">Compound <b>2</b> (200 mg) was dissolved in 6 mL THF; then, 200 mg of lithium hydroxide in 2 mL water was added. The reaction was stirred fiercely at 40 °C overnight. The resulting mixture was quenched with 20 mL 1 M HCl solution at 0 °C; then, the mixture was extracted with ethyl acetate (50 mL × 3). The organic phase was dried and concentrated in vacuo to afford 120 mg of compound <b>3</b>, white powder, mp 121–125 °C, yield = 67%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 6.47 (s, 1H), 6.05 (s, 1H), 4.70 (s, 2H), 2.85–2.72 (m, 1H), 2.24 (s, 3H), 2.05–1.93 (m, 2H), 1.96–1.86 (m, 2H), 1.86–1.77 (m, 1H), 1.52–1.18 (m, 5H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 168.98, 160.21, 153.10, 152.54, 116.64, 107.08, 77.95, 38.48, 32.57, 26.36, 21.70. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>14</sub>H<sub>19</sub>NO<sub>4</sub> M<sup>+</sup>, 265.1314; found, 265.1319.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 3-Cyclohexyl-2-hydroxyisoquinolin-1(2<i>H</i>)-one (<b>4</b>)</h4><div class="NLM_p last"><b>4b</b> (1.24 mmol) (0.31 g) was added into a solution of 0.52 g (7.44 mmol, 6 equiv) of hydroxylamine hydrochloride and 0.62 g of (11.2 mmol, 9 equiv) KOH in 8 mL of methanol. The mixture was refluxed for 8 h and then quenched with 2 N HCl at 0 °C. The resulting suspension was extracted with DCM (70 mL × 3). The combined organic phase was dried and concentrated in vacuo to afford the crude product. It was then purified through column chromatography (silica gel, methanol/DCM = 1:15) to afford 190 mg <b>4</b>, white solid, mp 117–121 °C, yield = 65%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 8.35 (d, <i>J</i> = 8.2 Hz, 1H), 7.63 (t, <i>J</i> = 7.2 Hz, 1H), 7.56 (d, <i>J</i> = 8.2 Hz, 1H), 7.47 (t, <i>J</i> = 7.2 Hz, 1H), 6.45 (s, 1H), 3.16–3.00 (m, 1H), 2.20–2.10 (m, 2H), 1.96–1.86 (m, 2H), 1.86–1.76 (m, 1H), 1.61–1.16 (m, 5H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 157.26, 144.38, 135.45, 131.73, 126.60, 126.11, 125.98, 101.39, 38.15, 31.73, 26.41, 26.13. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>15</sub>H<sub>17</sub>NO<sub>2</sub> M<sup>+</sup>, 243.1259; found, 243.1260.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 6-Cyclohexyl-1-hydroxypyridin-2(1<i>H</i>)-one (<b>5</b>)</h4><div class="NLM_p last"><b>5b</b> (121 mg) was refluxed in 6 mL of acetyl chloride for 12 h. Then, the acetyl chloride was removed under reduced pressure and 6 mL of methanol was added. The reaction mixture was refluxed for another 12 h and then concentrated in vacuo. The resulting crude product was purified through column chromatography (silica gel, methanol/DCM = 1:15) to afford 60 mg <b>5</b>, orange powder, mp 142–146 °C, yield = 50%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 7.59 (t, <i>J</i> = 8.0 Hz, 1H), 7.14 (d, <i>J</i> = 8.0 Hz, 1H), 6.59 (d, <i>J</i> = 8.0 Hz, 1H), 5.98–5.78 (br s, 1H), 3.30–3.16 (m, 1H), 2.15–2.05 (m, 2H), 1.94–1.84 (m, 2H), 1.84–1.74 (m, 1H), 1.60–1.15 (m, 5H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 157.77, 149.81, 136.81, 112.41, 102.77, 38.25, 31.10, 26.23, 25.96. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>11</sub>H<sub>15</sub>NO<sub>2</sub> M<sup>+</sup>, 193.1103; found, 193.1096.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Ethyl(<i>Z</i>)-3-methylpent-2-enoate (<b>A6</b>)</h4><div class="NLM_p last">To a suspension of 950 mg of CuI in 8 mL of anhydrous THF at −10 °C, 6.5 mL of CH<sub>3</sub>Li (1.6 M in diethoxymethane, Adamas-Beta) was added under nitrogen. After 20 min, orange (CH<sub>3</sub>)<sub>2</sub>CuLi was formed. At this moment, 630 mg of ethyl pent-2-ynoate in 5 mL of THF was added dropwise. The reaction mixture was allowed to warm to room temperature and stirred for 3 h. Then, it was quenched with NH<sub>4</sub>Cl (aq) and extracted with ethyl acetate. The organic phase was dried with anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to give 430 mg of ethyl (<i>Z</i>)-3-methylpent-2-enoate, colorless oil, yield = 60%. The NMR spectra of <b>A6</b> is consistent with the published data.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 6-Cyclohexyl-4-ethyl-1-hydroxypyridin-2(1<i>H</i>)-one (<b>6</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid, mp 88–92 °C, yield = 42%. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 6.37 (s, 1H), 6.22 (s, 1H), 3.02–3.12 (m, 1H), 2.55 (q, <i>J</i> = 7.6 Hz, 2H), 2.08–1.98 (m, 2H), 1.96–1.75 (m, 3H), 1.54–1.27 (m, 5H), 1.22 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (151 MHz, methanol-<i>d</i><sub>4</sub>): δ 159.43, 151.42, 111.38, 104.49, 42.12, 38.17, 33.97, 31.16, 28.00, 26.08, 25.69, 13.01, 10.14. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>13</sub>H<sub>19</sub>NO<sub>2</sub> M<sup>+</sup>, 221.1416; found, 221.1417.</div></div><div id="sec4_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 6-Cyclopropyl-1-hydroxy-4-methylpyridin-2(1<i>H</i>)-one (<b>7</b>)</h4><div class="NLM_p last">It was obtained as yellow powder, mp 122–125 °C, yield = 30%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 6.42 (s, 1H), 5.99 (s, 1H), 4.15 (t, <i>J</i> = 6.3 Hz, 2H), 2.84 (t, <i>J</i> = 7.6 Hz, 2H), 2.22 (s, 3H), 2.15–2.20 (m, 1H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 171.16, 159.88, 146.53, 112.00, 110.55, 63.73, 27.58, 25.84, 20.98. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>9</sub>H<sub>11</sub>NO<sub>2</sub> M<sup>+</sup>, 165.0790; found, 165.0791.</div></div><div id="sec4_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 6-Cyclobutyl-1-hydroxy-4-methylpyridin-2(1<i>H</i>)-one (<b>8</b>)</h4><div class="NLM_p last">It was obtained as a pale yellow solid, mp 100–103 °C, yield = 35% <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 6.43 (s, 1H), 6.03 (s, 1H), 3.70–3.80 (m, 1H), 2.35–2.47 (m, 2H), 2.25 (s, 3H), 2.00–2.20 (m, 3H), 1.89 (d, <i>J</i> = 9.4 Hz, 1H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 157.59, 148.48, 146.62, 112.19, 105.00, 35.04, 27.25, 21.59, 18.40. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>10</sub>H<sub>13</sub>NO<sub>2</sub> M<sup>+</sup>, 179.0946; found, 179.0947.</div></div><div id="sec4_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 6-Cyclopentyl-1-hydroxy-4-methylpyridin-2(1<i>H</i>)-one (9)</h4><div class="NLM_p last">It was obtained as yellow powder, mp 85–88 °C, yield = 45%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 6.41 (s, 1H), 6.04 (s, 1H), 3.44–3.24 (m, 1H), 2.22 (s, 3H), 2.18–2.06 (m, 2H), 1.91–1.50 (m, 6H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 157.62, 148.41, 147.44, 111.81, 104.71, 39.74, 31.09, 25.13, 21.63. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>11</sub>H<sub>15</sub>NO<sub>2</sub> M<sup>+</sup>, 193.1103; found, 193.1104.</div></div><div id="sec4_4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 6-Cycloheptyl-1-hydroxy-4-methylpyridin-2(1<i>H</i>)-one (<b>10</b>)</h4><div class="NLM_p last">It was obtained as a white solid, mp 94–97 °C, yield = 32%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 6.36 (s, 1H), 5.98 (s, 1H), 3.08–3.18 (m, 1H), 2.21 (s, 3H), 1.95–2.06 (m, 2H), 1.80–1.90 (m, 2H), 1.75–1.64 (m, 2H), 1.50–1.65 (m, 6H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 159.75, 153.38, 144.11, 111.02, 107.50, 39.22, 33.50, 27.94, 26.89, 21.17. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>13</sub>H<sub>19</sub>NO<sub>2</sub> M<sup>+</sup>, 221.1416; found, 221.1417.</div></div><div id="sec4_4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 6-((1<i>R</i>,2<i>S</i>,4<i>S</i>)-Bicyclo[2.2.1]heptan-2-yl)-1-hydroxy-4-methylpyridin-2(1<i>H</i>)-one (<b>11</b>)</h4><div class="NLM_p last">It was obtained as pale yellow powder, mp 138–141 °C, yield = 50%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.37 (s, 1H), 5.99 (s, 1H), 2.94–3.06 (m, 1H), 2.48 (s, 1H), 2.38 (s, 1H), 2.23 (s, 3H), 1.89 (t, <i>J</i> = 11.0 Hz, 1H), 1.47–1.77 (m, 3H), 1.20–1.46 (m, 4H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 157.68, 148.28, 148.09, 111.63, 104.59, 41.51, 40.08, 37.10, 36.65, 36.50, 29.80, 28.66, 21.72. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>13</sub>H<sub>17</sub>NO<sub>2</sub> M<sup>+</sup>, 219.1259; found, 219.1265.</div></div><div id="sec4_4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 6-((1<i>R</i>,2<i>S</i>,4<i>S</i>)-Bicyclo[2.2.1]heptan-2-yl)-1-hydroxy-4-methylpyridin-2(1<i>H</i>)-one Olamine (<b>11·Ola</b>)</h4><div class="NLM_p last"><b>11</b> (900 mg) was dissolved in 3 mL of hot ethyl acetate in 55 °C; then, 0.3 mL of olamine was added. After stirring for 10 min, the mixture was cooled to room temperature and the suspension was filtered and washed with ethyl acetate to afford 1.05 g 11 olamine, white solid, mp 120 °C (dec), yield = 91%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 6.32 (s, 1H), 5.98 (s, 1H), 3.75–4.15 (br s, 4H), 3.63 (t, <i>J</i> = 5.1 Hz, 2H), 2.95–3.05 (m, 1H), 2.88 (s, 2H), 2.46 (s, 1H), 2.37 (s, 1H), 2.21 (s, 3H), 1.98–1.78 (m, 1H), 1.76–1.17 (m, 7H). <sup>13</sup>C NMR (100 MHz, chloroform-<i>d</i>): δ 160.68, 152.21, 144.56, 111.86, 105.50, 60.71, 43.20, 42.00, 40.23, 37.83, 36.66, 30.01, 28.76, 21.30. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>13</sub>H<sub>17</sub>NO<sub>2</sub> M<sup>+</sup>, 219.1259; found, 219.1262.</div></div><div id="sec4_4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-Hydroxy-4,6-dimethylpyridin-2(1<i>H</i>)-one (<b>12</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid, mp 119–122 °C, yield = 35%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 6.45 (s, 1H), 6.05 (s, 1H), 2.45 (s, 3H), 2.22 (s, 3H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 157.90, 148.27, 140.89, 112.52, 108.34, 21.30, 16.83. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>7</sub>H<sub>9</sub>NO<sub>2</sub> M<sup>+</sup>, 139.0633; found, 139.0634.</div></div><div id="sec4_4_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-Hydroxy-4-methyl-6-propylpyridin-2(1<i>H</i>)-one (<b>13</b>)</h4><div class="NLM_p last">It was obtained as an orange solid, mp 78–81 °C, yield = 50%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 6.44 (s, 1H), 6.02 (s, 1H), 5.25–5.05 (br s, 1H), 2.74 (t, <i>J</i> = 7.7 Hz, 2H), 2.23 (s, 3H), 1.74 (q, <i>J</i> = 7.5 Hz, 2H), 1.01 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 148.55, 144.34, 112.44, 107.57, 32.34, 21.44, 20.51, 13.71. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>9</sub>H<sub>13</sub>NO<sub>2</sub> M<sup>+</sup>, 167.0946; found, 167.0949.</div></div><div id="sec4_4_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 1-Hydroxy-6-isobutyl-4-methylpyridin-2(1<i>H</i>)-one (<b>14</b>)</h4><div class="NLM_p last">It was obtained as yellow oil, yield = 32%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 6.45 (s, 1H), 6.34 (s, 1H), 2.28 (s, 3H), 2.03–2.13 (m, 1H), 1.38 (s, 6H), 1.20–1.30 (m, 2H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 157.55, 148.25, 143.05, 112.18, 108.50, 39.52, 26.77, 22.37, 21.43. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>10</sub>H<sub>15</sub>NO<sub>2</sub> M<sup>+</sup>, 181.1103; found, 181.1104.</div></div><div id="sec4_4_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-Hydroxy-4-methyl-6-pentylpyridin-2(1<i>H</i>)-one (<b>15</b>)</h4><div class="NLM_p last">It was obtained as an orange solid, mp 42–45 °C, yield = 49%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 6.40 (s, 1H), 5.98 (s, 1H), 2.74 (t, <i>J</i> = 7.8 Hz, 2H), 2.22 (s, 3H), 1.80–1.57 (m, 2H), 1.37 (q, <i>J</i> = 3.8 Hz, 4H), 1.01–0.77 (m, 3H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 157.67, 148.44, 144.37, 112.22, 107.24, 31.34, 30.34, 26.82, 22.36, 21.45, 13.94. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>11</sub>H<sub>19</sub>NO<sub>2</sub> M<sup>+</sup>, 195.1259; found, 195.1261.</div></div><div id="sec4_4_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 6-Heptyl-1-hydroxy-4-methylpyridin-2(1<i>H</i>)-one (<b>16</b>)</h4><div class="NLM_p last">It was obtained as an orange solid, mp 53–56 °C, yield = 50%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 6.38 (s, 1H), 5.98 (s, 1H), 2.89–2.66 (m, 2H), 2.20 (s, 3H), 1.69 (p, <i>J</i> = 7.5 Hz, 2H), 1.46–1.21 (m, 8H), 0.89 (t, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 157.71, 148.62, 144.63, 112.26, 107.52, 31.70, 30.40, 29.17, 28.96, 27.15, 22.61, 21.46, 14.08. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>13</sub>H<sub>21</sub>NO<sub>2</sub> M<sup>+</sup>, 223.1572; found, 223.1573.</div></div><div id="sec4_4_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1-Hydroxy-4-methyl-6-nonylpyridin-2(1<i>H</i>)-one (<b>17</b>)</h4><div class="NLM_p last">It was obtained as an orange solid, mp 59–62 °C, yield = 50%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 6.40 (s, 1H), 5.98 (s, 1H), 2.80–2.65 (m, 2H), 2.21 (s, 3H), 1.69 (p, <i>J</i> = 7.7 Hz, 2H), 1.46–1.14 (m, 12H), 0.98–0.75 (m, 3H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 157.66, 148.51, 144.41, 112.20, 107.34, 31.87, 30.37, 29.45, 29.29, 29.20, 27.14, 22.67, 21.46, 14.11. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>15</sub>H<sub>25</sub>NO<sub>2</sub> M<sup>+</sup>, 251.1885; found, 251.1884.</div></div><div id="sec4_4_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 1-Hydroxy-4-methyl-6-phenylpyridin-2(1<i>H</i>)-one (<b>18</b>)</h4><div class="NLM_p last">Compound <b>B18</b> (372 mg, 2 mmol) and hydroxylamine hydrochloride (2.45 g, 35 equiv) were refluxed in pyridine (10 mL) for 18 h; the reaction mixture was concentrated under reduced pressure and purified by the same method (see above) to give compound <b>18</b>, yellow powder, mp 110–115 °C, yield = 37%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 7.70–7.60 (m, 2H), 7.53–7.45 (m, 2H), 7.42–7.29 (m, 1H), 6.55 (s, 1H), 6.21 (s, 1H), 2.29 (s, 3H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 159.15, 143.97, 132.46, 129.50, 129.38, 129.26, 128.73, 128.01, 127.81, 126.64, 111.52, 21.25. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>12</sub>H<sub>11</sub>NO<sub>2</sub> M<sup>+</sup>, 201.0790; found, 201.0791.</div></div><div id="sec4_4_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 6-Benzyl-1-hydroxy-4-methylpyridin-2(1<i>H</i>)-one (<b>19</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid, mp 127–130 °C, yield = 35%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 7.39–7.29 (m, 3H), 7.22–7.28 (s, 2H), 6.43 (s, 1H), 5.81 (s, 1H), 4.10 (s, 2H), 2.17 (s, 3H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 157.51, 148.53, 143.03, 135.51, 128.80, 127.22, 112.73, 108.03, 36.12, 21.48. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>13</sub>H<sub>13</sub>NO<sub>2</sub> M<sup>+</sup>, 215.0946; found, 215.0947.</div></div><div id="sec4_4_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 3-Bromo-6-cyclohexyl-1-hydroxy-4-methylpyridin-2(1<i>H</i>)-one (<b>20</b>)</h4><div class="NLM_p last">It was obtained as white powder, mp 174–177 °C, yield = 90%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.09 (s, 1H), 3.03–2.93 (m, 1H), 2.34 (s, 3H), 1.95–2.15 (m, 2H), 1.83–1.94 (m, 2H), 1.75–1.93 (m, 1H), 1.18–1.55 (m, 5H). <sup>13</sup>C NMR (101 MHz, chloroform-<i>d</i>): δ 154.67, 147.64, 146.97, 108.30, 104.45, 38.04, 31.04, 29.59, 26.18, 25.91, 23.34. <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>, DEPT-135): δ CH104.60, CH38.02, CH<sub>2</sub>31.10, CH<sub>2</sub>26.18, CH<sub>3</sub>23.35. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>12</sub>H<sub>16</sub>BrNO<sub>2</sub> M<sup>+</sup>, 285.0364; found, 285.0362.</div></div><div id="sec4_4_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 5-Bromo-6-cyclohexyl-1-hydroxy-4-methylpyridin-2(1<i>H</i>)-one (<b>21</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid, mp 126–130 °C, yield = 5%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.54 (s, 1H), 3.65–3.46 (m, 1H), 2.33 (s, 3H), 2.30–2.21 (m, 2H), 1.85–1.95 (m, 2H), 1.60–1.82 (m, 2H), 1.18–1.55 (m, 4H). <sup>13</sup>C NMR (101 MHz, chloroform-<i>d</i>): δ 156.42, 149.11, 145.68, 112.48, 102.75, 44.67, 29.59, 27.28, 26.52, 25.54, 24.82. <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>, DEPT-135): δ CH112.51, CH44.70, CH<sub>2</sub>27.30, CH<sub>2</sub>26.54, CH<sub>2</sub>25.55, CH<sub>3</sub>24.81. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>12</sub>H<sub>16</sub>BrNO<sub>2</sub> M<sup>+</sup>, 285.0364; found, 285.0360.</div></div><div id="sec4_4_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 6-Cyclohexyl-1-hydroxy-3-iodo-4-methylpyridin-2(1<i>H</i>)-one (<b>22</b>)</h4><div class="NLM_p last">It was obtained as an orange solid, mp 161–165 °C, yield = 63%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.10 (s, 1H), 3.07–2.87 (br s, 1H), 2.39 (s, 3H), 1.95–2.15 (m, 2H), 1.75–1.94 (m, 3H), 1.10–1.58 (m, 5H). <sup>13</sup>C NMR (101 MHz, chloroform-<i>d</i>): δ 155.78, 152.04, 147.73, 104.62, 85.53, 37.99, 31.02, 28.60, 26.18, 25.92. <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>, DEPT-135): δ CH104.63, CH37.99, CH<sub>2</sub>31.02, CH<sub>3</sub>28.59, CH<sub>2</sub>26.17, CH<sub>2</sub>25.90. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>12</sub>H<sub>16</sub>INO<sub>2</sub> M<sup>+</sup>, 333.0226; found, 333.0225.</div></div><div id="sec4_4_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 3-Chloro-6-cyclohexyl-1-hydroxy-4-methylpyridin-2(1<i>H</i>)-one (<b>23</b>)</h4><div class="NLM_p">It was obtained as a white solid, mp 175–178 °C, yield = 70% <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 6.06 (s, 1H), 3.07–2.97 (m, 1H), 2.32 (s, 3H), 2.16–1.97 (m, 2H), 1.92–1.82 (m, 2H), 1.83–1.73 (m, 1H), 1.53–1.16 (m, 5H). <sup>13</sup>C NMR (101 MHz, chloroform-<i>d</i>): δ 154.70, 147.00, 145.35, 117.83, 104.30, 37.98, 31.16, 26.19, 25.92, 20.38. <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>, DEPT-135): δ CH104.21, CH<sub>2</sub>38.00, CH31.15, CH<sub>3</sub>26.06, CH<sub>2</sub>20.37. HRMS (EI) <i>m</i>/<i>z</i>: calcd for C<sub>12</sub>H<sub>16</sub>ClNO<sub>2</sub> M<sup>+</sup>, 241.0870; found, 241.0867.</div><div class="NLM_p last">The halogenated position of <b>20–23</b> was analyzed by comparing the <sup>13</sup>C and DEPT-135 <sup>13</sup>C NMR spectrogram of these compounds with the spectrogram of CPX which was reported by Brandel (2015).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div></div><div id="sec4_4_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 6-Cyclohexyl-1-hydroxy-4-methyl-2-oxo-1,2-dihydropyridine-3-carbaldehyde (<b>24</b>)</h4><div class="NLM_p last">Compound <b>24</b> is synthesized through a halogen–lithium exchange reaction using compound <b>20</b> as the reactant. To a solution of compound <b>20</b> (1.99 g, 7 mmol) in dry THF (60 mL), 310 mg NaH (60% wt, 7.7 mmol) was added at −10 °C under nitrogen. After stirring for 30 min, the resulting suspension was cooled to −78 °C. Then, 14 mL of <i>tert</i>-BuLi solution (1.3 mol/L in pentane) was added dropwise. When the color of the reaction mixture changed to thick orange, 2.5 mL of dry DMF was added. Next, shut down the cooling system; the stirring reaction mixture was allowed to warm to room temperature overnight. At last, the reaction was quenched by 1.5 N HCl at 0 °C. The organic phase was collected, and the aqueous phase was extracted with DCM two times. Combining the DCM solution and the organic phase, the combined mixture was washed by brine and dried by anhydrous Na<sub>2</sub>SO<sub>4</sub>. After removing the solvent under reduced pressure, the crude product was purified by column chromatography [methanol/DCM = 1:40 (v/v)] to give 705 mg of compound <b>24</b> (pale-green solid), yield = 43%, mp 106–109 °C. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 10.49 (s, 1H), 6.08 (s, 1H), 3.12–3.23 (m, 1H), 2.56 (s, 3H), 2.10–1.95 (m, 2H), 1.94–1.74 (m, 3H), 1.51–1.19 (m, 5H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 191.44, 157.13, 117.26, 115.79, 111.79, 108.73, 50.11, 38.37, 30.72, 26.16, 26.05. HRMS (ES+) <i>m</i>/<i>z</i>: calcd for C<sub>13</sub>H<sub>17</sub>NO<sub>3</sub>, 236.1286 [M + H]<sup>+</sup>; found, 236.1285.</div></div><div id="sec4_4_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 6-Cyclohexyl-1-hydroxy-4-methyl-3-((methylamino)methyl)pyridin-2(1<i>H</i>)-one (<b>25</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid, mp 103–107 °C, yield = 25%. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 6.42 (s, 1H), 4.20 (s, 2H), 3.49–3.34 (m, 1H), 2.76 (s, 3H), 2.35 (s, 3H), 2.10–1.98 (m, 2H), 1.92–1.75 (m, 3H), 1.55–1.26 (m, 5H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 158.42, 152.17, 149.44, 114.02, 105.50, 45.53, 38.16, 32.03, 30.99, 25.98, 25.59, 17.84.. HRMS (ES+) <i>m</i>/<i>z</i>: calcd for C<sub>14</sub>H<sub>22</sub>N<sub>2</sub>O<sub>2</sub>, 250.1681 [M + H]<sup>+</sup>; found, 250.1758.</div></div><div id="sec4_4_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 6-Cyclohexyl-1-hydroxy-4-methyl-3-((propylamino)methyl)pyridin-2(1<i>H</i>)-one (<b>26</b>)</h4><div class="NLM_p last">It was obtained as an orange solid, mp 79–83 °C, yield = 20%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.95–9.20 (br s, 1H), 6.18 (s, 1H), 4.22 (s, 1H), 3.49 (s, 1H), 2.68–2.86 (br s, 2H), 2.24 (s, 3H), 1.45–1.95 (m, 7H), 1.10–1.40 (m, 8H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 132.46, 130.89, 129.93, 129.85, 128.81, 108.45, 68.16, 65.58, 42.39, 38.74, 31.22, 29.70, 26.33, 22.70, 14.06, 11.16. HRMS (ES+) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>26</sub>N<sub>2</sub>O<sub>2</sub>, 279.2072 [M + H]<sup>+</sup>; found, 279.2075.</div></div><div id="sec4_4_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 6-Cyclohexyl-1-hydroxy-3-((isopropylamino)methyl)-4-methylpyridin-2(1<i>H</i>)-one (<b>27</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid, mp 72–76 °C, yield = 35%. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 5.93 (s, 1H), 3.93 (s, 2H), 3.48–3.34 (m, 1H), 3.21–3.09 (m, 1H), 2.21 (s, 3H), 1.96–1.72 (m, 5H), 1.47 (d, <i>J</i> = 6.5 Hz, 6H), 1.41–1.15 (m, 5H). <sup>13</sup>C NMR (151 MHz, methanol-<i>d</i><sub>4</sub>): δ 160.75, 154.09, 141.18, 106.61, 105.83, 49.45, 42.21, 37.46, 31.67, 31.31, 29.38, 26.31, 25.92, 18.53. HRMS (ES+) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>26</sub>N<sub>2</sub>O<sub>2</sub>, 279.2072 [M + H]<sup>+</sup>; found, 279.2074.</div></div><div id="sec4_4_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 6-Cyclohexyl-1-hydroxy-4-methyl-3-((prop-2-yn-1-ylamino)methyl)pyridin-2(1<i>H</i>)-one (<b>28</b>)</h4><div class="NLM_p last">It was obtained as a white solid, mp 155–159 °C, yield = 30%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.98 (s, 1H), 3.87 (s, 2H), 3.47 (d, <i>J</i> = 2.5 Hz, 2H), 3.05–2.86 (m, 1H), 2.30 (s, 3H), 2.26 (s, 1H), 2.07–1.96 (m, 2H), 1.74–1.94 (m, 3H), 1.56–1.17 (m, 5H). <sup>13</sup>C NMR (151 MHz, methanol-<i>d</i><sub>4</sub>): δ 152.94, 129.48, 106.63, 78.17, 77.95, 77.73, 53.47, 41.50, 31.69, 31.05, 26.21, 25.92, 25.80, 25.40. HRMS (ES+) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>22</sub>N<sub>2</sub>O<sub>2</sub>, 275.1759 [M + H]<sup>+</sup>; found, 275.1761.</div></div><div id="sec4_4_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 6-Cyclohexyl-3-((cyclopentylamino)methyl)-1-hydroxy-4-methylpyridin-2(1<i>H</i>)-one (<b>29</b>)</h4><div class="NLM_p last">It was obtained as an orange solid, mp 58–62 °C, yield = 27%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.93 (s, 1H), 5.00–4.65 (br s, 1H), 3.99 (s, 2H), 3.60–3.40 (m, 1H), 2.90–3.10 (m, 1H), 2.29 (s, 3H), 1.55–2.05 (m, 9H), 1.15–1.47 (m, 9H). <sup>13</sup>C NMR (151 MHz, methanol-<i>d</i><sub>4</sub>): δ 158.70, 152.25, 148.95, 114.43, 105.71, 59.46, 43.34, 38.11, 31.04, 29.40, 26.06, 25.65, 23.69, 18.02. HRMS (ES+) <i>m</i>/<i>z</i>: calcd for C<sub>18</sub>H<sub>28</sub>N<sub>2</sub>O<sub>2</sub>, 305.2229 [M + H]<sup>+</sup>; found, 305.2224.</div></div><div id="sec4_4_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 6-Cyclohexyl-1-hydroxy-4-methyl-3-((phenylamino)methyl)pyridin-2(1<i>H</i>)-one (<b>30</b>)</h4><div class="NLM_p last">It was obtained as an orange solid, mp 40–44 °C, yield = 17%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.19 (t, <i>J</i> = 7.5 Hz, 2H), 7.11 (t, <i>J</i> = 7.5 Hz, 1H), 6.76 (d, <i>J</i> = 7.5 Hz, 2H), 6.01 (s, 1H), 4.29 (s, 2H), 2.90–3.10 (m, 1H), 2.10 (s, 3H), 2.06–1.98 (m, 2H), 1.72–1.92 (m, 3H), 1.15–1.55 (m, 5H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 157.36, 148.13, 147.20, 146.16, 129.17, 119.99, 117.93, 113.69, 105.38, 40.93, 38.04, 31.10, 26.23, 25.97, 19.49. HRMS (ES+) <i>m</i>/<i>z</i>: calcd for C<sub>19</sub>H<sub>24</sub>N<sub>2</sub>O<sub>2</sub>, 313.1916 [M + H]<sup>+</sup>; found, 313.1917.</div></div><div id="sec4_4_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 6-Cyclohexyl-3-((heptylamino)methyl)-1-hydroxy-4-methylpyridin-2(1<i>H</i>)-one (<b>31</b>)</h4><div class="NLM_p last">It was obtained as an orange solid, mp 135–138 °C, yield = 20%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.40–8.10 (br s, 2H), 6.15 (s, 1H), 4.07 (s, 2H) 3.00–3.10 (br s, 1H), 2.97 (t, <i>J</i> = 7.7 Hz, 2H), 2.38 (s, 3H), 1.65–1.95 (m, 7H), 1.10–1.45 (m, 18H). <sup>13</sup>C NMR (151 MHz, chloroform-<i>d</i>): δ 158.16, 151.85, 148.46, 113.02, 106.48, 46.73, 44.58, 37.98, 31.55, 31.33, 28.73, 26.64, 26.21, 26.18, 25.94, 22.50, 19.73, 14.01. HRMS (ES+) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>34</sub>N<sub>2</sub>O<sub>2</sub>, 335.2698 [M + H]<sup>+</sup>; found, 335.2700.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Cell Culture</h3><div class="NLM_p">Human neuroblastoma SH-SY5Y cells (ATCC, 2266) were cultured in a 1:1 mixture of Eagle’s minimum essential medium and F12 medium (Gibco, USA), supplemented with 10% fetal bovine serum (FBS; Gibco, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin in a humidified atmosphere of 5% CO<sub>2</sub> at 37 °C. HT22 mouse hippocampal neuronal cells were purchased from Jennio Biotechnology Co., Ltd. and cultured in DMEM (Dulbecco’s modified Eagle’s medium) medium with 10% FBS and 100 U/mL penicillin and 100 μg/mL streptomycin.</div><div class="NLM_p last">Drug treatment: for the in vitro study, all of the derivatives including the ciclopirox and ciclopirox olamine (purchased from Sigma-Aldrich) were prepared at 10 mM with 100% DMSO as stock solution and freshly diluted with cell culture medium before use. Cells were incubated with the indicated concentrations of compounds immediately before OGD exposure or 2 h before H<sub>2</sub>O<sub>2</sub> and glutamate stimulus. For the in vivo study, the <b>11·Ola</b> and CPX olamine were dissolved in saline and administered intravenously after the monofilament was withdrawn for reperfusion.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> OGD, H<sub>2</sub>O<sub>2</sub>, and Glutamate Injury</h3><div class="NLM_p last">SH-SY5Y cells were seeded into 96-well plates at a density of 3 × 10<sup>5</sup> cells/mL. To mimic I/R injury, OGD injury was induced in SH-SY5Y cells. Briefly, the cells were washed with glucose-free Earle’s balanced salt solution buffer (117.2 mM NaCl, 5.3 mM KCl, 0.8 mM MgSO<sub>4</sub>, 26.2 mM NaHCO<sub>3</sub>, 1.8 mM CaCl<sub>2</sub>, and 1.0 mM NaH<sub>2</sub>PO<sub>4</sub>·2H<sub>2</sub>O) and maintained in glucose and serum-free DMEM (Gibco, Grand Island, NY) with/without indicated concentrations of compounds in a hypoxia chamber (H35 hypoxystation, Don Whitley Scientific) containing a mixture of 85%N<sub>2</sub>/10%H<sub>2</sub>/5%CO<sub>2</sub> at 37 °C for 2 h. Then, cells were supplemented with glucose and FBS and cultured in the incubator for another 24 h. The control group without OGD was cultured in a complete medium. For the H<sub>2</sub>O<sub>2</sub> injury, cells were changed to fresh media and pre-incubated with compounds for 2 h; then, H<sub>2</sub>O<sub>2</sub> freshly prepared from 8.8 M stock solution was added to the cells to a final concentration of 100 μM. Glutamate stimulus was conducted in the HT22 cell. Cells were seeded into 96-well plates at a density of 5 × 10<sup>4</sup> cells/mL and cultured for 12 h. Then, cells were treated with different concentrations of compounds for 2 h, followed by exposure to 10 mM <span class="smallcaps smallerCapital">l</span>-glutamic acid hydrochloride for 24 h.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Morphological Changes and Cell Viability Assay</h3><div class="NLM_p last">Morphological changes of cells were observed under the microscope (Nikon, TE200, Melville, NY, USA) after different toxic stimuli for 24 h. Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, BioDee Biotech, Beijing, China) assay. MTT (5 mg/mL) was added to each well and incubated away from light at 37 °C for 3 h. Then, the culture medium of each well was replaced with 100 μL of DMSO to fully dissolve the formazan, and absorbance was recorded by the DTX 800 multimode detector (Beckman Coulter, Fullerton, CA, USA) at 490 nm. The results were shown as the percentage of the control group.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Water-Solubility Experiment</h3><div class="NLM_p last">The water solubility of compounds <b>11</b>, <b>11·Ola</b>, CPX, and CPX olamine was determined by HPLC (Agilent 1100 with quaternary pump, DAD). Stock solutions of these samples were prepared in methanol. Then, 10 μL of dilute methanol solutions with concentrations of 0.1, 0.5, 0.8, 1, 1.6, 2, and 4 mg/mL were injected into the HPLC system to assess linearity. Calibration curves were plotted as the peak area versus the concentration of the sample. To prepare the saturated water solution, 10 mg of the compound was added to a 2 mL EP tube, and 0.5 mL of 0.9% saline was pipetted into the tube. If the solution was unsaturated and remained clear and transparent, the additional test compound was added. After stirring for 24 h, the solution was filtered with a syringe filter and 10 μL was injected into the HPLC system. Water solubility was calculated by comparing the peak area of the tested compound to the calibration curves.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Analysis of Apoptosis</h3><div class="NLM_p last">Apoptotic cells was identified through Annexin V-FITC and PI staining kit (BD Biosciences, San Jose, CA, USA). Annexin V-FITC stained phosphatidylserine before the loss of membrane integrity and detected the early apoptotic cells; membrane damage accompanies the later stages of cell death as a result of apoptotic or necrotic processes, which were permeable to PI-identified late apoptotic cells. SH-SY5Y cells were collected via centrifugation at 300<i>g</i> for 5 min. After washing twice with cold PBS, the cells were resuspended in 100 μL (1 × 10<sup>5</sup> cells) of the binding buffer. Annexin V-FITC (5 μL) and PI (5 μL) were added to the binding buffer, and the resulting mixture was incubated for 15 min at room temperature in the dark. Then, 400 μL binding buffer was added, and cells were measured through flow cytometry (BD Biosciences, San Jose, CA, USA) within 1 h.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> MCAO Model in Rats</h3><div class="NLM_p last">Focal cerebral ischemia was performed in male Sprague-Dawley rats (Shanghai Laboratory Animal Center, Chinese Academy of Sciences, China) through occlusion of the intraluminal middle cerebral artery using a reported method.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> All experimental procedures followed the National Institutes of Health Guide for the Care and Use of Laboratory Animals, as well as the guidelines of the Animal Care and Use Committee of Shanghai Institute of Materia Medica, Chinese Academy of Sciences. First, anesthetized rats with chloral hydrate (400 mg/kg, ip), and then, a 40 monofilament nylon suture (Beijing Sunbio Biotech Co., China) was introduced into the left internal carotid artery and positioned to occlude the MCA origin through the proximal external carotid artery. The suture was withdrawn to restore blood flow (reperfusion) after 2 h of occlusion. Saline (0.9%) solutions of edaravone (10 mg/kg), CPX olamine (3 mg/kg) and compound <b>11·Ola</b> (0.3 & 1 mg/kg) were injected through the tail vein immediately after reperfusion. The animal’s body temperature was maintained at 37.0 ± 0.5 °C through the surgical procedure.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Neurological Deficit Evaluation</h3><div class="NLM_p last">The neurological function was evaluated at 24 h after the reperfusion, according to the modified Neurological Severity Scores (mNSS).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The neurological deficits including motor, visual, and tactile responses, proprioception, performance on a balance beam, reflex responses, and abnormal movements (scale: 0–18; normal score, 0; maximal deficits core, 18) were graded by the mNSS. The experimenters blinded to the experimental groups performed the neurological scores assessment.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Measurements of Infarct Volume</h3><div class="NLM_p last">Infarct volumes were measured by triphenyltetrazolium chloride (TTC; Sinopharm Chemical Reagent Co. Ltd., Shanghai, China) staining. After mNSS evaluation, rat brain coronal sections (equally 2 mm thick) were prepared and stained with 1% TTC in a 37 °C chamber away from light for 15 min followed by fixation in paraformaldehyde solution (4%) for 24 h. Digital images were taken after the fixation and analyzed with the image analysis system (Image-Pro Plus). The infarct area was calculated by the formula: (area of normal hemisphere – area of noninfarcted ischemic hemisphere)/area of normal hemisphere × 100%.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> SH-SY5Y Cytotoxicity Assay</h3><div class="NLM_p last">SH-SY5Y cells were seeded into 96-well plates at a density of 3 × 10<sup>4</sup> cells/well and cultured for 24 h. For cytotoxicity assay, cells were treated with CPX olamine and compound <b>11·Ola</b> at the concentrations of 1.56, 3.13, 6.25, 12.5, 25, 50, and 100 μM and incubated for 24 h. For the other 20 compounds, two concentrations—1 and 10 μM were set. Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sangon Biotech, China) analysis and processed as described above. The cell viability was calculated and presented by the percentage of the no-treated control group.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> MRC-5 Cytotoxicity Assay</h3><div class="NLM_p last">MRC-5 (Medical Research Council cell strain 5) were cultured in the media which contained MEM +10% FBS +1% P/S +1% NEAA +1% SP in 5% carbon dioxygen atmosphere 37 °C. Cells were seeded into 96-well plates (Corning) at a density of 7000 cells per well for the following experiments. For the cytotoxicity test, cells were treated with CPX olamine and compound <b>11·Ola</b> at several concentrations for 72 h. Cell viability was measured by the cell counting kit (CCK-8), determined by measuring the absorbance at 450 nm. The cell viability was calculated and presented by the percentage of the vehicle-treated group.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Statistical Analysis</h3><div class="NLM_p last">All data were reported only if at least three independent experiments showed consistent results. The data were analyzed by one-way ANOVA followed by Dunnett’s test for multiple comparisons or by Student’s <i>t</i>-test for single comparison. Statistical significance was established at <i>p</i> value < 0.05.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01338" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44515" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44515" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01338?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01338</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">NMR multiplet reports and synthetic methods of the intermediates, HPLC reports for the purity check of compounds <b>1–31</b>, in vitro BBB permeation assay, oxygen radical absorbance capacity (ORAC-FL) assay, hERG cardiac toxicity assay, determination of metabolic stability in liver microsomes, bSDTNBI in silico prediction results, Fe-ion chelation experiment, effects of compounds on the viability of cells without insult, comparison of protective effects between compounds <b>11</b> and <b>16</b>, <sup>1</sup>H/<sup>13</sup>C NMR, MASS spectra and HPLC traces of compounds <b>1–31</b> and the intermediates, determination of the blood plasma concentrations of <b>11·Ola</b> and CPX olamine after intravenous administration in rats (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01338/suppl_file/jm9b01338_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01338/suppl_file/jm9b01338_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01338/suppl_file/jm9b01338_si_001.pdf">jm9b01338_si_001.pdf (11.97 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01338/suppl_file/jm9b01338_si_002.csv">jm9b01338_si_002.csv (2.94 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01338" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15811" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15811" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fei Mao</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span>; 
    <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5871-6878" title="Orcid link">http://orcid.org/0000-0001-5871-6878</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9bf6faf4fdfef2dbfef8eee8efb5feffeeb5f8f5"><span class="__cf_email__" data-cfemail="98f5f9f7fefdf1d8fdfbedebecb6fdfcedb6fbf6">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haiyan Zhang</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai Institute of Materia
Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, Beijing 100049, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2877-2040" title="Orcid link">http://orcid.org/0000-0002-2877-2040</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#244c5e4c454a4364574d49490a45470a474a"><span class="__cf_email__" data-cfemail="026a786a636c6542716b6f6f2c63612c616c">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Li</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span>; 
    <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7521-8798" title="Orcid link">http://orcid.org/0000-0002-7521-8798</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#cba1a2aaa5a7a28baea8beb8bfe5aeafbee5a8a5"><span class="__cf_email__" data-cfemail="22484b434c4e4b6247415751560c4746570c414c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Linghao Hu</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span>; 
    <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongxuan Feng</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai Institute of Materia
Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongguang Zhang</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai Institute of Materia
Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Songda Yu</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Institute of Materia Medica, Chinese Academy
of Sciences, 555 Zu Chong
Zhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qinyuan Zhao</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai Institute of Materia
Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Wang</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai Institute of Materia
Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fengxia Bao</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai Institute of Materia
Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xun Ding</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai Institute of Materia
Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiajing Hu</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manjiong Wang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span>; 
    <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yixiang Xu</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span>; 
    <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zengrui Wu</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaokang Li</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span>; 
    <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yun Tang</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2340-1109" title="Orcid link">http://orcid.org/0000-0003-2340-1109</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoyan Chen</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Institute of Materia Medica, Chinese Academy
of Sciences, 555 Zu Chong
Zhi Road, Shanghai 201203, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6559-8627" title="Orcid link">http://orcid.org/0000-0002-6559-8627</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>L.H. and H.F. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54844" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54844" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Natural Science Foundation of China (grants 81872747, 21672064, 81872859, and 81661148046), the National Key R&D Program of China (2017YFB0202600), the Innovative Research Team of High-level Local Universities in Shanghai, the National Special Fund for State Key Laboratory of Bioreactor Engineering (2060204), and the Shanghai Sailing Program (17YF1403600).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">Ola</td><td class="NLM_def"><p class="first last">olamine</p></td></tr><tr><td class="NLM_term">rtPA</td><td class="NLM_def"><p class="first last">recombinant tissue plasminogen activator</p></td></tr><tr><td class="NLM_term">NBP</td><td class="NLM_def"><p class="first last">racemic 3-<i>n</i>-butylphthalide</p></td></tr><tr><td class="NLM_term">I/R</td><td class="NLM_def"><p class="first last">ischemia–reperfusion</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">AIBN</td><td class="NLM_def"><p class="first last">azodiisobutyronitrile</p></td></tr><tr><td class="NLM_term"><i>m</i>CPBA</td><td class="NLM_def"><p class="first last">3-chloroperoxybenzoic acid</p></td></tr><tr><td class="NLM_term">NBS</td><td class="NLM_def"><p class="first last"><i>N</i>-bromosuccinimide</p></td></tr><tr><td class="NLM_term">NIS</td><td class="NLM_def"><p class="first last"><i>N</i>-iodosuccinimide</p></td></tr><tr><td class="NLM_term">NCS</td><td class="NLM_def"><p class="first last"><i>N</i>-chlorosuccinimide</p></td></tr><tr><td class="NLM_term">OGD</td><td class="NLM_def"><p class="first last">oxygen glucose deprivation</p></td></tr><tr><td class="NLM_term">CPX</td><td class="NLM_def"><p class="first last">ciclopirox</p></td></tr><tr><td class="NLM_term">MCAO</td><td class="NLM_def"><p class="first last">middle cerebral artery occlusion</p></td></tr><tr><td class="NLM_term">ORAC</td><td class="NLM_def"><p class="first last">oxygen radical absorbance capacity</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeability assay</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">bSDTNBI</td><td class="NLM_def"><p class="first last">balanced substructure–drug–target network-based inference</p></td></tr><tr><td class="NLM_term">HIF</td><td class="NLM_def"><p class="first last">hypoxia-inducible factor</p></td></tr><tr><td class="NLM_term">PHDs</td><td class="NLM_def"><p class="first last">prolyl hydroxylases</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08246" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08246" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 45 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Go, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozaffarian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roger, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benjamin, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaha, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullerton, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hailpern, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heit, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huffman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judd, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kissela, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittner, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lackland, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtman, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisabeth, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackey, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magid, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchar, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohler, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moy, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mussolino, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumar, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichol, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paynter, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorlie, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towfighi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turan, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virani, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, M. B.</span></span> <span> </span><span class="NLM_article-title">Executive Summary: Heart Disease and Stroke Statistics—2014 Update: a Report from the American Heart Association</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1161/01.cir.0000442015.53336.12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1161%2F01.cir.0000442015.53336.12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=24446411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A280%3ADC%252BC2cznt1ensg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2014&pages=399-410&author=A.+S.+Goauthor=D.+Mozaffarianauthor=V.+L.+Rogerauthor=E.+J.+Benjaminauthor=J.+D.+Berryauthor=M.+J.+Blahaauthor=S.+Daiauthor=E.+S.+Fordauthor=C.+S.+Foxauthor=S.+Francoauthor=H.+J.+Fullertonauthor=C.+Gillespieauthor=S.+M.+Hailpernauthor=J.+A.+Heitauthor=V.+J.+Howardauthor=M.+D.+Huffmanauthor=S.+E.+Juddauthor=B.+M.+Kisselaauthor=S.+J.+Kittnerauthor=D.+T.+Lacklandauthor=J.+H.+Lichtmanauthor=L.+D.+Lisabethauthor=R.+H.+Mackeyauthor=D.+J.+Magidauthor=G.+M.+Marcusauthor=A.+Marelliauthor=D.+B.+Matcharauthor=D.+K.+McGuireauthor=E.+R.+Mohlerauthor=C.+S.+Moyauthor=M.+E.+Mussolinoauthor=R.+W.+Neumarauthor=G.+Nicholauthor=D.+K.+Pandeyauthor=N.+P.+Paynterauthor=M.+J.+Reevesauthor=P.+D.+Sorlieauthor=J.+Steinauthor=A.+Towfighiauthor=T.+N.+Turanauthor=S.+S.+Viraniauthor=N.+D.+Wongauthor=D.+Wooauthor=M.+B.+Turnerauthor=M.+B.+Turner&title=Executive+Summary%3A+Heart+Disease+and+Stroke+Statistics%E2%80%942014+Update%3A+a+Report+from+the+American+Heart+Association&doi=10.1161%2F01.cir.0000442015.53336.12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association</span></div><div class="casAuthors">Go Alan S; Mozaffarian Dariush; Roger Veronique L; Benjamin Emelia J; Berry Jarett D; Blaha Michael J; Dai Shifan; Ford Earl S; Fox Caroline S; Franco Sheila; Fullerton Heather J; Gillespie Cathleen; Hailpern Susan M; Heit John A; Howard Virginia J; Huffman Mark D; Judd Suzanne E; Kissela Brett M; Kittner Steven J; Lackland Daniel T; Lichtman Judith H; Lisabeth Lynda D; Mackey Rachel H; Magid David J; Marcus Gregory M; Marelli Ariane; Matchar David B; McGuire Darren K; Mohler Emile R 3rd; Moy Claudia S; Mussolino Michael E; Neumar Robert W; Nichol Graham; Pandey Dilip K; Paynter Nina P; Reeves Matthew J; Sorlie Paul D; Stein Joel; Towfighi Amytis; Turan Tanya N; Virani Salim S; Wong Nathan D; Woo Daniel; Turner Melanie B</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">399-410</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRd1A4UrEIWorHHuJhbyicZfW6udTcc2eYs0F0gy29aBbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cznt1ensg%253D%253D&md5=73c5195faf3dfb3eed5369e27e4f231e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1161%2F01.cir.0000442015.53336.12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.cir.0000442015.53336.12%26sid%3Dliteratum%253Aachs%26aulast%3DGo%26aufirst%3DA.%2BS.%26aulast%3DMozaffarian%26aufirst%3DD.%26aulast%3DRoger%26aufirst%3DV.%2BL.%26aulast%3DBenjamin%26aufirst%3DE.%2BJ.%26aulast%3DBerry%26aufirst%3DJ.%2BD.%26aulast%3DBlaha%26aufirst%3DM.%2BJ.%26aulast%3DDai%26aufirst%3DS.%26aulast%3DFord%26aufirst%3DE.%2BS.%26aulast%3DFox%26aufirst%3DC.%2BS.%26aulast%3DFranco%26aufirst%3DS.%26aulast%3DFullerton%26aufirst%3DH.%2BJ.%26aulast%3DGillespie%26aufirst%3DC.%26aulast%3DHailpern%26aufirst%3DS.%2BM.%26aulast%3DHeit%26aufirst%3DJ.%2BA.%26aulast%3DHoward%26aufirst%3DV.%2BJ.%26aulast%3DHuffman%26aufirst%3DM.%2BD.%26aulast%3DJudd%26aufirst%3DS.%2BE.%26aulast%3DKissela%26aufirst%3DB.%2BM.%26aulast%3DKittner%26aufirst%3DS.%2BJ.%26aulast%3DLackland%26aufirst%3DD.%2BT.%26aulast%3DLichtman%26aufirst%3DJ.%2BH.%26aulast%3DLisabeth%26aufirst%3DL.%2BD.%26aulast%3DMackey%26aufirst%3DR.%2BH.%26aulast%3DMagid%26aufirst%3DD.%2BJ.%26aulast%3DMarcus%26aufirst%3DG.%2BM.%26aulast%3DMarelli%26aufirst%3DA.%26aulast%3DMatchar%26aufirst%3DD.%2BB.%26aulast%3DMcGuire%26aufirst%3DD.%2BK.%26aulast%3DMohler%26aufirst%3DE.%2BR.%26aulast%3DMoy%26aufirst%3DC.%2BS.%26aulast%3DMussolino%26aufirst%3DM.%2BE.%26aulast%3DNeumar%26aufirst%3DR.%2BW.%26aulast%3DNichol%26aufirst%3DG.%26aulast%3DPandey%26aufirst%3DD.%2BK.%26aulast%3DPaynter%26aufirst%3DN.%2BP.%26aulast%3DReeves%26aufirst%3DM.%2BJ.%26aulast%3DSorlie%26aufirst%3DP.%2BD.%26aulast%3DStein%26aufirst%3DJ.%26aulast%3DTowfighi%26aufirst%3DA.%26aulast%3DTuran%26aufirst%3DT.%2BN.%26aulast%3DVirani%26aufirst%3DS.%2BS.%26aulast%3DWong%26aufirst%3DN.%2BD.%26aulast%3DWoo%26aufirst%3DD.%26aulast%3DTurner%26aufirst%3DM.%2BB.%26aulast%3DTurner%26aufirst%3DM.%2BB.%26atitle%3DExecutive%2520Summary%253A%2520Heart%2520Disease%2520and%2520Stroke%2520Statistics%25E2%2580%25942014%2520Update%253A%2520a%2520Report%2520from%2520the%2520American%2520Heart%2520Association%26jtitle%3DCirculation%26date%3D2014%26volume%3D129%26spage%3D399%26epage%3D410%26doi%3D10.1161%2F01.cir.0000442015.53336.12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naghavi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abajobir, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbafati, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbas, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abd-Allah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abera, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aboyans, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adetokunboh, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afshin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, M. B.</span></span> <span> </span><span class="NLM_article-title">Global, Regional, and National Age-sex Specific Mortality for 264 Causes of Death, 1980–2016: a Systematic Analysis for the Global Burden of Disease Study 2016</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>390</i></span>,  <span class="NLM_fpage">1151</span>– <span class="NLM_lpage">1210</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(17)32152-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1016%2FS0140-6736%2817%2932152-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=28919116" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2017&pages=1151-1210&author=M.+Naghaviauthor=A.+A.+Abajobirauthor=C.+Abbafatiauthor=K.+M.+Abbasauthor=F.+Abd-Allahauthor=S.+F.+Aberaauthor=V.+Aboyansauthor=O.+Adetokunbohauthor=A.+Afshinauthor=A.+Agrawalauthor=A.+Ahmadiauthor=M.+B.+Ahmed&title=Global%2C+Regional%2C+and+National+Age-sex+Specific+Mortality+for+264+Causes+of+Death%2C+1980%E2%80%932016%3A+a+Systematic+Analysis+for+the+Global+Burden+of+Disease+Study+2016&doi=10.1016%2FS0140-6736%2817%2932152-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2817%2932152-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252817%252932152-9%26sid%3Dliteratum%253Aachs%26aulast%3DNaghavi%26aufirst%3DM.%26aulast%3DAbajobir%26aufirst%3DA.%2BA.%26aulast%3DAbbafati%26aufirst%3DC.%26aulast%3DAbbas%26aufirst%3DK.%2BM.%26aulast%3DAbd-Allah%26aufirst%3DF.%26aulast%3DAbera%26aufirst%3DS.%2BF.%26aulast%3DAboyans%26aufirst%3DV.%26aulast%3DAdetokunboh%26aufirst%3DO.%26aulast%3DAfshin%26aufirst%3DA.%26aulast%3DAgrawal%26aufirst%3DA.%26aulast%3DAhmadi%26aufirst%3DA.%26aulast%3DAhmed%26aufirst%3DM.%2BB.%26atitle%3DGlobal%252C%2520Regional%252C%2520and%2520National%2520Age-sex%2520Specific%2520Mortality%2520for%2520264%2520Causes%2520of%2520Death%252C%25201980%25E2%2580%25932016%253A%2520a%2520Systematic%2520Analysis%2520for%2520the%2520Global%2520Burden%2520of%2520Disease%2520Study%25202016%26jtitle%3DLancet%26date%3D2017%26volume%3D390%26spage%3D1151%26epage%3D1210%26doi%3D10.1016%2FS0140-6736%2817%2932152-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">GBD
2016 Disease and Injury Incidence and Prevalence Collaborators</span> <span> </span><span class="NLM_article-title">Global, Regional, and National Incidence,
Prevalence, and Years Lived with Disability for 328 Diseases and Injuries
for 195 Countries, 1990–2016: A Systematic Analysis for the
Global Burden of Disease Study 2016</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>390</i></span>,  <span class="NLM_fpage">1211</span>– <span class="NLM_lpage">1259</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(17)32154-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1016%2FS0140-6736%2817%2932154-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=28919117" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2017&pages=1211-1259&author=GBD%0A2016+Disease+and+Injury+Incidence+and+Prevalence+Collaborators&title=Global%2C+Regional%2C+and+National+Incidence%2C%0APrevalence%2C+and+Years+Lived+with+Disability+for+328+Diseases+and+Injuries%0Afor+195+Countries%2C+1990%E2%80%932016%3A+A+Systematic+Analysis+for+the%0AGlobal+Burden+of+Disease+Study+2016&doi=10.1016%2FS0140-6736%2817%2932154-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2817%2932154-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252817%252932154-2%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DGlobal%252C%2520Regional%252C%2520and%2520National%2520Incidence%252C%250APrevalence%252C%2520and%2520Years%2520Lived%2520with%2520Disability%2520for%2520328%2520Diseases%2520and%2520Injuries%250Afor%2520195%2520Countries%252C%25201990%25E2%2580%25932016%253A%2520A%2520Systematic%2520Analysis%2520for%2520the%250AGlobal%2520Burden%2520of%2520Disease%2520Study%25202016%26jtitle%3DLancet%26date%3D2017%26volume%3D390%26spage%3D1211%26epage%3D1259%26doi%3D10.1016%2FS0140-6736%2817%2932154-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wardlaw, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berge, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Zoppo, G. J.</span></span> <span> </span><span class="NLM_article-title">Thrombolysis for Acute Ischaemic Stroke</span>. <i>Cochrane Database Syst. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">CD000213</span>, <span class="refDoi"> DOI: 10.1002/14651858.CD000213.pub3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1002%2F14651858.CD000213.pub3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=CD000213&author=J.+M.+Wardlawauthor=V.+Murrayauthor=E.+Bergeauthor=G.+J.+del+Zoppo&title=Thrombolysis+for+Acute+Ischaemic+Stroke&doi=10.1002%2F14651858.CD000213.pub3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD000213.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD000213.pub3%26sid%3Dliteratum%253Aachs%26aulast%3DWardlaw%26aufirst%3DJ.%2BM.%26aulast%3DMurray%26aufirst%3DV.%26aulast%3DBerge%26aufirst%3DE.%26aulast%3Ddel%2BZoppo%26aufirst%3DG.%2BJ.%26atitle%3DThrombolysis%2520for%2520Acute%2520Ischaemic%2520Stroke%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2014%26volume%3D7%26spage%3DCD000213%26doi%3D10.1002%2F14651858.CD000213.pub3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">(accessed July 21, 2019)</p></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zahuranec, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majersik, J. J.</span></span> <span> </span><span class="NLM_article-title">Percentage of Acute Stroke Patients Eligible for Endovascular Treatment</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">S22</span>– <span class="NLM_lpage">S25</span>, <span class="refDoi"> DOI: 10.1212/wnl.0b013e31826957cf</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1212%2Fwnl.0b013e31826957cf" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=23008402" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2012&pages=S22-S25&author=D.+B.+Zahuranecauthor=J.+J.+Majersik&title=Percentage+of+Acute+Stroke+Patients+Eligible+for+Endovascular+Treatment&doi=10.1212%2Fwnl.0b013e31826957cf"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1212%2Fwnl.0b013e31826957cf&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252Fwnl.0b013e31826957cf%26sid%3Dliteratum%253Aachs%26aulast%3DZahuranec%26aufirst%3DD.%2BB.%26aulast%3DMajersik%26aufirst%3DJ.%2BJ.%26atitle%3DPercentage%2520of%2520Acute%2520Stroke%2520Patients%2520Eligible%2520for%2520Endovascular%2520Treatment%26jtitle%3DNeurology%26date%3D2012%26volume%3D79%26spage%3DS22%26epage%3DS25%26doi%3D10.1212%2Fwnl.0b013e31826957cf" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Edaravone
Acute Infarction Study Group</span> <span> </span><span class="NLM_article-title">Effect of a Novel Free Radical Scavenger, Edaravone (MCI-186), on
Acute Brain Infarction. Randomized, Placebo-controlled, Double-blind
Study at Multicenters</span>. <i>Cerebrovasc. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">222</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1159/000069318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1159%2F000069318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=12715790" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=222-229&author=Edaravone%0AAcute+Infarction+Study+Group&title=Effect+of+a+Novel+Free+Radical+Scavenger%2C+Edaravone+%28MCI-186%29%2C+on%0AAcute+Brain+Infarction.+Randomized%2C+Placebo-controlled%2C+Double-blind%0AStudy+at+Multicenters&doi=10.1159%2F000069318"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1159%2F000069318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000069318%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DEffect%2520of%2520a%2520Novel%2520Free%2520Radical%2520Scavenger%252C%2520Edaravone%2520%2528MCI-186%2529%252C%2520on%250AAcute%2520Brain%2520Infarction.%2520Randomized%252C%2520Placebo-controlled%252C%2520Double-blind%250AStudy%2520at%2520Multicenters%26jtitle%3DCerebrovasc.%2520Dis.%26date%3D2003%26volume%3D15%26spage%3D222%26epage%3D229%26doi%3D10.1159%2F000069318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, M.</span></span> <span> </span><span class="NLM_article-title">Meta-analysis of Effect of dl-3-butylphthalide Injection on Neurological Function of Patients with Acute Cerebral Infarction</span>. <i>Chin. J. New Drugs Clin. Rem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=492-498&author=H.+Xieauthor=L.+Wangauthor=M.+Hanauthor=M.+Yao&title=Meta-analysis+of+Effect+of+dl-3-butylphthalide+Injection+on+Neurological+Function+of+Patients+with+Acute+Cerebral+Infarction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DM.%26atitle%3DMeta-analysis%2520of%2520Effect%2520of%2520dl-3-butylphthalide%2520Injection%2520on%2520Neurological%2520Function%2520of%2520Patients%2520with%2520Acute%2520Cerebral%2520Infarction%26jtitle%3DChin.%2520J.%2520New%2520Drugs%2520Clin.%2520Rem.%26date%3D2016%26volume%3D7%26spage%3D492%26epage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chavez, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barone, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feuerstein, G. Z.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic Interventions for Stroke</span>. <i>Stroke</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">e558</span>– <span class="NLM_lpage">e563</span>, <span class="refDoi"> DOI: 10.1161/strokeaha.109.559914</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1161%2Fstrokeaha.109.559914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=19745180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGjsb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2009&pages=e558-e563&author=J.+C.+Chavezauthor=O.+Hurkoauthor=F.+C.+Baroneauthor=G.+Z.+Feuerstein&title=Pharmacologic+Interventions+for+Stroke&doi=10.1161%2Fstrokeaha.109.559914"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic Interventions for Stroke: Looking Beyond the Thrombolysis Time Window into the Penumbra with Biomarkers, not a Stop Watch</span></div><div class="casAuthors">Chavez, Juan C.; Hurko, Orest; Barone, Frank C.; Feuerstein, Giora Z.</div><div class="citationInfo"><span class="NLM_cas:title">Stroke</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e558-e563</span>CODEN:
                <span class="NLM_cas:coden">SJCCA7</span>;
        ISSN:<span class="NLM_cas:issn">0039-2499</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Background and Purpose: The majority of pharmacol. agents for stroke were developed based on the assumption that neurol. deficits will be reduced upon the successful interruption of biochem. mechanisms leading to neuronal death.  Despite significant evidence of preclin. efficacy, none of these agents succeeded.  They either failed to demonstrate efficacy in the clinic or their development was halted for safety, strategic, or com. reasons.  Summary of Review: This "neuroprotection strategy" has focused primarily on targets in the neurotoxic environment that occurs under ischemic conditions.  In many cases, these agents were designed to tackle events that are known to start almost immediately after onset of ischemia, which is far before a realistic therapeutic time window opens for most, if not all, patients with stroke.  In other instances, they were evaluated beyond a realistic timeframe in which one could expect significant salvageable tissue or penumbra to exist.  Surprisingly, most of these agents were not evaluated in conjunction with strategies for improving perfusion to the affected tissue, indicating an overoptimistic assumption that neuroprotection alone could be sufficient to halt injury caused by an abrupt interruption of brain blood flow.  Conclusions: We provide a constructive translational medicine perspective about how one could improve the drug development process with the hope that the probability for success can increase in our quest to establish a novel therapy for stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUbehRObDyBrVg90H21EOLACvtfcHk0ljsVpit5a1tEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGjsb%252FJ&md5=db4161cadb475322fee461ce595de317</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1161%2Fstrokeaha.109.559914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252Fstrokeaha.109.559914%26sid%3Dliteratum%253Aachs%26aulast%3DChavez%26aufirst%3DJ.%2BC.%26aulast%3DHurko%26aufirst%3DO.%26aulast%3DBarone%26aufirst%3DF.%2BC.%26aulast%3DFeuerstein%26aufirst%3DG.%2BZ.%26atitle%3DPharmacologic%2520Interventions%2520for%2520Stroke%26jtitle%3DStroke%26date%3D2009%26volume%3D40%26spage%3De558%26epage%3De563%26doi%3D10.1161%2Fstrokeaha.109.559914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chioua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Alonso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalo-Gobernado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayuso, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escobar-Peso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infantes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadjipavlou-Litina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoya, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montaner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcázar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">New Quinolylnitrones for Stroke Therapy: Antioxidant and Neuroprotective. (Z)-N-t-Butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine Oxide as a New Lead-Compound for Ischemic Stroke Treatment</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2184</span>– <span class="NLM_lpage">2201</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01987</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01987" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVWjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2184-2201&author=M.+Chiouaauthor=E.+Mart%C3%ADnez-Alonsoauthor=R.+Gonzalo-Gobernadoauthor=M.+I.+Ayusoauthor=A.+Escobar-Pesoauthor=L.+Infantesauthor=D.+Hadjipavlou-Litinaauthor=J.+J.+Montoyaauthor=J.+Montanerauthor=A.+Alc%C3%A1zarauthor=J.+Marco-Contelles&title=New+Quinolylnitrones+for+Stroke+Therapy%3A+Antioxidant+and+Neuroprotective.+%28Z%29-N-t-Butyl-1-%282-chloro-6-methoxyquinolin-3-yl%29methanimine+Oxide+as+a+New+Lead-Compound+for+Ischemic+Stroke+Treatment&doi=10.1021%2Facs.jmedchem.8b01987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">New Quinolylnitrones for Stroke Therapy: Antioxidant and Neuroprotective (Z)-N-tert-Butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine Oxide as a New Lead-Compound for Ischemic Stroke Treatment</span></div><div class="casAuthors">Chioua, Mourad; Martinez-Alonso, Emma; Gonzalo-Gobernado, Rafael; Ayuso, Maria I.; Escobar-Peso, Alejandro; Infantes, Lourdes; Hadjipavlou-Litina, Dimitra; Montoya, Juan J.; Montaner, Joan; Alcazar, Alberto; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2184-2201</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe herein the synthesis and neuroprotective capacity of an array of 31 compds. comprising quinolyloximes, quinolylhydrazones, quinolylimines, QNs, and related heterocyclic azolylnitrones.  Neuronal cultures subjected to oxygen-glucose deprivation (OGD), as exptl. model for ischemic conditions, were treated with our mols. at the onset of recovery period after OGD and showed that most of these QNs, but not the azo mols., improved neuronal viability 24 h after recovery.  Esp., QN (Z)-N-tert-butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine oxide (I) was shown as a very potent neuroprotective agent.  Antioxidant anal. based on the ability of I to trap different types of toxic radical oxygenated species supported and confirmed its strong neuroprotective capacity.  Finally, I showed also neuroprotection induction in two in vivo models of cerebral ischemia, decreasing neuronal death and reducing infarct size, allowing us to conclude that I can be considered as new lead-compd. for ischemic stroke treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfCp1AW7e0XLVg90H21EOLACvtfcHk0liimiR7Xq48fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVWjtbs%253D&md5=0f23023ae2328f11dab4bf332442d636</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01987%26sid%3Dliteratum%253Aachs%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DMart%25C3%25ADnez-Alonso%26aufirst%3DE.%26aulast%3DGonzalo-Gobernado%26aufirst%3DR.%26aulast%3DAyuso%26aufirst%3DM.%2BI.%26aulast%3DEscobar-Peso%26aufirst%3DA.%26aulast%3DInfantes%26aufirst%3DL.%26aulast%3DHadjipavlou-Litina%26aufirst%3DD.%26aulast%3DMontoya%26aufirst%3DJ.%2BJ.%26aulast%3DMontaner%26aufirst%3DJ.%26aulast%3DAlc%25C3%25A1zar%26aufirst%3DA.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DNew%2520Quinolylnitrones%2520for%2520Stroke%2520Therapy%253A%2520Antioxidant%2520and%2520Neuroprotective.%2520%2528Z%2529-N-t-Butyl-1-%25282-chloro-6-methoxyquinolin-3-yl%2529methanimine%2520Oxide%2520as%2520a%2520New%2520Lead-Compound%2520for%2520Ischemic%2520Stroke%2520Treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2184%26epage%3D2201%26doi%3D10.1021%2Facs.jmedchem.8b01987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arundine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tymianski, M.</span></span> <span> </span><span class="NLM_article-title">Molecular Mechanisms of Glutamate-dependent Neurodegeneration in Ischemia and Traumatic Brain Injury</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">668</span>, <span class="refDoi"> DOI: 10.1007/s00018-003-3319-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1007%2Fs00018-003-3319-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=15052409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsFyrtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2004&pages=657-668&author=M.+Arundineauthor=M.+Tymianski&title=Molecular+Mechanisms+of+Glutamate-dependent+Neurodegeneration+in+Ischemia+and+Traumatic+Brain+Injury&doi=10.1007%2Fs00018-003-3319-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury</span></div><div class="casAuthors">Arundine, M.; Tymianski, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">657-668</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Stroke and neuro trauma mediate neuronal death through a series of events that involve multiple interdependent mol. pathways.  It has been suggested that these pathways are triggered following elevations in extracellular excitatory amino acids, primarily glutamate.  This report outlines mechanisms involving glutamate-mediated excitotoxicity with specific focus on (i) the role of Ca2+ in neurotoxicity, (ii) the concept of "source specificity" of neurotoxicity, (iii) the role of the ionotropic N-methyl-D-aspartate (NMDA)-subtype glutamate receptor and its assocd. submembrane mols. that may give rise to signaling specificity in excitotoxicity and (iv) the role of glutamate-mediated free-radical generation and assocd. cell death pathways.  We also highlight a novel, peptide-based approach for uncoupling NMDA receptors from excitotoxicity in the rat central nervous system subjected to focal ischemia, thereby reducing stroke infarct vol. and improving neurol. functioning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz1t1bFIW-SrVg90H21EOLACvtfcHk0liimiR7Xq48fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsFyrtbo%253D&md5=33699e6badf3c87f2a6719d1e5731180</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00018-003-3319-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-003-3319-x%26sid%3Dliteratum%253Aachs%26aulast%3DArundine%26aufirst%3DM.%26aulast%3DTymianski%26aufirst%3DM.%26atitle%3DMolecular%2520Mechanisms%2520of%2520Glutamate-dependent%2520Neurodegeneration%2520in%2520Ischemia%2520and%2520Traumatic%2520Brain%2520Injury%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2004%26volume%3D61%26spage%3D657%26epage%3D668%26doi%3D10.1007%2Fs00018-003-3319-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span> <span> </span><span class="NLM_article-title">Role of Inflammation and Its Mediators in Acute Ischemic Stroke</span>. <i>J. Cardiovasc. Transl. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">834</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.1007/s12265-013-9508-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1007%2Fs12265-013-9508-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=24006091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A280%3ADC%252BC3sbltlGqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=834-851&author=R.+Jinauthor=L.+Liuauthor=S.+Zhangauthor=A.+Nandaauthor=G.+Li&title=Role+of+Inflammation+and+Its+Mediators+in+Acute+Ischemic+Stroke&doi=10.1007%2Fs12265-013-9508-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Role of inflammation and its mediators in acute ischemic stroke</span></div><div class="casAuthors">Jin Rong; Liu Lin; Zhang Shihao; Nanda Anil; Li Guohong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cardiovascular translational research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">834-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammation plays an important role in the pathogenesis of ischemic stroke and other forms of ischemic brain injury.  Increasing evidence suggests that inflammatory response is a double-edged sword, as it not only exacerbates secondary brain injury in the acute stage of stroke but also beneficially contributes to brain recovery after stroke.  In this article, we provide an overview on the role of inflammation and its mediators in acute ischemic stroke.  We discuss various pro-inflammatory and anti-inflammatory responses in different phases after ischemic stroke and the possible reasons for their failures in clinical trials.  Undoubtedly, there is still much to be done in order to translate promising pre-clinical findings into clinical practice.  A better understanding of the dynamic balance between pro- and anti-inflammatory responses and identifying the discrepancies between pre-clinical studies and clinical trials may serve as a basis for designing effective therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkoa7zhFP3lTjk2McQZ6XmfW6udTcc2eYLg_lBf2h3grntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbltlGqug%253D%253D&md5=6304a78caaf8d0514af563f73db5480f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs12265-013-9508-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12265-013-9508-6%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DNanda%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DG.%26atitle%3DRole%2520of%2520Inflammation%2520and%2520Its%2520Mediators%2520in%2520Acute%2520Ischemic%2520Stroke%26jtitle%3DJ.%2520Cardiovasc.%2520Transl.%2520Res.%26date%3D2013%26volume%3D6%26spage%3D834%26epage%3D851%26doi%3D10.1007%2Fs12265-013-9508-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-m.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-l.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, H.-x.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.-m.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-y.</span></span> <span> </span><span class="NLM_article-title">Dual Anti-ischemic Effects of Rosmarinic Acid n-Butyl Ester via Alleviation of DAPK-p53-mediated Neuronal Damage and Microglial Inflammation</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">468</span>, <span class="refDoi"> DOI: 10.1038/aps.2016.156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1038%2Faps.2016.156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=28216621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsV2qurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=459-468&author=L.+Wuauthor=H.-m.+Wangauthor=J.-l.+Liauthor=H.-x.+Fengauthor=W.-m.+Zhaoauthor=H.-y.+Zhang&title=Dual+Anti-ischemic+Effects+of+Rosmarinic+Acid+n-Butyl+Ester+via+Alleviation+of+DAPK-p53-mediated+Neuronal+Damage+and+Microglial+Inflammation&doi=10.1038%2Faps.2016.156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Dual anti-ischemic effects of rosmarinic acid n-butyl ester via alleviation of DAPK-p53-mediated neuronal damage and microglial inflammation</span></div><div class="casAuthors">Wu, Lei; Wang, Hong-min; Li, Jin-long; Feng, Hong-xuan; Zhao, Wei-min; Zhang, Hai-yan</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">459-468</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The discovery of efficacious anti-ischemic drugs remains a challenge.  Recently we have found that rosmarinic acid Bu ester (RABE), a deriv. of rosmarinic acid, significantly protects SH-SY5Y cells against oxygen glucose deprivation (OGD)-induced cell death.  In the present study we simultaneously investigated the effects of RABE on the two key players in the pathophysiol. of cerebral ischemia, ischemic neuronal damage and microglial inflammation.  Pretreatment with RABE (1, 10 μmol/L) dose-dependently attenuated OGD- or H2O2-induced redn. of the viability of SH-SY5Y neuroblastoma cells.  RABE pretreatment concurrently reduced the apoptotic cell rate, down-regulated the expression of the pro-apoptotic proteins Bax and p53, and up-regulated the expression of the anti-apoptotic protein phosphorylated death-assocd. protein kinase (DAPK).  Furthermore, pretreatment with RABE (3 μmol/L) markedly inhibited lipopolysaccharide (LPS)-induced increases in the release of TNF-α, IL-1β, NO and PGE2, and the expression levels of iNOS, and COX-2 in cultured rat microglial cells.  In conclusion, these results reveal for the first time the potential anti-ischemic effects of RABE on neuronal and glial cells and elucidate the mol. mechanisms involved in its dual beneficial profiles in vitro.  RABE may be a promising drug lead/candidate for the treatment of ischemic stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7dcgNIOLyhLVg90H21EOLACvtfcHk0lh2ie5kc524nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsV2qurc%253D&md5=ac8a694b16950a11c50ee0ca40511b8b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Faps.2016.156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2016.156%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.-m.%26aulast%3DLi%26aufirst%3DJ.-l.%26aulast%3DFeng%26aufirst%3DH.-x.%26aulast%3DZhao%26aufirst%3DW.-m.%26aulast%3DZhang%26aufirst%3DH.-y.%26atitle%3DDual%2520Anti-ischemic%2520Effects%2520of%2520Rosmarinic%2520Acid%2520n-Butyl%2520Ester%2520via%2520Alleviation%2520of%2520DAPK-p53-mediated%2520Neuronal%2520Damage%2520and%2520Microglial%2520Inflammation%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2017%26volume%3D38%26spage%3D459%26epage%3D468%26doi%3D10.1038%2Faps.2016.156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. Y.</span></span> <span> </span><span class="NLM_article-title">A Novel Caffeoyl Triterpene Attenuates Cerebral Ischemic Injury with Potent Anti-inflammatory and Hypothermic Effects</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1111/jnc.13046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1111%2Fjnc.13046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=25626516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVSmtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2015&pages=93-103&author=Z.+Ruanauthor=H.+M.+Wangauthor=X.+T.+Huangauthor=Y.+Fuauthor=J.+Wuauthor=C.+Y.+Yeauthor=J.+L.+Liauthor=L.+Wuauthor=Q.+Gongauthor=W.+M.+Zhaoauthor=H.+Y.+Zhang&title=A+Novel+Caffeoyl+Triterpene+Attenuates+Cerebral+Ischemic+Injury+with+Potent+Anti-inflammatory+and+Hypothermic+Effects&doi=10.1111%2Fjnc.13046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A novel caffeoyl triterpene attenuates cerebral ischemic injury with potent anti-inflammatory and hypothermic effects</span></div><div class="casAuthors">Ruan, Zhi; Wang, Hong Min; Huang, Xiao Tian; Fu, Yan; Wu, Jian; Ye, Chun Yan; Li, Jin Long; Wu, Lei; Gong, Qi; Zhao, Wei Min; Zhang, Hai Yan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-103</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Despite the intense efforts in searching for stroke therapies, an urgent need still exists to explore novel neuroprotective agents for ischemic stroke that have high efficacy and wide therapeutic time-window.  Here, we provide the first demonstration that 28-O-caffeoyl betulin (B-CA), a novel deriv. of naturally occurring caffeoyl triterpene, could significantly alleviate brain infarction and neurol. deficit when given as late as 6 h after transient middle cerebral artery occlusion in the rat.  Moreover, post-ischemia B-CA administration exhibited long-term (14 days post stroke) protective effects on both brain infarction and functional (i.e., motor and sensory) deficits.  Protective B-CA effects correlated with decreased inflammatory responses as indicated by inhibition of microglia and astrocyte activation [stained with ionized calcium-binding adapter mol. 1 (Iba-1) and glial fibrillary acidic protein (GFAP) antibody, resp.], as well as suppression of tumor necrosis factor-α, interleukin-1β, and cyclooxygenase-2 overprodn. in the ipsilateral cortex of ischemic rat.  B-CA administration caused significant hypothermia in the focal cerebral ischemic rat, which may contribute to its ameliorative effects on brain damage and inflammation.  In view of its potency in wide therapeutic time-window, robust anti-inflammatory and hypothermic effects, this novel caffeoyl triterpene deriv. may lead toward the development of effective therapeutic strategies for the treatment of ischemic stroke.  We documented for the first time that 28-O-caffeoyl betulin (B-CA), a novel synthetic caffeoyl triterpene inspired from active natural principles of Celastrus orbiculatus Thunb, possessed robust neuroprotection with a wide and clin. useful therapeutic time window against ischemic stroke, correlating with the anti-inflammatory and hypothermic effects.  Thus, this novel caffeoyl triterpene deriv. may lead toward the development of effective therapeutic strategies for the treatment of ischemic stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXEBFvuHBYv7Vg90H21EOLACvtfcHk0lh2ie5kc524nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVSmtb8%253D&md5=4fcfc14231aa604575f2d414209b837a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13046%26sid%3Dliteratum%253Aachs%26aulast%3DRuan%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DH.%2BM.%26aulast%3DHuang%26aufirst%3DX.%2BT.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DC.%2BY.%26aulast%3DLi%26aufirst%3DJ.%2BL.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DW.%2BM.%26aulast%3DZhang%26aufirst%3DH.%2BY.%26atitle%3DA%2520Novel%2520Caffeoyl%2520Triterpene%2520Attenuates%2520Cerebral%2520Ischemic%2520Injury%2520with%2520Potent%2520Anti-inflammatory%2520and%2520Hypothermic%2520Effects%26jtitle%3DJ.%2520Neurochem.%26date%3D2015%26volume%3D133%26spage%3D93%26epage%3D103%26doi%3D10.1111%2Fjnc.13046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potential Anti-Ischemic Stroke Agent: 3-Pentylbenzo[c]thiophen-1(3H)-one</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7173</span>– <span class="NLM_lpage">7181</span>, <span class="refDoi"> DOI: 10.1021/jm300681r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300681r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyns7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7173-7181&author=J.+Wuauthor=J.+Lingauthor=X.+Wangauthor=T.+Liauthor=J.+Liuauthor=Y.+Laiauthor=H.+Jiauthor=S.+Pengauthor=J.+Tianauthor=Y.+Zhang&title=Discovery+of+a+Potential+Anti-Ischemic+Stroke+Agent%3A+3-Pentylbenzo%5Bc%5Dthiophen-1%283H%29-one&doi=10.1021%2Fjm300681r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potential anti-ischemic stroke agent: 3-Pentylbenzo[c]thiophen-1(3H)-one</span></div><div class="casAuthors">Wu, Jing; Ling, Jingjing; Wang, Xuliang; Li, Tingting; Liu, Jingchao; Lai, Yisheng; Ji, Hui; Peng, Sixun; Tian, Jide; Zhang, Yihua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7173-7181</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of novel antithrombotic agents with strong free radical scavenging activity is of great significance for the treatment of ischemic stroke.  In the present study, 3-alkyl/arylalkyl-substituted benzo[c]thiophen-1(3H)-ones I(R = Et, nPr, Bu, pentyl,isopentyl, hexyl, heptyl, Bn) were designed and synthesized.  The most active compd. I(R = pentyl) significantly inhibited the ADP (ADP) induced and arachidonic acid (AA) induced in vitro platelet aggregation, superior to clin. used antiplatelet drug aspirin (ASP) and anti-ischemic stroke drugs 3-n-butylphthalide (NBP) and edaravone (Eda).  More importantly, in comparison with both NBP and Eda, I(R = pentyl) exhibited stronger antithrombotic and free radical scavenging activities and better or comparable neuroprotective effects against ischemia/reperfusion (I/R) in rats by ameliorating neurobehavioral function, reducing infarct size and brain-water content, attenuating cerebral damage, and normalizing the levels of oxidative enzymes.  Overall, our findings may provide an alternative strategy for the design of novel anti-ischemic stroke agents more potent than drugs like NBP and Eda.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpndCquiwopMbVg90H21EOLACvtfcHk0li2F-7GcBlR3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyns7fN&md5=a9bda7b9ed49ebd198d52acb83c6fd57</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm300681r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300681r%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLing%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520a%2520Potential%2520Anti-Ischemic%2520Stroke%2520Agent%253A%25203-Pentylbenzo%255Bc%255Dthiophen-1%25283H%2529-one%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7173%26epage%3D7181%26doi%3D10.1021%2Fjm300681r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maples, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, R. A.</span></span> <span> </span><span class="NLM_article-title">Nitrone-Related Therapeutics</span>. <i>CNS Drugs</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1071</span>– <span class="NLM_lpage">1084</span>, <span class="refDoi"> DOI: 10.2165/00023210-200418150-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.2165%2F00023210-200418150-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=15581379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVSmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1071-1084&author=K.+R.+Maplesauthor=A.+R.+Greenauthor=R.+A.+Floyd&title=Nitrone-Related+Therapeutics&doi=10.2165%2F00023210-200418150-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Nitrone-related therapeutics: potential of NXY-059 for the treatment of acute ischaemic stroke</span></div><div class="casAuthors">Maples, Kirk R.; Green, A. Richard; Floyd, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1071-1084</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  At present, none of the neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease and stroke are treatable with compds. that slow or halt neuronal cell death.  However, the prototype nitrone radical trap α-phenyl-tert-butylnitrone (PBN) has been shown to be an effective neuroprotective agent in various models of neurodegeneration.  Some of these data are briefly reviewed as an introduction to an examn. of the effect of the novel nitrone radical trapping agent disodium 2,4-disulfophenyl-N-tert-butylnitrone (NXY-059) in various animal models of stroke.  NXY-059 has been shown to be an effective neuroprotective agent in both transient (reperfusion) and permanent focal ischemia models in rats.  In both types of model, NXY-059 has a large window of opportunity, providing effective neuroprotection when given up to 5 h after the start of the occlusion in transient ischemia and 4 h after the start of permanent ischemia.  The compd. is also effective in a marmoset permanent ischemia model when administered up to 4 h after the start of the occlusion.  In this model it has been found to attenuate the problem of spatial neglect and maintain function to the paretic arm.  NXY-059 administration also improves motor function in a rat hemorrhagic stroke model and has a neuroprotective effect in a rabbit thromboembolic stroke model.  The compd. is also well tolerated in stroke patients at plasma levels shown to provide a max. neuroprotective effect in animal models of stroke.  NXY-059, like PBN, is a nitrone with free radical trapping properties and this may be the basis of its neuroprotective action.  However, expts. with PBN and NXY-059 suggest the possibility of other mechanisms being involved and these are also reviewed.  Further expts. are required to fully elucidate the mechanism of action of these very effective neuroprotective agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV5lI5bUg1OrVg90H21EOLACvtfcHk0li2F-7GcBlR3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVSmug%253D%253D&md5=3656154309f3ac81b5ef81add8c7ec78</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2165%2F00023210-200418150-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00023210-200418150-00003%26sid%3Dliteratum%253Aachs%26aulast%3DMaples%26aufirst%3DK.%2BR.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26aulast%3DFloyd%26aufirst%3DR.%2BA.%26atitle%3DNitrone-Related%2520Therapeutics%26jtitle%3DCNS%2520Drugs%26date%3D2004%26volume%3D18%26spage%3D1071%26epage%3D1084%26doi%3D10.2165%2F00023210-200418150-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lees, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zivin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashwood, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davalos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diener, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyden, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuaib, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hårdemark, H.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasiewski, W. W.</span></span> <span> </span><span class="NLM_article-title">NXY-059 for Acute Ischemic Stroke</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>354</i></span>,  <span class="NLM_fpage">588</span>– <span class="NLM_lpage">600</span>, <span class="refDoi"> DOI: 10.1056/nejmoa052980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1056%2Fnejmoa052980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=16467546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlKjt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2006&pages=588-600&author=K.+R.+Leesauthor=J.+A.+Zivinauthor=T.+Ashwoodauthor=A.+Davalosauthor=S.+M.+Davisauthor=H.-C.+Dienerauthor=J.+Grottaauthor=P.+Lydenauthor=A.+Shuaibauthor=H.-G.+H%C3%A5rdemarkauthor=W.+W.+Wasiewski&title=NXY-059+for+Acute+Ischemic+Stroke&doi=10.1056%2Fnejmoa052980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">NXY-059 for acute ischemic stroke</span></div><div class="casAuthors">Lees, Kennedy.; Zivin, Justin A.; Ashwood, Tim; Davalos, Antonio; Davis, Stephen M.; Diener, Hans-Christoph; Grotta, James; Lyden, Patrick; Shuaib, Ashfaq; Hardemark, Hans-Goran; Wasiewski, Warren W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">588-600</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">NXY-059 is a free-radical-trapping agent that is neuroprotective in animal models of stroke.  We tested whether it would reduce disability in humans after acute ischemic stroke.  We conducted a randomized, double-blind, placebo-controlled trial involving 1722 patients with acute ischemic stroke who were randomly assigned to receive a 72-h infusion of placebo or i.v. NXY-059 within 6 h after the onset of the stroke.  The primary outcome was disability at 90 days, as measured according to scores on the modified Rankin scale for disability (range, 0 to 5, with 0 indicating no residual symptoms and 5 indicating bed-bound, requiring const. care).  Among the 1699 subjects included in the efficacy anal., NXY-059 significantly improved the overall distribution of scores on the modified Rankin scale, as compared with placebo (P=0.038 by the Cochran-Mantel-Haenszel test).  The common odds ratio for improvement across all categories of the scale was 1.20 (95 % confidence interval, 1.01 to 1.42).  Mortality and rates of serious and nonserious adverse events were each similar in the two groups.  NXY-059 did not improve neurol. functioning as measured according to the National Institutes of Health Stroke Scale (NIHSS): the difference between the two groups in the change from baseline scores was 0.1 point (95 % confidence interval, -1.4 to 1.1; P = 0.86).  Likewise, no improvement was obsd. according to the Barthel index (P = 0.14).  In a post hoc anal. of patients who also received alteplase, NXY-059 was assocd. with a lower incidence of any hemorrhagic transformation (P=0.001) and symptomatic intracranial hemorrhage (P = 0.036).  The administration of NXY-059 within six hours after the onset of acute ischemic stroke significantly improved the primary outcome (reduced disability at 90 days), but it did not significantly improve other outcome measures, including neurol. functioning as measured by the NIHSS score.  Addnl. research is needed to confirm whether NXY-059 is beneficial in ischemic stroke. (ClinicalTrials.gov no., NCT00119626.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxgTdttmpFFLVg90H21EOLACvtfcHk0lhWcRbYXFlJRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlKjt70%253D&md5=5f26d20befc4af0fadff81d820af489c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa052980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa052980%26sid%3Dliteratum%253Aachs%26aulast%3DLees%26aufirst%3DK.%2BR.%26aulast%3DZivin%26aufirst%3DJ.%2BA.%26aulast%3DAshwood%26aufirst%3DT.%26aulast%3DDavalos%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DS.%2BM.%26aulast%3DDiener%26aufirst%3DH.-C.%26aulast%3DGrotta%26aufirst%3DJ.%26aulast%3DLyden%26aufirst%3DP.%26aulast%3DShuaib%26aufirst%3DA.%26aulast%3DH%25C3%25A5rdemark%26aufirst%3DH.-G.%26aulast%3DWasiewski%26aufirst%3DW.%2BW.%26atitle%3DNXY-059%2520for%2520Acute%2520Ischemic%2520Stroke%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D354%26spage%3D588%26epage%3D600%26doi%3D10.1056%2Fnejmoa052980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zivin, J. A.</span></span> <span> </span><span class="NLM_article-title">Clinical Trials of Neuroprotective Therapies</span>. <i>Stroke</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">791</span>– <span class="NLM_lpage">793</span>, <span class="refDoi"> DOI: 10.1161/01.str.0000252090.44428.82</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1161%2F01.str.0000252090.44428.82" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=17261740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FlslCrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2007&pages=791-793&author=J.+A.+Zivin&title=Clinical+Trials+of+Neuroprotective+Therapies&doi=10.1161%2F01.str.0000252090.44428.82"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical trials of neuroprotective therapies</span></div><div class="casAuthors">Zivin Justin A</div><div class="citationInfo"><span class="NLM_cas:title">Stroke</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2 Suppl</span>),
    <span class="NLM_cas:pages">791-3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">There have been numerous failures in the field of acute stroke therapy over many years, but the first large clinical trial showing preliminary indications of efficacy and safety of a neuroprotective drug, NXY-059, has now been fully reported.  If confirmed, it will mean that a second therapy for acute stroke has been identified and neuroprotective drug development as a class can proceed.  Additionally, a new class of drugs, HMG CoA-reductase inhibitors (statins), specifically high-dose atorvastatin, has been shown to be safe and effective for secondary stroke prevention.  This drug should now become a regular part of stroke patient care.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQq3s1xqi4_THwOGIfWJ7-GfW6udTcc2eaK5-oZWm1xD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FlslCrsQ%253D%253D&md5=011cda0d2f75a5e8d1ea01837f792880</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1161%2F01.str.0000252090.44428.82&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.str.0000252090.44428.82%26sid%3Dliteratum%253Aachs%26aulast%3DZivin%26aufirst%3DJ.%2BA.%26atitle%3DClinical%2520Trials%2520of%2520Neuroprotective%2520Therapies%26jtitle%3DStroke%26date%3D2007%26volume%3D38%26spage%3D791%26epage%3D793%26doi%3D10.1161%2F01.str.0000252090.44428.82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lohaus, G.</span>; <span class="NLM_string-name">Dittmar, W.</span></span> <span> </span><span class="NLM_article-title">Antimycotic 1-hydroxy-2-pyridones</span>. <span class="NLM_patent">ZA 6906039</span>, March 2, <span class="NLM_year">1970</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1970&author=G.+Lohaus&author=W.+Dittmar&title=Antimycotic+1-hydroxy-2-pyridones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLohaus%26aufirst%3DG.%26atitle%3DAntimycotic%25201-hydroxy-2-pyridones%26date%3D1970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larchmont, L. A. G.</span>; <span class="NLM_string-name">Farinelli, S. E.</span></span> <span> </span><span class="NLM_article-title">Use of Ciclopirox or a Pharmaceutically Acceptable Salt Thereof for Inhibiting Neuronal Cell Damage or Neuronal Cell Death</span>. U.S. Patent <span class="NLM_patent">5,846,984A</span>, Dec 8, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=L.+A.+G.+Larchmont&author=S.+E.+Farinelli&title=Use+of+Ciclopirox+or+a+Pharmaceutically+Acceptable+Salt+Thereof+for+Inhibiting+Neuronal+Cell+Damage+or+Neuronal+Cell+Death"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLarchmont%26aufirst%3DL.%2BA.%2BG.%26atitle%3DUse%2520of%2520Ciclopirox%2520or%2520a%2520Pharmaceutically%2520Acceptable%2520Salt%2520Thereof%2520for%2520Inhibiting%2520Neuronal%2520Cell%2520Damage%2520or%2520Neuronal%2520Cell%2520Death%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Repurposing Antimycotic Ciclopirox Olamine as a Promising Anti-ischemic Stroke Agent</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, (in press) <span class="refDoi"> DOI: 10.1016/j.apsb.2019.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1016%2Fj.apsb.2019.08.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=H.+Fengauthor=L.+Huauthor=H.+Zhuauthor=L.+Taoauthor=L.+Wuauthor=Q.+Zhaoauthor=Y.+Gaoauthor=Q.+Gongauthor=F.+Maoauthor=X.+Liauthor=H.+Zhouauthor=J.+Liauthor=H.+Zhang&title=Repurposing+Antimycotic+Ciclopirox+Olamine+as+a+Promising+Anti-ischemic+Stroke+Agent&doi=10.1016%2Fj.apsb.2019.08.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2019.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2019.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DTao%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DRepurposing%2520Antimycotic%2520Ciclopirox%2520Olamine%2520as%2520a%2520Promising%2520Anti-ischemic%2520Stroke%2520Agent%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2019%26doi%3D10.1016%2Fj.apsb.2019.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ayuso, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chioua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Alonso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montaner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masjuán, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadjipavlou-Litina, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcázar, A.</span></span> <span> </span><span class="NLM_article-title">CholesteroNitrones for Stroke</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6704</span>– <span class="NLM_lpage">6709</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00755</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00755" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1OqsLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6704-6709&author=M.+I.+Ayusoauthor=M.+Chiouaauthor=E.+Mart%C3%ADnez-Alonsoauthor=E.+Sorianoauthor=J.+Montanerauthor=J.+Masju%C3%A1nauthor=D.+J.+Hadjipavlou-Litinaauthor=J.+Marco-Contellesauthor=A.+Alc%C3%A1zar&title=CholesteroNitrones+for+Stroke&doi=10.1021%2Facs.jmedchem.5b00755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">CholesteroNitrones for Stroke</span></div><div class="casAuthors">Ayuso, Maria I.; Chioua, Mourad; Martinez-Alonso, Emma; Soriano, Elena; Montaner, Joan; Masjuan, Jaime; Hadjipavlou-Litina, Dimitra J.; Marco-Contelles, Jose; Alcazar, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6704-6709</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This study describes CholesteroNitrone as an antioxidant and neuroprotective agent against ischemic injury.  Neuroprotection was assessed using in vitro and in vivo exptl. ischemia models.  The compd. significantly increased cell viability, induced neuroprotection following ischemic reperfusion, and decreased neurol. deficit scores in treated animals, supporting the next preclin. studies as a potential agent for the treatment of stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlFdwoZbvfw7Vg90H21EOLACvtfcHk0liXqwt9HSLVsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1OqsLjF&md5=a42e237f98c64f29033e9f9952cad984</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00755%26sid%3Dliteratum%253Aachs%26aulast%3DAyuso%26aufirst%3DM.%2BI.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DMart%25C3%25ADnez-Alonso%26aufirst%3DE.%26aulast%3DSoriano%26aufirst%3DE.%26aulast%3DMontaner%26aufirst%3DJ.%26aulast%3DMasju%25C3%25A1n%26aufirst%3DJ.%26aulast%3DHadjipavlou-Litina%26aufirst%3DD.%2BJ.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DAlc%25C3%25A1zar%26aufirst%3DA.%26atitle%3DCholesteroNitrones%2520for%2520Stroke%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6704%26epage%3D6709%26doi%3D10.1021%2Facs.jmedchem.5b00755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chioua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sucunza, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadjipavlou-Litina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcázar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayuso, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oset-Gasque, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monjas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samadi, A.</span></span> <span> </span><span class="NLM_article-title">α-Aryl-N-alkyl Nitrones, as Potential Agents for Stroke Treatment: Synthesis, Theoretical Calculations, Antioxidant, Anti-inflammatory, Neuroprotective, and Brain–Blood Barrier Permeability Properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1021/jm201105a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201105a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFCms73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=153-168&author=M.+Chiouaauthor=D.+Sucunzaauthor=E.+Sorianoauthor=D.+Hadjipavlou-Litinaauthor=A.+Alc%C3%A1zarauthor=I.+Ayusoauthor=M.+J.+Oset-Gasqueauthor=M.+P.+Gonz%C3%A1lezauthor=L.+Monjasauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=J.+Marco-Contellesauthor=A.+Samadi&title=%CE%B1-Aryl-N-alkyl+Nitrones%2C+as+Potential+Agents+for+Stroke+Treatment%3A+Synthesis%2C+Theoretical+Calculations%2C+Antioxidant%2C+Anti-inflammatory%2C+Neuroprotective%2C+and+Brain%E2%80%93Blood+Barrier+Permeability+Properties&doi=10.1021%2Fjm201105a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">α-Aryl-N-alkyl Nitrones, as Potential Agents for Stroke Treatment: Synthesis, Theoretical Calculations, Antioxidant, Anti-inflammatory, Neuroprotective, and Brain-Blood Barrier Permeability Properties</span></div><div class="casAuthors">Chioua, Mourad; Sucunza, David; Soriano, Elena; Hadjipavlou-Litina, Dimitra; Alcazar, Alberto; Ayuso, Irene; Oset-Gasque, Maria Jesus; Gonzalez, Maria Pilar; Monjas, Leticia; Rodriguez-Franco, Maria Isabel; Marco-Contelles, Jose; Samadi, Abdelouahid</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153-168</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the synthesis, theor. calcns., the antioxidant, anti-inflammatory, and neuroprotective properties, and the ability to cross the blood-brain barrier (BBB) of (Z)-α-aryl and heteroaryl-N-alkyl nitrones as potential agents for stroke treatment.  The majority of nitrones compete with DMSO for hydroxyl radicals, and most of them are potent lipoxygenase inhibitors.  Cell viability-related (MTT assay) studies clearly showed that some of these nitrones give rise to significant neuroprotection.  When the compds. were tested for necrotic cell death (LDH release test), several of the nitrones proved to be neuroprotective agents.  In vitro evaluation of the BBB penetration of selected nitrones using the PAMPA-BBB assay showed that all of them cross the BBB.  Two permeable quinoline nitrones show potent combined antioxidant and neuroprotective properties and, therefore, can be considered as new lead compds. for further development in specific tests for potential stroke treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT5WLMSQF7qLVg90H21EOLACvtfcHk0liXqwt9HSLVsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFCms73O&md5=731f2b2ae0945585e8e65a669a3a53a4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm201105a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201105a%26sid%3Dliteratum%253Aachs%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DSucunza%26aufirst%3DD.%26aulast%3DSoriano%26aufirst%3DE.%26aulast%3DHadjipavlou-Litina%26aufirst%3DD.%26aulast%3DAlc%25C3%25A1zar%26aufirst%3DA.%26aulast%3DAyuso%26aufirst%3DI.%26aulast%3DOset-Gasque%26aufirst%3DM.%2BJ.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DM.%2BP.%26aulast%3DMonjas%26aufirst%3DL.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DSamadi%26aufirst%3DA.%26atitle%3D%25CE%25B1-Aryl-N-alkyl%2520Nitrones%252C%2520as%2520Potential%2520Agents%2520for%2520Stroke%2520Treatment%253A%2520Synthesis%252C%2520Theoretical%2520Calculations%252C%2520Antioxidant%252C%2520Anti-inflammatory%252C%2520Neuroprotective%252C%2520and%2520Brain%25E2%2580%2593Blood%2520Barrier%2520Permeability%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D153%26epage%3D168%26doi%3D10.1021%2Fjm201105a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tenti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parada, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">León, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Revelles, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briones, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menéndez, J. C.</span></span> <span> </span><span class="NLM_article-title">New 5-Unsubstituted Dihydropyridines with Improved CaV1.3 Selectivity as Potential Neuroprotective Agents against Ischemic Injury</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4313</span>– <span class="NLM_lpage">4323</span>, <span class="refDoi"> DOI: 10.1021/jm500263v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500263v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFWns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4313-4323&author=G.+Tentiauthor=E.+Paradaauthor=R.+Le%C3%B3nauthor=J.+Egeaauthor=S.+Mart%C3%ADnez-Revellesauthor=A.+M.+Brionesauthor=V.+Sridharanauthor=M.+G.+L%C3%B3pezauthor=M.+T.+Ramosauthor=J.+C.+Men%C3%A9ndez&title=New+5-Unsubstituted+Dihydropyridines+with+Improved+CaV1.3+Selectivity+as+Potential+Neuroprotective+Agents+against+Ischemic+Injury&doi=10.1021%2Fjm500263v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">New 5-Unsubstituted Dihydropyridines with Improved CaV1.3 Selectivity as Potential Neuroprotective Agents against Ischemic Injury</span></div><div class="casAuthors">Tenti, Giammarco; Parada, Esther; Leon, Rafael; Egea, Javier; Martinez-Revelles, Sonia; Briones, Ana Maria; Sridharan, Vellaisamy; Lopez, Manuela G.; Ramos, Maria Teresa; Menendez, J. Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4313-4323</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">C5-unsubstituted-C6-aryl-1,4-dihydropyridines were prepd. by a CAN-catalyzed multicomponent reaction from chalcones, β-dicarbonyl compds., and ammonium acetate.  These compds. were able to block Ca2+ entry after a depolarizing stimulus and showed an improved Cav1.3/Cav1.2 selectivity in comparison with nifedipine.  Furthermore, they were able to protect neuroblastoma cells against Ca2+ overload and oxidative stress models.  Their selectivity ratio makes them highly interesting for the treatment of neurol. disorders where Ca2+ dyshomeostasis and high levels of oxidative stress have been demonstrated.  Furthermore, their low potency toward the cardiovascular channel subtype makes them safer by reducing their probable side effects, in comparison to classical 1,4-dihydropyridines.  Some compds. afforded good protective profile in a postincubation model that simulates the real clin. situation of ictus patients, offering a therapeutic window of opportunity of great interest for patient recovery after a brain ischemic episode.  Good activities were also found in acute ischemia/reperfusion models of oxygen and glucose deprivation.  Compds. I and II were found to be most active.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE2qOTrNT3NbVg90H21EOLACvtfcHk0lh7XuL80sXg2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFWns74%253D&md5=f9ed28bdea3ac4d3dda8e06159f6e4b5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm500263v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500263v%26sid%3Dliteratum%253Aachs%26aulast%3DTenti%26aufirst%3DG.%26aulast%3DParada%26aufirst%3DE.%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DMart%25C3%25ADnez-Revelles%26aufirst%3DS.%26aulast%3DBriones%26aufirst%3DA.%2BM.%26aulast%3DSridharan%26aufirst%3DV.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DRamos%26aufirst%3DM.%2BT.%26aulast%3DMen%25C3%25A9ndez%26aufirst%3DJ.%2BC.%26atitle%3DNew%25205-Unsubstituted%2520Dihydropyridines%2520with%2520Improved%2520CaV1.3%2520Selectivity%2520as%2520Potential%2520Neuroprotective%2520Agents%2520against%2520Ischemic%2520Injury%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4313%26epage%3D4323%26doi%3D10.1021%2Fjm500263v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghiselli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azzini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferro-Luzzi, A.</span></span> <span> </span><span class="NLM_article-title">A Fluorescence-Based Method for Measuring Total Plasma Antioxidant Capability</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1016/0891-5849(94)00102-p</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1016%2F0891-5849%2894%2900102-p" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=7896168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADyaK2MXjtVequrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1995&pages=29-36&author=A.+Ghiselliauthor=M.+Serafiniauthor=G.+Maianiauthor=E.+Azziniauthor=A.+Ferro-Luzzi&title=A+Fluorescence-Based+Method+for+Measuring+Total+Plasma+Antioxidant+Capability&doi=10.1016%2F0891-5849%2894%2900102-p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A fluorescence-based method for measuring total plasma antioxidant capability</span></div><div class="casAuthors">Ghiselli, Andrea; Serafini, Mauro; Maiani, Giuseppe; Azzini, Elena; Ferro-Luzzi, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-36</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The total Radical-Trapping Antioxidant Parameter (TRAP) of 10 freshly prepd. human plasmas was measured by a new fluorometric assay.  In this method, the rate of peroxidn. induced by 2,2'-diazobis (2-amidinopropane) dihydrochloride (ABAP) was monitored through the loss of fluorescence of the protein R-P phycoerythrin (R-PE).  The lag-phase induced by plasma was compared to that induced by 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox, a water-sol. analog of vitamin E).  Proteins (but not their sulphydryl groups) interfere with the anal., partially protecting R-PE when all plasma antioxidants are exhausted.  A Trolox-induced lag-phase must therefore be measured on each plasma sample.  We found that ascorbate (2.5-5.3%), α-tocopherol (2.9-8.5%), urate (19.6-61.0%), and thiol groups (17.3-42.3%) jointly explain up to 70% of TRAP.  Thus, either other compds. present in plasma are likely to exert antioxidant action, or a marked synergistic action between antioxidants should be postulated to exist.  This latter hypothesis is supported by the finding that the simultaneous inactivation of ascorbate and thiol groups produces a loss in antioxidant capacity of plasma greater (26%) than the sum of the decreases produced by the sep. inactivation of each of the two compds.  The proposed method appears simple, reliable, and allows the rapid handling of a reasonable no. of freshly prepd. plasma samples.  Given the rapid loss of TRAP upon storage, the latter characteristic is crucial in studies on humans, involving a large no. of subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopUf8A-YNPNbVg90H21EOLACvtfcHk0lgyL0_tmrQBbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtVequrY%253D&md5=557ae0d6c94b5935b0c6e45f25514c68</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2F0891-5849%2894%2900102-p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0891-5849%252894%252900102-p%26sid%3Dliteratum%253Aachs%26aulast%3DGhiselli%26aufirst%3DA.%26aulast%3DSerafini%26aufirst%3DM.%26aulast%3DMaiani%26aufirst%3DG.%26aulast%3DAzzini%26aufirst%3DE.%26aulast%3DFerro-Luzzi%26aufirst%3DA.%26atitle%3DA%2520Fluorescence-Based%2520Method%2520for%2520Measuring%2520Total%2520Plasma%2520Antioxidant%2520Capability%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D1995%26volume%3D18%26spage%3D29%26epage%3D36%26doi%3D10.1016%2F0891-5849%2894%2900102-p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galili, S.</span>; <span class="NLM_string-name">Hovav, R.</span></span> <span> </span><span class="NLM_article-title">Chapter 16-Determination of Polyphenols, Flavonoids, and Antioxidant Capacity in Dry Seeds</span>. In  <i>Polyphenols in Plants</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, R. R.</span></span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">323</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1016%2FB978-0-12-397934-6.00016-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=305-323&author=S.+Galili&author=R.+Hovavauthor=R.+R.+Watson&title=Polyphenols+in+Plants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-397934-6.00016-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-397934-6.00016-4%26sid%3Dliteratum%253Aachs%26aulast%3DGalili%26aufirst%3DS.%26atitle%3DChapter%252016-Determination%2520of%2520Polyphenols%252C%2520Flavonoids%252C%2520and%2520Antioxidant%2520Capacity%2520in%2520Dry%2520Seeds%26btitle%3DPolyphenols%2520in%2520Plants%26aulast%3DWatson%26aufirst%3DR.%2BR.%26pub%3DAcademic%2520Press%26date%3D2014%26spage%3D305%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Piperlongumine Analogues and Discovery of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators as Potential Neuroprotective Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5242</span>– <span class="NLM_lpage">5255</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00410</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00410" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVansLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5242-5255&author=S.+Pengauthor=B.+Zhangauthor=X.+Mengauthor=J.+Yaoauthor=J.+Fang&title=Synthesis+of+Piperlongumine+Analogues+and+Discovery+of+Nuclear+Factor+Erythroid+2-Related+Factor+2+%28Nrf2%29+Activators+as+Potential+Neuroprotective+Agents&doi=10.1021%2Facs.jmedchem.5b00410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Piperlongumine Analogues and Discovery of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators as Potential Neuroprotective Agents</span></div><div class="casAuthors">Peng, Shoujiao; Zhang, Baoxin; Meng, Xianke; Yao, Juan; Fang, Jianguo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5242-5255</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cellular antioxidant system plays key roles in blocking or retarding the pathogenesis of adult neurodegenerative disorders as elevated oxidative stress has been implicated in the pathophysiol. of such diseases.  Mols. with the ability in enhancing the antioxidant defense thus are promising candidates as neuroprotective agents.  We reported herein the synthesis of piperlongumine analogs and evaluation of their cytoprotection against hydrogen peroxide- and 6-hydroxydopamine-induced neuronal cell oxidative damage in the neuron-like PC12 cells.  The structure-activity relationship was delineated after the cytotoxicity and protection screening.  Two compds., I and II, displayed low cytotoxicity and confer potent protection of PC12 cells from the oxidative injury via upregulation of a panel of cellular antioxidant mols.  Genetically silencing the transcription factor Nrf2, a master regulator of the cellular stress responses, suppresses the cytoprotection, indicating the crit. involvement of Nrf2 for the cellular action of compds. I and II in PC12 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3vh6ljVXbz7Vg90H21EOLACvtfcHk0lgyL0_tmrQBbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVansLrF&md5=9bdbf8554832250c47056d352b1d42df</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00410%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520Piperlongumine%2520Analogues%2520and%2520Discovery%2520of%2520Nuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528Nrf2%2529%2520Activators%2520as%2520Potential%2520Neuroprotective%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5242%26epage%3D5255%26doi%3D10.1021%2Facs.jmedchem.5b00410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasgar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenyon, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadhav, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Leyen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holman, T. R.</span></span> <span> </span><span class="NLM_article-title">Potent and Selective Inhibitors of Human Reticulocyte 12/15-Lipoxygenase as Anti-Stroke Therapies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4035</span>– <span class="NLM_lpage">4048</span>, <span class="refDoi"> DOI: 10.1021/jm401915r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401915r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFGmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4035-4048&author=G.+Raiauthor=N.+Joshiauthor=J.+E.+Jungauthor=Y.+Liuauthor=L.+Schultzauthor=A.+Yasgarauthor=S.+Perryauthor=G.+Diazauthor=Q.+Zhangauthor=V.+Kenyonauthor=A.+Jadhavauthor=A.+Simeonovauthor=E.+H.+Loauthor=K.+van+Leyenauthor=D.+J.+Maloneyauthor=T.+R.+Holman&title=Potent+and+Selective+Inhibitors+of+Human+Reticulocyte+12%2F15-Lipoxygenase+as+Anti-Stroke+Therapies&doi=10.1021%2Fjm401915r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and Selective Inhibitors of Human Reticulocyte 12/15-Lipoxygenase as Anti-Stroke Therapies</span></div><div class="casAuthors">Rai, Ganesha; Joshi, Netra; Jung, Joo Eun; Liu, Yu; Schultz, Lena; Yasgar, Adam; Perry, Steve; Diaz, Giovanni; Zhang, Qiangli; Kenyon, Victor; Jadhav, Ajit; Simeonov, Anton; Lo, Eng H.; van Leyen, Klaus; Maloney, David J.; Holman, Theodore R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4035-4048</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A key challenge facing drug discovery today is variability of the drug target between species, such as with 12/15-lipoxygenase (12/15-LOX), which contributes to ischemic brain injury, but its human and rodent isoenzymes have different inhibitor specificities.  In the current work, we have utilized a quant. high-throughput (qHTS) screen to identify compd. I (ML351), a novel chemotype for 12/15-LOX inhibition that has nanomolar potency (IC50 = 200 nM) against human 12/15-LOX and is protective against oxidative glutamate toxicity in mouse neuronal HT22 cells.  In addn., it exhibited greater than 250-fold selectivity vs. related LOX isoenzymes, was a mixed inhibitor, and did not reduce the active-site ferric ion.  Lastly, I significantly reduced infarct size following permanent focal ischemia in a mouse model of ischemic stroke.  As such, this represents the first report of a selective inhibitor of human 12/15-LOX with demonstrated in vivo activity in proof-of-concept mouse models of stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOKcxDniVzKrVg90H21EOLACvtfcHk0liMbPf1T-lKYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFGmtb4%253D&md5=a7dbbc4bda0605ef1e2f44add66b6718</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm401915r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401915r%26sid%3Dliteratum%253Aachs%26aulast%3DRai%26aufirst%3DG.%26aulast%3DJoshi%26aufirst%3DN.%26aulast%3DJung%26aufirst%3DJ.%2BE.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSchultz%26aufirst%3DL.%26aulast%3DYasgar%26aufirst%3DA.%26aulast%3DPerry%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DKenyon%26aufirst%3DV.%26aulast%3DJadhav%26aufirst%3DA.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DLo%26aufirst%3DE.%2BH.%26aulast%3Dvan%2BLeyen%26aufirst%3DK.%26aulast%3DMaloney%26aufirst%3DD.%2BJ.%26aulast%3DHolman%26aufirst%3DT.%2BR.%26atitle%3DPotent%2520and%2520Selective%2520Inhibitors%2520of%2520Human%2520Reticulocyte%252012%252F15-Lipoxygenase%2520as%2520Anti-Stroke%2520Therapies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4035%26epage%3D4048%26doi%3D10.1021%2Fjm401915r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potential Anti-Ischemic Stroke Agent: 3-Pentylbenzo[c]thiophen-1(3H)-one</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7173</span>– <span class="NLM_lpage">7181</span>, <span class="refDoi"> DOI: 10.1021/jm300681r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300681r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyns7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7173-7181&author=J.+Wuauthor=J.+Lingauthor=X.+Wangauthor=T.+Liauthor=J.+Liuauthor=Y.+Laiauthor=H.+Jiauthor=S.+Pengauthor=J.+Tianauthor=Y.+Zhang&title=Discovery+of+a+Potential+Anti-Ischemic+Stroke+Agent%3A+3-Pentylbenzo%5Bc%5Dthiophen-1%283H%29-one&doi=10.1021%2Fjm300681r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potential anti-ischemic stroke agent: 3-Pentylbenzo[c]thiophen-1(3H)-one</span></div><div class="casAuthors">Wu, Jing; Ling, Jingjing; Wang, Xuliang; Li, Tingting; Liu, Jingchao; Lai, Yisheng; Ji, Hui; Peng, Sixun; Tian, Jide; Zhang, Yihua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7173-7181</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of novel antithrombotic agents with strong free radical scavenging activity is of great significance for the treatment of ischemic stroke.  In the present study, 3-alkyl/arylalkyl-substituted benzo[c]thiophen-1(3H)-ones I(R = Et, nPr, Bu, pentyl,isopentyl, hexyl, heptyl, Bn) were designed and synthesized.  The most active compd. I(R = pentyl) significantly inhibited the ADP (ADP) induced and arachidonic acid (AA) induced in vitro platelet aggregation, superior to clin. used antiplatelet drug aspirin (ASP) and anti-ischemic stroke drugs 3-n-butylphthalide (NBP) and edaravone (Eda).  More importantly, in comparison with both NBP and Eda, I(R = pentyl) exhibited stronger antithrombotic and free radical scavenging activities and better or comparable neuroprotective effects against ischemia/reperfusion (I/R) in rats by ameliorating neurobehavioral function, reducing infarct size and brain-water content, attenuating cerebral damage, and normalizing the levels of oxidative enzymes.  Overall, our findings may provide an alternative strategy for the design of novel anti-ischemic stroke agents more potent than drugs like NBP and Eda.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpndCquiwopMbVg90H21EOLACvtfcHk0liMbPf1T-lKYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyns7fN&md5=a9bda7b9ed49ebd198d52acb83c6fd57</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm300681r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300681r%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLing%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520a%2520Potential%2520Anti-Ischemic%2520Stroke%2520Agent%253A%25203-Pentylbenzo%255Bc%255Dthiophen-1%25283H%2529-one%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7173%26epage%3D7181%26doi%3D10.1021%2Fjm300681r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danino, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Förster, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenigsberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Major, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, B.</span></span> <span> </span><span class="NLM_article-title">Identification of Highly Promising Antioxidants/Neuroprotectants Based on Nucleoside 5′-Phosphorothioate Scaffold. Synthesis, Activity, and Mechanisms of Action</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8427</span>– <span class="NLM_lpage">8443</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00575</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00575" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1altLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8427-8443&author=S.+Azranauthor=O.+Daninoauthor=D.+F%C3%B6rsterauthor=S.+Kenigsbergauthor=G.+Reiserauthor=M.+Dixitauthor=V.+Singhauthor=D.+T.+Majorauthor=B.+Fischer&title=Identification+of+Highly+Promising+Antioxidants%2FNeuroprotectants+Based+on+Nucleoside+5%E2%80%B2-Phosphorothioate+Scaffold.+Synthesis%2C+Activity%2C+and+Mechanisms+of+Action&doi=10.1021%2Facs.jmedchem.5b00575"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Highly Promising Antioxidants/Neuroprotectants Based on Nucleoside 5'-Phosphorothioate Scaffold. Synthesis, Activity, and Mechanisms of Action</span></div><div class="casAuthors">Azran, Sagit; Danino, Ortal; Forster, Daniel; Kenigsberg, Sarah; Reiser, Georg; Dixit, Mudit; Singh, Vijay; Major, Dan T.; Fischer, Bilha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8427-8443</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">With a view to identify novel and biocompatible neuroprotectants, we designed nucleoside 5'-thiophosphate analogs, 6-11.  We identified 2-SMe-ADP(α-S), 7A, as a most promising neuroprotectant. 7A reduced ROS prodn. in PC12 cells under oxidizing conditions, IC50 of 0.08 vs 21 μM for ADP.  Furthermore, 7A rescued primary neurons subjected to oxidn., EC50 of 0.04 vs 19 μM for ADP. 7A is a most potent P2Y1-R agonist, EC50 of 0.0026 μM.  Activity of 7A in cells involved P2Y1/12-R as indicated by blocking P2Y12-R or P2Y1-R.  Compd. 7A inhibited Fenton reaction better than EDTA, IC50 of 37 vs 54 μM, due to radical scavenging, IC50 of 12.5 vs 30 μM for ADP, and Fe(II)-chelation, IC50 of 80 vs >200 μM for ADP (ferrozine assay).  In addn., 7A was stable in human blood serum, t1/2 of 15 vs 1.5 h for ADP, and resisted hydrolysis by NPP1/3, 2-fold vs ADP.  Hence, we propose 7A as a highly promising neuroprotectant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvBo7PyA9HOLVg90H21EOLACvtfcHk0lhbLMvzPdZGhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1altLfK&md5=1611932aab3d86053cc23dfc9ba23593</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00575%26sid%3Dliteratum%253Aachs%26aulast%3DAzran%26aufirst%3DS.%26aulast%3DDanino%26aufirst%3DO.%26aulast%3DF%25C3%25B6rster%26aufirst%3DD.%26aulast%3DKenigsberg%26aufirst%3DS.%26aulast%3DReiser%26aufirst%3DG.%26aulast%3DDixit%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DV.%26aulast%3DMajor%26aufirst%3DD.%2BT.%26aulast%3DFischer%26aufirst%3DB.%26atitle%3DIdentification%2520of%2520Highly%2520Promising%2520Antioxidants%252FNeuroprotectants%2520Based%2520on%2520Nucleoside%25205%25E2%2580%25B2-Phosphorothioate%2520Scaffold.%2520Synthesis%252C%2520Activity%252C%2520and%2520Mechanisms%2520of%2520Action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8427%26epage%3D8443%26doi%3D10.1021%2Facs.jmedchem.5b00575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Förster, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danino, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, B.</span></span> <span> </span><span class="NLM_article-title">Highly Efficient Biocompatible Neuroprotectants with Dual Activity as Antioxidants and P2Y Receptor Agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4938</span>– <span class="NLM_lpage">4952</span>, <span class="refDoi"> DOI: 10.1021/jm400197m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400197m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFehsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4938-4952&author=S.+Azranauthor=D.+F%C3%B6rsterauthor=O.+Daninoauthor=Y.+Nadelauthor=G.+Reiserauthor=B.+Fischer&title=Highly+Efficient+Biocompatible+Neuroprotectants+with+Dual+Activity+as+Antioxidants+and+P2Y+Receptor+Agonists&doi=10.1021%2Fjm400197m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Efficient Biocompatible Neuroprotectants with Dual Activity as Antioxidants and P2Y Receptor Agonists</span></div><div class="casAuthors">Azran, Sagit; Forster, Daniel; Danino, Ortal; Nadel, Yael; Reiser, Georg; Fischer, Bilha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4938-4952</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Currently, there is a need for novel, biocompatible, and effective neuroprotectants for the treatment of neurodegenerative diseases and brain injury assocd. with oxidative damage.  Here, the authors developed nucleotide-based neuroprotectants acting dually as antioxidants and P2Y-R agonists.  To improve the potency, selectivity, and metabolic stability of ATP/ADP, the authors substituted adenine C2-position by Cl and Pα/Pβ position by borano group.  These substituted nucleotides inhibited oxidn. in cell-free systems (Fe(II)-H2O2), as detected by ESR (IC50 up to 175 μM), and ABTS assay (IC50 up to 40 μM).  They also inhibited FeSO4-induced oxidative stress in PC12 cells (IC50 of 80-200 nM).  2-Cl-ADP(α-BH3) was found to be the most potent P2Y1-R agonist currently known (EC50 7 nM) and protected primary cortical neurons from FeSO4 insult (EC50 170 nM).  In addn., it proved to be metabolically stable in human blood serum (t1/2 7 vs. 1.5 h for ADP).  Hence, the authors propose 2-Cl-ADP(α-BH3) as a highly promising neuroprotectant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0wqQCfTDBp7Vg90H21EOLACvtfcHk0lhWDiJarBFHVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFehsr8%253D&md5=b6d078bca5a1fc44bde39883369cee48</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm400197m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400197m%26sid%3Dliteratum%253Aachs%26aulast%3DAzran%26aufirst%3DS.%26aulast%3DF%25C3%25B6rster%26aufirst%3DD.%26aulast%3DDanino%26aufirst%3DO.%26aulast%3DNadel%26aufirst%3DY.%26aulast%3DReiser%26aufirst%3DG.%26aulast%3DFischer%26aufirst%3DB.%26atitle%3DHighly%2520Efficient%2520Biocompatible%2520Neuroprotectants%2520with%2520Dual%2520Activity%2520as%2520Antioxidants%2520and%2520P2Y%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4938%26epage%3D4952%26doi%3D10.1021%2Fjm400197m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Hypoxia Inducible Factor 1alpha Promotes Endogenous Adaptive Response in Rat Model of Chronic Cerebral Hypoperfusion</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3</span>, <span class="refDoi"> DOI: 10.3390/ijms18010003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.3390%2Fijms18010003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFCnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=3&author=Y.+Yangauthor=J.+Juauthor=M.+Dengauthor=J.+Wangauthor=H.+Liuauthor=L.+Xiongauthor=J.+Zhang&title=Hypoxia+Inducible+Factor+1alpha+Promotes+Endogenous+Adaptive+Response+in+Rat+Model+of+Chronic+Cerebral+Hypoperfusion&doi=10.3390%2Fijms18010003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia inducible factor 1 promotes endogenous adaptive response in rat model of chronic cerebral hypoperfusion</span></div><div class="casAuthors">Yang, Ying; Ju, Jieyang; Deng, Min; Wang, Jing; Liu, Hui; Xiong, Li; Zhang, Junjian</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3/1-3/20</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Hypoxia inducible factor 1α (HIF-1α), a pivotal regulator of gene expression in response to hypoxia and ischemia, is now considered to regulate both pro-survival and pro-death responses depending on the duration and severity of the stress.  We previously showed that chronic global cerebral hypoperfusion (CCH) triggered long-lasting accumulation of HIF-1α protein in the hippocampus of rats.  However, the role of the stabilized HIF-1 in CCH is obscure.  Here, we knock down endogenous HIF-1α to det. whether and how HIF-1 affects the disease processes and phenotypes of CCH.  Lentivirus expressing HIF-1α small hairpin RNA was injected into the bilateral hippocampus and bilateral ventricles to knock down HIF-1α gene expression in the hippocampus and other brain areas.  Permanent bilateral common carotid artery occlusions, known as 2-vessel occlusions (2VOs), were used to induce CCH in rats.  Angiogenesis, oxidative stress, histopathol. changes of the brain, and cognitive function were tested.  Knockdown of HIF-1α prior to 2VO significantly exacerbates the impairment of learning and memory after four weeks of CCH.  Mech., reduced cerebral angiogenesis, increased oxidative damage, and increased d. of astrocytes and microglia in the cortex and some subregions of hippocampus are also shown after four weeks of CCH.  Furthermore, HIF-1α knockdown also disrupts upregulation of regulated downstream genes.  Our findings suggest that HIF-1α-protects the brain from oxidative stress and inflammation response in the disease process of CCH.  Accumulated HIF-1α during CCH mediates endogenous adaptive processes to defend against more severe hypoperfusion injury of the brain, which may provide a therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMlPwCddabT7Vg90H21EOLACvtfcHk0lhWDiJarBFHVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFCnsLg%253D&md5=8ffc6b62c85b5143d68eedeca232af9b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3390%2Fijms18010003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18010003%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DJu%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DXiong%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DHypoxia%2520Inducible%2520Factor%25201alpha%2520Promotes%2520Endogenous%2520Adaptive%2520Response%2520in%2520Rat%2520Model%2520of%2520Chronic%2520Cerebral%2520Hypoperfusion%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26spage%3D3%26doi%3D10.3390%2Fijms18010003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadakis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyte, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallichan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibson, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchan, A. M.</span></span> <span> </span><span class="NLM_article-title">Neuroprotection by Dimethyloxalylglycine Following Permanent and Transient Focal Cerebral Ischemia in Rats</span>. <i>J. Cereb. Blood Flow Metab.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">143</span>, <span class="refDoi"> DOI: 10.1038/jcbfm.2010.60</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1038%2Fjcbfm.2010.60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=20407463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlequw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=132-143&author=S.+Nagelauthor=M.+Papadakisauthor=R.+Chenauthor=L.+C.+Hoyteauthor=K.+J.+Brooksauthor=D.+Gallichanauthor=N.+R.+Sibsonauthor=C.+Pughauthor=A.+M.+Buchan&title=Neuroprotection+by+Dimethyloxalylglycine+Following+Permanent+and+Transient+Focal+Cerebral+Ischemia+in+Rats&doi=10.1038%2Fjcbfm.2010.60"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats</span></div><div class="casAuthors">Nagel, Simon; Papadakis, Michalis; Chen, Ruoli; Hoyte, Lisa C.; Brooks, Keith J.; Gallichan, Daniel; Sibson, Nicola R.; Pugh, Chris; Buchan, Alastair M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">132-143</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Dimethyloxalylglycine (DMOG) is an inhibitor of prolyl-4-hydroxylase domain (PHD) enzymes that regulate the stability of hypoxia-inducible factor (HIF).  We investigated the effect of DMOG on the outcome after permanent and transient middle cerebral artery occlusion (p/tMCAO) in the rat.  Before and after pMCAO, rats were treated with 40 mg/kg, 200 mg/kg DMOG, or vehicle, and with 40 mg/kg or vehicle after tMCAO.  Serial magnetic resonance imaging (MRI) was performed to assess infarct evolution and regional cerebral blood flow (rCBF).  Both doses significantly reduced infarct vols., but only 40 mg/kg improved the behavior after 24 h of pMCAO.  Animals receiving 40 mg/kg were more likely to maintain rCBF values above 30% from the contralateral hemisphere within 24 h of pMCAO.  DMOG after tMCAO significantly reduced the infarct vols. and improved behavior at 24 h and 8 days and also improved the rCBF after 24 h.  A consistent and significant upregulation of both mRNA and protein levels of vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (eNOS) was assocd. with the obsd. neuroprotection, although this was not consistently related to HIF-1α levels at 24 h and 8 days.  Thus, DMOG afforded neuroprotection both at 24 h after pMCAO and at 24 h and 8 days after tMCAO.  This effect was assocd. with an increase of VEGF and eNOS and was mediated by improved rCBF after DMOG treatment.  Journal of Cerebral Blood Flow & Metab. (2011) 31, 132-143; doi:10.1038/jcbfm.2010.60; published online 21 Apr. 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn5j8hu4vDY7Vg90H21EOLACvtfcHk0lj-JDyBbQb8BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlequw%253D%253D&md5=f7318845f27e741c82b46f4fde000e4f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2010.60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2010.60%26sid%3Dliteratum%253Aachs%26aulast%3DNagel%26aufirst%3DS.%26aulast%3DPapadakis%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DHoyte%26aufirst%3DL.%2BC.%26aulast%3DBrooks%26aufirst%3DK.%2BJ.%26aulast%3DGallichan%26aufirst%3DD.%26aulast%3DSibson%26aufirst%3DN.%2BR.%26aulast%3DPugh%26aufirst%3DC.%26aulast%3DBuchan%26aufirst%3DA.%2BM.%26atitle%3DNeuroprotection%2520by%2520Dimethyloxalylglycine%2520Following%2520Permanent%2520and%2520Transient%2520Focal%2520Cerebral%2520Ischemia%2520in%2520Rats%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2011%26volume%3D31%26spage%3D132%26epage%3D143%26doi%3D10.1038%2Fjcbfm.2010.60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katschinski, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhardt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheid, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenger, R. H.</span></span> <span> </span><span class="NLM_article-title">The Antimycotic Ciclopirox Olamine Induces HIF-1alpha Stability, VEGF expression, and Angiogenesis</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">763</span>, <span class="refDoi"> DOI: 10.1096/fj.02-0586fje</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1096%2Ffj.02-0586fje" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=12594177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislGlt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=761-763&author=T.+Lindenauthor=D.+M.+Katschinskiauthor=K.+Eckhardtauthor=A.+Scheidauthor=H.+Pagelauthor=R.+H.+Wenger&title=The+Antimycotic+Ciclopirox+Olamine+Induces+HIF-1alpha+Stability%2C+VEGF+expression%2C+and+Angiogenesis&doi=10.1096%2Ffj.02-0586fje"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The antimycotic ciclopirox olamine induces HIF-1α stability, VEGF expression, and angiogenesis</span></div><div class="casAuthors">Linden, Tobias; Katschinski, Dorthe M.; Eckhardt, Katrin; Scheid, Annette; Pagel, Horst; Wenger, Roland H.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">761-763, 10.1096/fj.0586fje</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">The heterodimeric hypoxia-inducible factor (HIF)-1 is a master regulator of oxygen homeostasis.  Protein stability and transactivation function of the a subunit are controlled by iron- and oxygen-dependent hydroxylation of proline and asparagine residues.  The anti-mycotic ciclopirox olamine (CPX) is a lipophilic bidentate iron chelator that stabilizes HIF-1α under normoxic conditions at lower concns. than other iron chelators, probably by inhibiting HIF-1α hydroxylation.  As shown by the inhibition of iron-dependent quenching of FITC-labeled deferoxamine (DFX) fluorescence, CPX appears to have an even higher affinity for iron than DFX.  Initial observations that treatment with 1% CPX, but not with placebo, occasionally caused reddening of wound margins in a mouse skin wound model prompted us to investigate the capability of CPX to induce angiogenesis.  CPX-induced HIF-1-mediated reporter gene activity and endogenous HIF-1 target gene expression, including elevation of transcription, mRNA, and protein levels of the vascular endothelial growth factor (VEGF).  In the chick chorioallantoic membrane assay, inert polymer disks contg. CPX but not the solvent alone induced angiogenesis.  In summary, these results suggest that CPX induces angiogenesis in vivo via HIF-1 and VEGF induction.  Therefore, CPX might serve as an alternative to recombinant VEGF treatment or to VEGF gene therapy for therapeutic angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEvhtlKtKalbVg90H21EOLACvtfcHk0liN4h6KnyTTeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislGlt70%253D&md5=dd39c593d247c43036f591011d5b308a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1096%2Ffj.02-0586fje&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.02-0586fje%26sid%3Dliteratum%253Aachs%26aulast%3DLinden%26aufirst%3DT.%26aulast%3DKatschinski%26aufirst%3DD.%2BM.%26aulast%3DEckhardt%26aufirst%3DK.%26aulast%3DScheid%26aufirst%3DA.%26aulast%3DPagel%26aufirst%3DH.%26aulast%3DWenger%26aufirst%3DR.%2BH.%26atitle%3DThe%2520Antimycotic%2520Ciclopirox%2520Olamine%2520Induces%2520HIF-1alpha%2520Stability%252C%2520VEGF%2520expression%252C%2520and%2520Angiogenesis%26jtitle%3DFASEB%2520J.%26date%3D2003%26volume%3D17%26spage%3D761%26epage%3D763%26doi%3D10.1096%2Ffj.02-0586fje" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span> <span> </span><span class="NLM_article-title">SDTNBI: an Integrated Network and Chemoinformatics Tool For Systematic Prediction of Drug–target Interactions and Drug Repositioning</span>. <i>Briefings Bioinf.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">347</span>, <span class="refDoi"> DOI: 10.1093/bib/bbw012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1093%2Fbib%2Fbbw012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=26944082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivVaqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=333-347&author=Z.+Wuauthor=F.+Chengauthor=J.+Liauthor=W.+Liauthor=G.+Liuauthor=Y.+Tang&title=SDTNBI%3A+an+Integrated+Network+and+Chemoinformatics+Tool+For+Systematic+Prediction+of+Drug%E2%80%93target+Interactions+and+Drug+Repositioning&doi=10.1093%2Fbib%2Fbbw012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">SDTNBI: an integrated network and chemoinformatics tool for systematic prediction of drug-target interactions and drug repositioning</span></div><div class="casAuthors">Wu, Zengrui; Cheng, Feixiong; Li, Jie; Li, Weihua; Liu, Guixia; Tang, Yun</div><div class="citationInfo"><span class="NLM_cas:title">Briefings in Bioinformatics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">333-347</span>CODEN:
                <span class="NLM_cas:coden">BBIMFX</span>;
        ISSN:<span class="NLM_cas:issn">1477-4054</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Computational prediction of drug-target interactions (DTIs) and drug repositioning provides a low-cost and high-efficiency approach for drug discovery and development.  The traditional social network-derived methods based on the na.ovrddot.ive DTI topol. information cannot predict potential targets for new chem. entities or failed drugs in clin. trials.  There are currently millions of com. available mols. with biol. relevant representations in chem. databases.  It is urgent to develop novel computational approaches to predict targets for new chem. entities and failed drugs on a large scale.  In this study, we developed a useful tool, namely substructure-drug-target network-based inference (SDTNBI), to prioritize potential targets for old drugs, failed drugs and new chem. entities.  SDTNBI incorporates network and chemoinformatics to bridge the gap between new chem. entities and known DTI network.  High performance was yielded in 10-fold and leave-one-out cross validations using four benchmark data sets, covering G protein-coupled receptors, kinases, ion channels and nuclear receptors.  Furthermore, the highest areas under the receiver operating characteristic curve were 0.797 and 0.863 for two external validation sets, resp.  Finally, we identified thousands of new potential DTIs via implementing SDTNBI on a global network.  As a proof-of-principle, we showcased the use of SDTNBI to identify novel anticancer indications for nonsteroidal anti-inflammatory drugs by inhibiting AKR1C3, CA9 or CA12.  In summary, SDTNBI is a powerful network-based approach that predicts potential targets for new chem. entities on a large scale and will provide a new tool for DTI prediction and drug repositioning.  The program and predicted DTIs are available on request.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwVHm2U7tYlLVg90H21EOLACvtfcHk0liN4h6KnyTTeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivVaqurY%253D&md5=0520946f0d2be84fdad7173a04fb9fc0</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1093%2Fbib%2Fbbw012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbib%252Fbbw012%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DY.%26atitle%3DSDTNBI%253A%2520an%2520Integrated%2520Network%2520and%2520Chemoinformatics%2520Tool%2520For%2520Systematic%2520Prediction%2520of%2520Drug%25E2%2580%2593target%2520Interactions%2520and%2520Drug%2520Repositioning%26jtitle%3DBriefings%2520Bioinf.%26date%3D2017%26volume%3D18%26spage%3D333%26epage%3D347%26doi%3D10.1093%2Fbib%2Fbbw012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marco, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valhondo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martín-Fontecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Villa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Río, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagredo, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrecillas, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frechilla, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benhamú, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Rodríguez, M. L.</span></span> <span> </span><span class="NLM_article-title">New Serotonin 5-HT1A Receptor Agonists with Neuroprotective Effect against Ischemic Cell Damage</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7986</span>– <span class="NLM_lpage">7999</span>, <span class="refDoi"> DOI: 10.1021/jm2007886</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2007886" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOgu73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7986-7999&author=I.+Marcoauthor=M.+Valhondoauthor=M.+Mart%C3%ADn-Fontechaauthor=H.+V%C3%A1zquez-Villaauthor=J.+Del+R%C3%ADoauthor=A.+Planasauthor=O.+Sagredoauthor=J.+A.+Ramosauthor=I.+R.+Torrecillasauthor=L.+Pardoauthor=D.+Frechillaauthor=B.+Benham%C3%BAauthor=M.+L.+L%C3%B3pez-Rodr%C3%ADguez&title=New+Serotonin+5-HT1A+Receptor+Agonists+with+Neuroprotective+Effect+against+Ischemic+Cell+Damage&doi=10.1021%2Fjm2007886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">New Serotonin 5-HT1A Receptor Agonists with Neuroprotective Effect against Ischemic Cell Damage</span></div><div class="casAuthors">Marco, Isabel; Valhondo, Margarita; Martin-Fontecha, Mar; Vazquez-Villa, Henar; Del Rio, Joaquin; Planas, Anna; Sagredo, Onintza; Ramos, Jose A.; Torrecillas, Ivan R.; Pardo, Leonardo; Frechilla, Diana; Benhamu, Bellindo; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7986-7999</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the synthesis of 32 new compds. based on structural modifications of different moieties of previously described lead UCM-2550.  The new nonpiperazine derivs., representing second-generation agonists, were assessed for binding affinity, selectivity, and functional activity at the 5-HT1A receptor (5-HT1AR).  Computational β2-based homol. models of the ligand-receptor complexes were used to explain the obsd. structure-affinity relationships.  Selected candidates were also evaluated for their potential in vitro and in vivo neuroprotective properties.  Interestingly, (2-{6-[(3,4-dihydro-2H-chromen-2-ylmethyl)amino]hexyl}tetrahydro-1H-pyrrolo[1,2-c]imidazole-1,3(2H)-dione) has been characterized as a high-affinity and potent 5-HT1AR agonist (Ki = 5.9 nM, EC50 = 21.8 nM) and exhibits neuroprotective effect in neurotoxicity assays in primary cell cultures from rat hippocampus and in the MCAO model of focal cerebral ischemia in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplOiTkeejxUbVg90H21EOLACvtfcHk0ljI5kWnF_0VAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOgu73L&md5=65f3249c302236c9be04cf1bb99f8e91</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm2007886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007886%26sid%3Dliteratum%253Aachs%26aulast%3DMarco%26aufirst%3DI.%26aulast%3DValhondo%26aufirst%3DM.%26aulast%3DMart%25C3%25ADn-Fontecha%26aufirst%3DM.%26aulast%3DV%25C3%25A1zquez-Villa%26aufirst%3DH.%26aulast%3DDel%2BR%25C3%25ADo%26aufirst%3DJ.%26aulast%3DPlanas%26aufirst%3DA.%26aulast%3DSagredo%26aufirst%3DO.%26aulast%3DRamos%26aufirst%3DJ.%2BA.%26aulast%3DTorrecillas%26aufirst%3DI.%2BR.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DFrechilla%26aufirst%3DD.%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DNew%2520Serotonin%25205-HT1A%2520Receptor%2520Agonists%2520with%2520Neuroprotective%2520Effect%2520against%2520Ischemic%2520Cell%2520Damage%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7986%26epage%3D7999%26doi%3D10.1021%2Fjm2007886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Novel Hybrids of Optically Active Ring-Opened 3-n-Butylphthalide Derivative and Isosorbide as Potential Anti-Ischemic Stroke Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3078</span>– <span class="NLM_lpage">3089</span>, <span class="refDoi"> DOI: 10.1021/jm4001693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4001693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlersr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3078-3089&author=X.+Wangauthor=L.+Wangauthor=T.+Liauthor=Z.+Huangauthor=Y.+Laiauthor=H.+Jiauthor=X.+Wanauthor=J.+Xuauthor=J.+Tianauthor=Y.+Zhang&title=Novel+Hybrids+of+Optically+Active+Ring-Opened+3-n-Butylphthalide+Derivative+and+Isosorbide+as+Potential+Anti-Ischemic+Stroke+Agents&doi=10.1021%2Fjm4001693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Hybrids of Optically Active Ring-Opened 3-n-Butylphthalide Derivative and Isosorbide as Potential Anti-Ischemic Stroke Agents</span></div><div class="casAuthors">Wang, Xiaoli; Wang, Linna; Li, Tingting; Huang, Zhangjian; Lai, Yisheng; Ji, Hui; Wan, Xiaolong; Xu, Jinyi; Tian, Jide; Zhang, Yihua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3078-3089</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In search of novel anti-ischemic stroke agents with higher potency than a known drug 3-n-butylphthalide (NBP), a series of glycoside hybrids, e.g. I, from optically active ring-opened NBP deriv. and isosorbide were synthesized for evaluating their anti-ischemic stroke activity.  Compd. I displayed the strongest activity in inhibiting the ADP and arachidonic acid (AA)-induced platelet aggregation in vitro, with 10.0- and 8.4-fold more effectiveness than (S)-NBP, resp.  Furthermore, I was stable in artificial gastrointestinal fluids and could penetrate the blood-brain barrier (BBB) with an appreciate lipid/water partition coeff. relative to (S)-NBP.  More importantly, oral treatment with I protected from acute thrombosis and inhibited the ischemia/reperfusion-related brain injury in animals.  Our findings suggest that I may be promising for further evaluation for the intervention of ischemic stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2jxmyrF5QhrVg90H21EOLACvtfcHk0ljI5kWnF_0VAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlersr8%253D&md5=0c4aec09a2a24f7948a28339463fccc5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm4001693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4001693%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DWan%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DNovel%2520Hybrids%2520of%2520Optically%2520Active%2520Ring-Opened%25203-n-Butylphthalide%2520Derivative%2520and%2520Isosorbide%2520as%2520Potential%2520Anti-Ischemic%2520Stroke%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3078%26epage%3D3089%26doi%3D10.1021%2Fjm4001693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babcock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.-q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.-b.</span></span> <span> </span><span class="NLM_article-title">Activation of Human Ether-a-go-go Related Gene (hERG) Potassium Channels by Small Molecules</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">781</span>– <span class="NLM_lpage">788</span>, <span class="refDoi"> DOI: 10.1038/aps.2011.70</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1038%2Faps.2011.70" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=21623390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFyjur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=781-788&author=P.-z.+Zhouauthor=J.+Babcockauthor=L.-q.+Liuauthor=M.+Liauthor=Z.-b.+Gao&title=Activation+of+Human+Ether-a-go-go+Related+Gene+%28hERG%29+Potassium+Channels+by+Small+Molecules&doi=10.1038%2Faps.2011.70"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of human ether-a-go-go related gene (hERG) potassium channels by small molecules</span></div><div class="casAuthors">Zhou, Ping-zheng; Babcock, Joseph; Liu, Lian-qing; Li, Min; Gao, Zhao-bing</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">781-788</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Human ether-a-go-go related gene (hERG) potassium (K+) channels play a crit. role in cardiac action potential repolarization.  Mutations that reduce hERG conductance or surface expression may cause congenital long QT syndrome (LQTS).  However, the channels can be inhibited by structurally diverse small mols., resulting in an acquired form of LQTS.  Consequently, small mols. that increase the hERG current may be of value for treatment for LQTS.  So far, 9 hERG activators were reported.  The aim of this review is to discuss recent advances concerning the identification and action mechanism of hERG activators.  Acta Pharmacologica Sinica (2011) 32: 781-788; doi: 10.1038/aps.2011.70; published online 30 May 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEvf2nAFthM7Vg90H21EOLACvtfcHk0ljZMr_UU917qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFyjur8%253D&md5=72e6fdcc441a14a1a8f0ef86e52d2b9c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Faps.2011.70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2011.70%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DP.-z.%26aulast%3DBabcock%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.-q.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DZ.-b.%26atitle%3DActivation%2520of%2520Human%2520Ether-a-go-go%2520Related%2520Gene%2520%2528hERG%2529%2520Potassium%2520Channels%2520by%2520Small%2520Molecules%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2011%26volume%3D32%26spage%3D781%26epage%3D788%26doi%3D10.1038%2Faps.2011.70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delarue, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girault, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debreu-Fontaine, M.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaeïd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grellier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sergheraert, C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in Vitro and in Vivo Antimalarial Activity of New 4-Anilinoquinolines</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">2827</span>– <span class="NLM_lpage">2833</span>, <span class="refDoi"> DOI: 10.1021/jm010842o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010842o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltlClsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2827-2833&author=S.+Delarueauthor=S.+Giraultauthor=L.+Maesauthor=M.-A.+Debreu-Fontaineauthor=M.+Labae%C3%AFdauthor=P.+Grellierauthor=C.+Sergheraert&title=Synthesis+and+in+Vitro+and+in+Vivo+Antimalarial+Activity+of+New+4-Anilinoquinolines&doi=10.1021%2Fjm010842o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro and in vivo antimalarial activity of new 4-anilinoquinolines</span></div><div class="casAuthors">Delarue, Sandrine; Girault, Sophie; Maes, Louis; Debreu-Fontaine, Marie-Ange; Labaeied, Mehdi; Grellier, Philippe; Sergheraert, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2827-2833</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of 4-anilinoquinolines, e.g., I, with two proton-accepting side chains has been synthesized.  Antimalarial activity and levels of cytotoxicity upon both MRC-5 cells and macrophages were found to be highly dependent upon the features of these side chains.  Several compds. were found to be active in the low nanomolar range, against both chloroquine-sensitive and -resistant strains of Plasmodium falciparum in vitro.  From among them, a morpholino deriv. cured mice infected by Plasmodium berghei and displayed a lower toxicity than amodiaquine upon mouse macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFBF8Weq9xkbVg90H21EOLACvtfcHk0ljZMr_UU917qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltlClsrk%253D&md5=f986f00d19c5902faeaf1b22ca929209</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm010842o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010842o%26sid%3Dliteratum%253Aachs%26aulast%3DDelarue%26aufirst%3DS.%26aulast%3DGirault%26aufirst%3DS.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DDebreu-Fontaine%26aufirst%3DM.-A.%26aulast%3DLabae%25C3%25AFd%26aufirst%3DM.%26aulast%3DGrellier%26aufirst%3DP.%26aulast%3DSergheraert%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Antimalarial%2520Activity%2520of%2520New%25204-Anilinoquinolines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2827%26epage%3D2833%26doi%3D10.1021%2Fjm010842o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingram, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierroz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spingler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keiser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Ferrocenyl Derivatives of the Anthelmintic Praziquantel: Design, Synthesis, and Biological Evaluation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8790</span>– <span class="NLM_lpage">8798</span>, <span class="refDoi"> DOI: 10.1021/jm301077m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301077m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8790-8798&author=M.+Patraauthor=K.+Ingramauthor=V.+Pierrozauthor=S.+Ferrariauthor=B.+Spinglerauthor=J.+Keiserauthor=G.+Gasser&title=Ferrocenyl+Derivatives+of+the+Anthelmintic+Praziquantel%3A+Design%2C+Synthesis%2C+and+Biological+Evaluation&doi=10.1021%2Fjm301077m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Ferrocenyl derivatives of the anthelmintic praziquantel: design, synthesis, and biological evaluation</span></div><div class="casAuthors">Patra, Malay; Ingram, Katrin; Pierroz, Vanessa; Ferrari, Stefano; Spingler, Bernhard; Keiser, Jennifer; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8790-8798</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design, synthesis, and biol. evaluation of 18 ferrocenyl derivs. I [Fc = ferrocenyl, 1/2(1,1'-ferrocenediyl), bis(ferrocenylcarbonyl)methyl; 4A-12A, X = CO, bond; n = 1-4; Y = bond; 4B-12B, X = 4-piperidinylcarbonyl; Y = CO, bond; n = 1-4] of the most well-known drug against schistosomiasis, namely praziquantel (PZQ), are reported.  These compds., which have been all isolated as racemates, were unambiguously characterized by 1H and 13C NMR spectroscopy, mass spectrometry, and elemental anal. as well as by x-ray crystallog. for 4A, 5A, and 7A.  Cytotoxicity studies revealed that the complexes were moderately toxic toward a cervical cancer cell line (HeLa) and, importantly, significantly less active toward a noncancerous cell line (MRC-5).  The in vitro anthelmintic activity of the 18 ferrocenyl PZQ derivs. was tested against adult Schistosoma mansoni, and values in the micromolar range (26-68 μM) were detd. for the four most active compds.  It was also demonstrated using two compds. of the series as models (8A and 8B) that the complexes were stable when incubated for 24 h at 37° in human plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW9b3zQZLtAbVg90H21EOLACvtfcHk0li0GMivMsyg5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsr7I&md5=cba4112ec4d7d52681cff4366970c890</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm301077m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301077m%26sid%3Dliteratum%253Aachs%26aulast%3DPatra%26aufirst%3DM.%26aulast%3DIngram%26aufirst%3DK.%26aulast%3DPierroz%26aufirst%3DV.%26aulast%3DFerrari%26aufirst%3DS.%26aulast%3DSpingler%26aufirst%3DB.%26aulast%3DKeiser%26aufirst%3DJ.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DFerrocenyl%2520Derivatives%2520of%2520the%2520Anthelmintic%2520Praziquantel%253A%2520Design%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8790%26epage%3D8798%26doi%3D10.1021%2Fjm301077m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anglin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, B. V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span> <span> </span><span class="NLM_article-title">Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">542</span>– <span class="NLM_lpage">546</span>, <span class="refDoi"> DOI: 10.1021/ml400036z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400036z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=542-546&author=B.+Zhengauthor=Y.+Yaoauthor=Z.+Liuauthor=L.+Dengauthor=J.+L.+Anglinauthor=H.+Jiangauthor=B.+V.+V.+Prasadauthor=Y.+Song&title=Crystallographic+Investigation+and+Selective+Inhibition+of+Mutant+Isocitrate+Dehydrogenase&doi=10.1021%2Fml400036z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase</span></div><div class="casAuthors">Zheng, Baisong; Yao, Yuan; Liu, Zhen; Deng, Lisheng; Anglin, Justin L.; Jiang, Hong; Prasad, B. V. Venkataram; Song, Yongcheng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">542-546</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutations in isocitrate dehydrogenase (IDH), a key enzyme in the tricarboxylic acid cycle, have recently been found in ∼75% glioma and ∼20% acute myeloid leukemia.  Different from the wild-type enzyme, mutant IDH1 catalyzes the redn. of α-ketoglutaric acid to D-2-hydroxyglutaric acid.  Strong evidence has shown mutant IDH1 represents a novel target for this type of cancer.  We found two 1-hydroxypyridin-2-one compds. that are potent inhibitors of R132H and R132C IDH1 mutants with Ki values as low as 120 nM.  These compds. exhibit >60-fold selectivity against wild-type IDH1 and can inhibit the prodn. of D-2-hydroxyglutaric acid in IDH1 mutated cells, representing novel chem. probes for cancer biol. studies.  We also report the first inhibitor-bound crystal structures of IDH1(R132H), showing these inhibitors have H-bond, electrostatic, and hydrophobic interactions with the mutant enzyme.  Comparison with the substrate-bound IDH1 structures revealed the structural basis for the high enzyme selectivity of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH0vzVLGCPZLVg90H21EOLACvtfcHk0li0GMivMsyg5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWrtLg%253D&md5=c34c67949fe816bdf151525a578535f3</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fml400036z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400036z%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DAnglin%26aufirst%3DJ.%2BL.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DPrasad%26aufirst%3DB.%2BV.%2BV.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DCrystallographic%2520Investigation%2520and%2520Selective%2520Inhibition%2520of%2520Mutant%2520Isocitrate%2520Dehydrogenase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D542%26epage%3D546%26doi%3D10.1021%2Fml400036z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kogiso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases: Synthesis, Structure–Activity Relationship, and Selective Antitumor Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8307</span>– <span class="NLM_lpage">8318</span>, <span class="refDoi"> DOI: 10.1021/jm500660f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500660f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Khu7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8307-8318&author=Z.+Liuauthor=Y.+Yaoauthor=M.+Kogisoauthor=B.+Zhengauthor=L.+Dengauthor=J.+J.+Qiuauthor=S.+Dongauthor=H.+Lvauthor=J.+M.+Galloauthor=X.-N.+Liauthor=Y.+Song&title=Inhibition+of+Cancer-Associated+Mutant+Isocitrate+Dehydrogenases%3A+Synthesis%2C+Structure%E2%80%93Activity+Relationship%2C+and+Selective+Antitumor+Activity&doi=10.1021%2Fjm500660f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases: Synthesis, Structure-Activity Relationship, and Selective Antitumor Activity</span></div><div class="casAuthors">Liu, Zhen; Yao, Yuan; Kogiso, Mari; Zheng, Baisong; Deng, Lisheng; Qiu, Jihui J.; Dong, Shuo; Lv, Hua; Gallo, James M.; Li, Xiao-Nan; Song, Yongcheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8307-8318</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutations of isocitrate dehydrogenase 1 (IDH1) are frequently found in certain cancers such as glioma.  Different from the wild-type (WT) IDH1, the mutant enzymes catalyze the redn. of α-ketoglutaric acid to D-2-hydroxyglutaric acid (D2HG), leading to cancer initiation.  Several 1-hydroxypyridin-2-one compds. were identified to be inhibitors of IDH1(R132H).  A total of 61 derivs. were synthesized, and their structure-activity relationships were investigated.  Potent IDH1(R132H) inhibitors were identified with Ki values as low as 140 nM, while they possess weak or no activity against WT IDH1.  Activities of selected compds. against IDH1(R132C) were found to be correlated with their inhibitory activities against IDH1(R132H), as well as cellular prodn. of D2HG, with R2 of 0.83 and 0.73, resp.  Several inhibitors, e.g., I, were found to be permeable through the blood-brain barrier in a cell-based model assay and exhibit potent and selective activity (EC50 = 0.26-1.8 μM) against glioma cells with the IDH1 R132H mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNdW-Y0b-flbVg90H21EOLACvtfcHk0ljAZwLXuW-BrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Khu7nF&md5=a348026146bbdeca471b0277fff0fd93</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm500660f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500660f%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DKogiso%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DJ.%2BJ.%26aulast%3DDong%26aufirst%3DS.%26aulast%3DLv%26aufirst%3DH.%26aulast%3DGallo%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DX.-N.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520Cancer-Associated%2520Mutant%2520Isocitrate%2520Dehydrogenases%253A%2520Synthesis%252C%2520Structure%25E2%2580%2593Activity%2520Relationship%252C%2520and%2520Selective%2520Antitumor%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8307%26epage%3D8318%26doi%3D10.1021%2Fjm500660f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shangguan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joullié, M.</span></span> <span> </span><span class="NLM_article-title">A Copper-Carbodiimide Approach to the Phomopsin Tripeptide Side Chain</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">6748</span>– <span class="NLM_lpage">6750</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2009.09.072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1016%2Fj.tetlet.2009.09.072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=20802791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWlsrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=6748-6750&author=N.+Shangguanauthor=M.+Joulli%C3%A9&title=A+Copper-Carbodiimide+Approach+to+the+Phomopsin+Tripeptide+Side+Chain&doi=10.1016%2Fj.tetlet.2009.09.072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A copper-carbodiimide approach to the phomopsin tripeptide side chain</span></div><div class="casAuthors">Shangguan, Ning; Joullie, Madeleine</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">6748-6750</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A one-step copper-carbodiimide elimination was used to provide the (E)-dehydroisoleucine moiety in the phomopsin side chain stereoselectively.  An efficient approach to the phomopsin tripeptide side chain was developed to be used in the total syntheses of phomopsins A and B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbaQci2taEVrVg90H21EOLACvtfcHk0ljAZwLXuW-BrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWlsrzE&md5=7e6d176f5da15fd2d86ec3cfa84c1991</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2009.09.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2009.09.072%26sid%3Dliteratum%253Aachs%26aulast%3DShangguan%26aufirst%3DN.%26aulast%3DJoulli%25C3%25A9%26aufirst%3DM.%26atitle%3DA%2520Copper-Carbodiimide%2520Approach%2520to%2520the%2520Phomopsin%2520Tripeptide%2520Side%2520Chain%26jtitle%3DTetrahedron%2520Lett.%26date%3D2009%26volume%3D50%26spage%3D6748%26epage%3D6750%26doi%3D10.1016%2Fj.tetlet.2009.09.072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brandel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartigny, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couvrat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eusébio, M. E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canotilho, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petit, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coquerel, G.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Reversible Phase Transitions in Molecular Crystals: Case of Ciclopirox</span>. <i>Chem. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">6360</span>– <span class="NLM_lpage">6373</span>, <span class="refDoi"> DOI: 10.1021/acs.chemmater.5b02389</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemmater.5b02389" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVWntLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=6360-6373&author=C.+Brandelauthor=Y.+Cartignyauthor=N.+Couvratauthor=M.+E.+S.+Eus%C3%A9bioauthor=J.+Canotilhoauthor=S.+Petitauthor=G.+Coquerel&title=Mechanisms+of+Reversible+Phase+Transitions+in+Molecular+Crystals%3A+Case+of+Ciclopirox&doi=10.1021%2Facs.chemmater.5b02389"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of Reversible Phase Transitions in Molecular Crystals: Case of Ciclopirox</span></div><div class="casAuthors">Brandel, Clement; Cartigny, Yohann; Couvrat, Nicolas; Eusebio, M. Ermelinda S.; Canotilho, Joao; Petit, Samuel; Coquerel, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry of Materials</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6360-6373</span>CODEN:
                <span class="NLM_cas:coden">CMATEX</span>;
        ISSN:<span class="NLM_cas:issn">0897-4756</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The detailed characterization of several subambient solid state transitions occurring in the pharmaceutical ingredient Ciclopirox between -20° and -85° was performed by using a combination of DSC, cold-stage optical microscopy, vibrational spectroscopies, solid state NMR at controlled temp., structural analyses by single crystal x-ray diffraction, and temp.-resolved X-ray powder diffraction.  The global anal. of the available data reveals that the mechanisms of these reversible transitions involve a subtle compromise between phenomena related to mol. disorder, cooperative release of strains induced by cooling, and structural reorganization assocd. with topotactic changes in crystal lattice and symmetry.  However, no major change in the main features of crystal packings is obsd. during the successive single crystal-to-single crystal transitions, which highlights the difficulty to classify such transitions in the frame of conventional theor. frameworks.  The successive thermal events and related structural changes or relaxations can be seen as the consequences of a deconvolution phenomenon for the global phase transition between the dynamically disordered room temp. form (space group C2/c, Z = 8, Z' = 1) and the ordered low-temp. form (space group P21/c, Z = 48, Z' = 12).  In this respect, the intermediate form(s) can be seen as transient states of kinetic origin with a questionable genuine crystallog. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLP7mFOQyt8bVg90H21EOLACvtfcHk0lhIrRGGUDlm5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVWntLvI&md5=e7df5c8e9e68025e30cbe3460896c91b</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.chemmater.5b02389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemmater.5b02389%26sid%3Dliteratum%253Aachs%26aulast%3DBrandel%26aufirst%3DC.%26aulast%3DCartigny%26aufirst%3DY.%26aulast%3DCouvrat%26aufirst%3DN.%26aulast%3DEus%25C3%25A9bio%26aufirst%3DM.%2BE.%2BS.%26aulast%3DCanotilho%26aufirst%3DJ.%26aulast%3DPetit%26aufirst%3DS.%26aulast%3DCoquerel%26aufirst%3DG.%26atitle%3DMechanisms%2520of%2520Reversible%2520Phase%2520Transitions%2520in%2520Molecular%2520Crystals%253A%2520Case%2520of%2520Ciclopirox%26jtitle%3DChem.%2520Mater.%26date%3D2015%26volume%3D27%26spage%3D6360%26epage%3D6373%26doi%3D10.1021%2Facs.chemmater.5b02389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Longa, E. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, R.</span></span> <span> </span><span class="NLM_article-title">Reversible Middle Cerebral Artery Occlusion without Craniotomy in Rats</span>. <i>Stroke</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1161/01.str.20.1.84</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1161%2F01.str.20.1.84" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=2643202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A280%3ADyaL1M7gtFWhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1989&pages=84-91&author=E.+Z.+Longaauthor=P.+R.+Weinsteinauthor=S.+Carlsonauthor=R.+Cummins&title=Reversible+Middle+Cerebral+Artery+Occlusion+without+Craniotomy+in+Rats&doi=10.1161%2F01.str.20.1.84"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible middle cerebral artery occlusion without craniectomy in rats</span></div><div class="casAuthors">Longa E Z; Weinstein P R; Carlson S; Cummins R</div><div class="citationInfo"><span class="NLM_cas:title">Stroke</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-91</span>
        ISSN:<span class="NLM_cas:issn">0039-2499</span>.
    </div><div class="casAbstract">To develop a simple, relatively noninvasive small-animal model of reversible regional cerebral ischemia, we tested various methods of inducing infarction in the territory of the right middle cerebral artery (MCA) by extracranial vascular occlusion in rats.  In preliminary studies, 60 rats were anesthetized with ketamine and different combinations of vessels were occluded; blood pressure and arterial blood gases were monitored.  Neurologic deficit, mortality rate, gross pathology, and in some instances, electroencephalogram and histochemical staining results were evaluated in all surviving rats.  The principal procedure consisted of introducing a 4-0 nylon intraluminal suture into the cervical internal carotid artery (ICA) and advancing it intracranially to block blood flow into the MCA; collateral blood flow was reduced by interrupting all branches of the external carotid artery (ECA) and all extracranial branches of the ICA.  In some groups of rats, bilateral vertebral or contralateral carotid artery occlusion was also performed.  India ink perfusion studies in 20 rats documented blockage of MCA blood flow in 14 rats subjected to permanent occlusion and the restoration of blood flow to the MCA territory in six rats after withdrawal of the suture from the ICA.  The best method of MCA occlusion was then selected for further confirmatory studies, including histologic examination, in five additional groups of rats anesthetized with halothane.  Seven of eight rats that underwent permanent occlusion of the MCA had resolving moderately severe neurologic deficits (Grade 2 of 4) and unilateral infarcts averaging 37.6 +/- 5.5% of the coronal sectional area at 72 hours after the onset of occlusion.(ABSTRACT TRUNCATED AT 250 WORDS)</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-hfBvofz-K_tos8R3JUhXfW6udTcc2eZ7nAiMXpTtYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M7gtFWhuw%253D%253D&md5=299efbee4d90d6aee124ca4167210ceb</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1161%2F01.str.20.1.84&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.str.20.1.84%26sid%3Dliteratum%253Aachs%26aulast%3DLonga%26aufirst%3DE.%2BZ.%26aulast%3DWeinstein%26aufirst%3DP.%2BR.%26aulast%3DCarlson%26aufirst%3DS.%26aulast%3DCummins%26aufirst%3DR.%26atitle%3DReversible%2520Middle%2520Cerebral%2520Artery%2520Occlusion%2520without%2520Craniotomy%2520in%2520Rats%26jtitle%3DStroke%26date%3D1989%26volume%3D20%26spage%3D84%26epage%3D91%26doi%3D10.1161%2F01.str.20.1.84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanberg, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willing, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Ramos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chopp, M.</span></span> <span> </span><span class="NLM_article-title">Intravenous Administration of Human Umbilical Cord Blood Reduces Behavioral Deficits after Stroke in Rats</span>. <i>Stroke</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">2682</span>– <span class="NLM_lpage">2688</span>, <span class="refDoi"> DOI: 10.1161/hs1101.098367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1161%2Fhs1101.098367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=11692034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A280%3ADC%252BD3MnktFemsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2001&pages=2682-2688&author=J.+Chenauthor=P.+R.+Sanbergauthor=Y.+Liauthor=L.+Wangauthor=M.+Luauthor=A.+E.+Willingauthor=J.+Sanchez-Ramosauthor=M.+Chopp&title=Intravenous+Administration+of+Human+Umbilical+Cord+Blood+Reduces+Behavioral+Deficits+after+Stroke+in+Rats&doi=10.1161%2Fhs1101.098367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats</span></div><div class="casAuthors">Chen J; Sanberg P R; Li Y; Wang L; Lu M; Willing A E; Sanchez-Ramos J; Chopp M</div><div class="citationInfo"><span class="NLM_cas:title">Stroke</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2682-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Human umbilical cord blood cells (HUCBC) are rich in stem and progenitor cells.  In this study we tested whether intravenously infused HUCBC enter brain, survive, differentiate, and improve neurological functional recovery after stroke in rats.  In addition, we tested whether ischemic brain tissue extract selectively induces chemotaxis of HUCBC in vitro.  METHODS:  Adult male Wistar rats were subjected to transient (2-hour) middle cerebral artery occlusion (MCAO).  Experimental groups were as follows: group 1, MCAO alone (n=5); group 2, 3x10(6) HUCBC injected into tail vein at 24 hours after MCAO (n=6) (animals of groups 1 and 2 were killed at 14 days after MCAO); group 3, MCAO alone (n=5); group 4, MCAO injected with PBS at 1 day after stroke (n=8); and group 5, 3x10(6) HUCBC injected into tail vein at 7 days after MCAO (n=5).  Rats of groups 3, 4, and 5 were killed at 35 days after MCAO.  Behavioral tests (rotarod and Modified Neurological Severity Score [mNSS]) were performed.  Immunohistochemical staining was used to identify cells derived from HUCBC.  Chemotactic activity of ischemia brain tissue extracts toward HUCBC at different time points was evaluated in vitro.  RESULTS:  Treatment at 24 hours after MCAO with HUCBC significantly improved functional recovery, as evidenced by the rotarod test and mNSS (P<0.05).  Treatment at 7 days after MCAO with HUCBC significantly improved function only on the mNSS (P<0.05).  Some HUCBC were reactive for the astrocyte marker glial fibrillary acidic protein and the neuronal markers NeuN and microtubule-associated protein 2.  In vitro, significant HUCBC migration activity was present at 24 hours after MCAO (P<0.01) compared with normal brain tissue.  CONCLUSIONS:  Intravenously administered HUCBC enter brain, survive, migrate, and improve functional recovery after stroke.  HUCBC transplantation may provide a cell source to treat stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ22Smdbsm0SMrRqEXsZufAfW6udTcc2eafCC9AJa_F67ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MnktFemsw%253D%253D&md5=d91929883c97c51bcc90235902e672b9</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1161%2Fhs1101.098367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252Fhs1101.098367%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DSanberg%26aufirst%3DP.%2BR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DWilling%26aufirst%3DA.%2BE.%26aulast%3DSanchez-Ramos%26aufirst%3DJ.%26aulast%3DChopp%26aufirst%3DM.%26atitle%3DIntravenous%2520Administration%2520of%2520Human%2520Umbilical%2520Cord%2520Blood%2520Reduces%2520Behavioral%2520Deficits%2520after%2520Stroke%2520in%2520Rats%26jtitle%3DStroke%26date%3D2001%26volume%3D32%26spage%3D2682%26epage%3D2688%26doi%3D10.1161%2Fhs1101.098367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jeffrey Lin, Maryam Zangi, Tanguturi Venkata Narayana Hajay Kumar, Makala Shakar Reddy, Lingala Vijaya Raghava Reddy, Subir Kumar Sadhukhan, Daniel P. Bradley, Brenda Moreira-Walsh, Tiffany C. Edwards, Austin T. O’Dea, John E. Tavis, Marvin J. Meyers, <span class="NLM_string-name hlFld-ContribAuthor">Maureen J. Donlin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Derivatives of Ciclopirox are Effective Inhibitors of Cryptococcus neoformans. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (12)
                                     , 8477-8487. <a href="https://doi.org/10.1021/acsomega.1c00273" title="DOI URL">https://doi.org/10.1021/acsomega.1c00273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.1c00273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.1c00273%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DSynthetic%252BDerivatives%252Bof%252BCiclopirox%252Bare%252BEffective%252BInhibitors%252Bof%252BCryptococcus%252Bneoformans%26aulast%3DLin%26aufirst%3DJeffrey%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15012021%26date%3D09022021%26date%3D15032021%26volume%3D6%26issue%3D12%26spage%3D8477%26epage%3D8487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yajuan Qin, Lingling Feng, Xin Fan, Liping Zheng, Yu Zhang, Lei Chang, <span class="NLM_string-name hlFld-ContribAuthor">Tingyou Li</span>. </span><span class="cited-content_cbyCitation_article-title">Neuroprotective Effect of N-Cyclohexylethyl-[A/G]-[D/E]-X-V Peptides on Ischemic Stroke by Blocking nNOS–CAPON Interaction. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 244-255. <a href="https://doi.org/10.1021/acschemneuro.0c00739" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00739</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00739%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DNeuroprotective%252BEffect%252Bof%252BN-Cyclohexylethyl-%25255BA%25252FG%25255D-%25255BD%25252FE%25255D-X-V%252BPeptides%252Bon%252BIschemic%252BStroke%252Bby%252BBlocking%252BnNOS%2525E2%252580%252593CAPON%252BInteraction%26aulast%3DQin%26aufirst%3DYajuan%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D18112020%26date%3D10122020%26date%3D23122020%26volume%3D12%26issue%3D1%26spage%3D244%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atsushi  Nakayama</span>, <span class="hlFld-ContribAuthor ">Tenta  Nakamura</span>, <span class="hlFld-ContribAuthor ">Tabassum  Ara</span>, <span class="hlFld-ContribAuthor ">Tatsuya  Fukuta</span>, <span class="hlFld-ContribAuthor ">Sangita  Karanjit</span>, <span class="hlFld-ContribAuthor ">Takeshi  Harada</span>, <span class="hlFld-ContribAuthor ">Asuka  Oda</span>, <span class="hlFld-ContribAuthor ">Hideo  Sato</span>, <span class="hlFld-ContribAuthor ">Masahiro  Abe</span>, <span class="hlFld-ContribAuthor ">Kentaro  Kogure</span>, <span class="hlFld-ContribAuthor ">Kosuke  Namba</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a novel antioxidant based on a dimeric dihydroisocoumarin derivative. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2021,</strong> <em>74 </em>, 153176. <a href="https://doi.org/10.1016/j.tetlet.2021.153176" title="DOI URL">https://doi.org/10.1016/j.tetlet.2021.153176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2021.153176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2021.153176%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DDevelopment%252Bof%252Ba%252Bnovel%252Bantioxidant%252Bbased%252Bon%252Ba%252Bdimeric%252Bdihydroisocoumarin%252Bderivative%26aulast%3DNakayama%26aufirst%3DAtsushi%26date%3D2021%26volume%3D74%26spage%3D153176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of NBP and edaravone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of CPX and pyridone derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1–19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) iodoethane, K<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C; (b) methyl 2-bromoacetate, K<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux; (c) lithium hydroxide, water/THF, 40 °C; (d) SOCl<sub>2</sub>, then methanol and Et<sub>3</sub>N; (e) ethynylcyclohexane, Et<sub>3</sub>N, CuI, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, toluene, 4.5 h, 40 °C under Ar; (f) NH<sub>2</sub>OH, KOH, CH<sub>3</sub>OH, reflux; (g) cyclohexylmagnesium bromide, Pd(dppf)Cl<sub>2</sub>; (h) <i>m</i>CPBA, DCM, reflux; (i) acetyl chloride, reflux, then MeOH; (j) AlCl<sub>3</sub>, DCM, reflux; (k) H<sub>2</sub>SO<sub>4</sub>, acetic acid; (l) only for <b>B19</b>: phenylboronic acid, Pd(dppf)Cl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, reflux; (m) P<sub>4</sub>S<sub>10</sub>, toluene, reflux; (n) NH<sub>2</sub>OH·HCl pyridine, reflux.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>20–31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NBS/NIS/NCS, AIBN, CCl<sub>4</sub>, reflux; (b) NaH, THF, 0 °C, then <i>tert</i>-BuLi, DMF, THF, −78 °C; (c) Na(CH<sub>3</sub>COO)<sub>3</sub>BH, acetic acid, Cl(CH<sub>2</sub>)<sub>2</sub>Cl, r. t.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Neuroprotective Effect of compounds <b>4</b>, <b>6</b>, <b>10</b>, <b>11</b>, <b>21</b>, <b>22</b>, and <b>29</b> at concentrations in the range from 0.25 μM to 4 μM on SH-SY5Y cells exposed to OGD injury. The data are presented as the percentage of surviving cells relative to control cells (100%) and as the mean ± SD, <i>n</i> = 3, ###<i>p</i> < 0.001 versus control, *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 versus OGD group, one-way ANOVA, Dunnett’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>11·Ola</b> decreases OGD-induced apoptosis in SH-SY5Y cells. (A) Representative plot of Annexin V-FITC/PI staining; (B) statistical results of the apoptotic rate (<i>n</i> = 4, error bars represent standard error of the mean (SEM), ###<i>p</i> < 0.001 vs control, ***<i>p</i> < 0.001 vs OGD group, <i>t</i>-test); (C) photomicrographs of cell morphology (scale bar = 100 μm).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Neuroprotective Effect of compound <b>11·Ola</b> on HT22 cells subjected to glutamate stimulus (A) and SH-SY5Y cells exposed to H<sub>2</sub>O<sub>2</sub> injury (B). The data are presented as the percentage of surviving cells relative to control cells (100%) and as the mean ± SD, <i>n</i> = 3 for (A), <i>n</i> = 4 for (B). ###<i>p</i> < 0.001 vs control, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 vs glutamate group or H<sub>2</sub>O<sub>2</sub> group, one-way ANOVA, Dunnett’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. bSDTNBI prediction (A), absorption spectra of CPX, <b>11</b>, and <b>1</b> (60 μM) alone and in the presence of FeSO<sub>4</sub>, ammonium iron(III) citrate (120 μM) (B–D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/medium/jm9b01338_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of Compound <b>11·Ola</b> on infarct area and neurological function after 2 h of MCAO and 24 h of reperfusion. (A) Representative picture of TTC staining, (B) quantification of infarct volumes, (C) neurological severity scores. (<i>n</i> = 15–18, data are presented as mean ± SEM, ###<i>p</i> < 0.001 vs sham group, *<i>p</i> < 0.05, **<i>p</i> < 0.01, vs vehicle-treated MCAO group, one-way ANOVA, Dunnett’s multiple comparison test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01338/20200207/images/large/jm9b01338_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01338&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i77">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61574" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61574" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 45 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Go, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozaffarian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roger, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benjamin, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaha, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullerton, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hailpern, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heit, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huffman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judd, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kissela, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittner, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lackland, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtman, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisabeth, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackey, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magid, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchar, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohler, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moy, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mussolino, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumar, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichol, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paynter, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorlie, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towfighi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turan, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virani, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, M. B.</span></span> <span> </span><span class="NLM_article-title">Executive Summary: Heart Disease and Stroke Statistics—2014 Update: a Report from the American Heart Association</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1161/01.cir.0000442015.53336.12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1161%2F01.cir.0000442015.53336.12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=24446411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A280%3ADC%252BC2cznt1ensg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2014&pages=399-410&author=A.+S.+Goauthor=D.+Mozaffarianauthor=V.+L.+Rogerauthor=E.+J.+Benjaminauthor=J.+D.+Berryauthor=M.+J.+Blahaauthor=S.+Daiauthor=E.+S.+Fordauthor=C.+S.+Foxauthor=S.+Francoauthor=H.+J.+Fullertonauthor=C.+Gillespieauthor=S.+M.+Hailpernauthor=J.+A.+Heitauthor=V.+J.+Howardauthor=M.+D.+Huffmanauthor=S.+E.+Juddauthor=B.+M.+Kisselaauthor=S.+J.+Kittnerauthor=D.+T.+Lacklandauthor=J.+H.+Lichtmanauthor=L.+D.+Lisabethauthor=R.+H.+Mackeyauthor=D.+J.+Magidauthor=G.+M.+Marcusauthor=A.+Marelliauthor=D.+B.+Matcharauthor=D.+K.+McGuireauthor=E.+R.+Mohlerauthor=C.+S.+Moyauthor=M.+E.+Mussolinoauthor=R.+W.+Neumarauthor=G.+Nicholauthor=D.+K.+Pandeyauthor=N.+P.+Paynterauthor=M.+J.+Reevesauthor=P.+D.+Sorlieauthor=J.+Steinauthor=A.+Towfighiauthor=T.+N.+Turanauthor=S.+S.+Viraniauthor=N.+D.+Wongauthor=D.+Wooauthor=M.+B.+Turnerauthor=M.+B.+Turner&title=Executive+Summary%3A+Heart+Disease+and+Stroke+Statistics%E2%80%942014+Update%3A+a+Report+from+the+American+Heart+Association&doi=10.1161%2F01.cir.0000442015.53336.12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association</span></div><div class="casAuthors">Go Alan S; Mozaffarian Dariush; Roger Veronique L; Benjamin Emelia J; Berry Jarett D; Blaha Michael J; Dai Shifan; Ford Earl S; Fox Caroline S; Franco Sheila; Fullerton Heather J; Gillespie Cathleen; Hailpern Susan M; Heit John A; Howard Virginia J; Huffman Mark D; Judd Suzanne E; Kissela Brett M; Kittner Steven J; Lackland Daniel T; Lichtman Judith H; Lisabeth Lynda D; Mackey Rachel H; Magid David J; Marcus Gregory M; Marelli Ariane; Matchar David B; McGuire Darren K; Mohler Emile R 3rd; Moy Claudia S; Mussolino Michael E; Neumar Robert W; Nichol Graham; Pandey Dilip K; Paynter Nina P; Reeves Matthew J; Sorlie Paul D; Stein Joel; Towfighi Amytis; Turan Tanya N; Virani Salim S; Wong Nathan D; Woo Daniel; Turner Melanie B</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">399-410</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRd1A4UrEIWorHHuJhbyicZfW6udTcc2eadjF9W6qutl7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cznt1ensg%253D%253D&md5=73c5195faf3dfb3eed5369e27e4f231e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1161%2F01.cir.0000442015.53336.12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.cir.0000442015.53336.12%26sid%3Dliteratum%253Aachs%26aulast%3DGo%26aufirst%3DA.%2BS.%26aulast%3DMozaffarian%26aufirst%3DD.%26aulast%3DRoger%26aufirst%3DV.%2BL.%26aulast%3DBenjamin%26aufirst%3DE.%2BJ.%26aulast%3DBerry%26aufirst%3DJ.%2BD.%26aulast%3DBlaha%26aufirst%3DM.%2BJ.%26aulast%3DDai%26aufirst%3DS.%26aulast%3DFord%26aufirst%3DE.%2BS.%26aulast%3DFox%26aufirst%3DC.%2BS.%26aulast%3DFranco%26aufirst%3DS.%26aulast%3DFullerton%26aufirst%3DH.%2BJ.%26aulast%3DGillespie%26aufirst%3DC.%26aulast%3DHailpern%26aufirst%3DS.%2BM.%26aulast%3DHeit%26aufirst%3DJ.%2BA.%26aulast%3DHoward%26aufirst%3DV.%2BJ.%26aulast%3DHuffman%26aufirst%3DM.%2BD.%26aulast%3DJudd%26aufirst%3DS.%2BE.%26aulast%3DKissela%26aufirst%3DB.%2BM.%26aulast%3DKittner%26aufirst%3DS.%2BJ.%26aulast%3DLackland%26aufirst%3DD.%2BT.%26aulast%3DLichtman%26aufirst%3DJ.%2BH.%26aulast%3DLisabeth%26aufirst%3DL.%2BD.%26aulast%3DMackey%26aufirst%3DR.%2BH.%26aulast%3DMagid%26aufirst%3DD.%2BJ.%26aulast%3DMarcus%26aufirst%3DG.%2BM.%26aulast%3DMarelli%26aufirst%3DA.%26aulast%3DMatchar%26aufirst%3DD.%2BB.%26aulast%3DMcGuire%26aufirst%3DD.%2BK.%26aulast%3DMohler%26aufirst%3DE.%2BR.%26aulast%3DMoy%26aufirst%3DC.%2BS.%26aulast%3DMussolino%26aufirst%3DM.%2BE.%26aulast%3DNeumar%26aufirst%3DR.%2BW.%26aulast%3DNichol%26aufirst%3DG.%26aulast%3DPandey%26aufirst%3DD.%2BK.%26aulast%3DPaynter%26aufirst%3DN.%2BP.%26aulast%3DReeves%26aufirst%3DM.%2BJ.%26aulast%3DSorlie%26aufirst%3DP.%2BD.%26aulast%3DStein%26aufirst%3DJ.%26aulast%3DTowfighi%26aufirst%3DA.%26aulast%3DTuran%26aufirst%3DT.%2BN.%26aulast%3DVirani%26aufirst%3DS.%2BS.%26aulast%3DWong%26aufirst%3DN.%2BD.%26aulast%3DWoo%26aufirst%3DD.%26aulast%3DTurner%26aufirst%3DM.%2BB.%26aulast%3DTurner%26aufirst%3DM.%2BB.%26atitle%3DExecutive%2520Summary%253A%2520Heart%2520Disease%2520and%2520Stroke%2520Statistics%25E2%2580%25942014%2520Update%253A%2520a%2520Report%2520from%2520the%2520American%2520Heart%2520Association%26jtitle%3DCirculation%26date%3D2014%26volume%3D129%26spage%3D399%26epage%3D410%26doi%3D10.1161%2F01.cir.0000442015.53336.12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naghavi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abajobir, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbafati, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbas, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abd-Allah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abera, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aboyans, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adetokunboh, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afshin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, M. B.</span></span> <span> </span><span class="NLM_article-title">Global, Regional, and National Age-sex Specific Mortality for 264 Causes of Death, 1980–2016: a Systematic Analysis for the Global Burden of Disease Study 2016</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>390</i></span>,  <span class="NLM_fpage">1151</span>– <span class="NLM_lpage">1210</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(17)32152-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1016%2FS0140-6736%2817%2932152-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=28919116" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2017&pages=1151-1210&author=M.+Naghaviauthor=A.+A.+Abajobirauthor=C.+Abbafatiauthor=K.+M.+Abbasauthor=F.+Abd-Allahauthor=S.+F.+Aberaauthor=V.+Aboyansauthor=O.+Adetokunbohauthor=A.+Afshinauthor=A.+Agrawalauthor=A.+Ahmadiauthor=M.+B.+Ahmed&title=Global%2C+Regional%2C+and+National+Age-sex+Specific+Mortality+for+264+Causes+of+Death%2C+1980%E2%80%932016%3A+a+Systematic+Analysis+for+the+Global+Burden+of+Disease+Study+2016&doi=10.1016%2FS0140-6736%2817%2932152-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2817%2932152-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252817%252932152-9%26sid%3Dliteratum%253Aachs%26aulast%3DNaghavi%26aufirst%3DM.%26aulast%3DAbajobir%26aufirst%3DA.%2BA.%26aulast%3DAbbafati%26aufirst%3DC.%26aulast%3DAbbas%26aufirst%3DK.%2BM.%26aulast%3DAbd-Allah%26aufirst%3DF.%26aulast%3DAbera%26aufirst%3DS.%2BF.%26aulast%3DAboyans%26aufirst%3DV.%26aulast%3DAdetokunboh%26aufirst%3DO.%26aulast%3DAfshin%26aufirst%3DA.%26aulast%3DAgrawal%26aufirst%3DA.%26aulast%3DAhmadi%26aufirst%3DA.%26aulast%3DAhmed%26aufirst%3DM.%2BB.%26atitle%3DGlobal%252C%2520Regional%252C%2520and%2520National%2520Age-sex%2520Specific%2520Mortality%2520for%2520264%2520Causes%2520of%2520Death%252C%25201980%25E2%2580%25932016%253A%2520a%2520Systematic%2520Analysis%2520for%2520the%2520Global%2520Burden%2520of%2520Disease%2520Study%25202016%26jtitle%3DLancet%26date%3D2017%26volume%3D390%26spage%3D1151%26epage%3D1210%26doi%3D10.1016%2FS0140-6736%2817%2932152-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">GBD
2016 Disease and Injury Incidence and Prevalence Collaborators</span> <span> </span><span class="NLM_article-title">Global, Regional, and National Incidence,
Prevalence, and Years Lived with Disability for 328 Diseases and Injuries
for 195 Countries, 1990–2016: A Systematic Analysis for the
Global Burden of Disease Study 2016</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>390</i></span>,  <span class="NLM_fpage">1211</span>– <span class="NLM_lpage">1259</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(17)32154-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1016%2FS0140-6736%2817%2932154-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=28919117" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2017&pages=1211-1259&author=GBD%0A2016+Disease+and+Injury+Incidence+and+Prevalence+Collaborators&title=Global%2C+Regional%2C+and+National+Incidence%2C%0APrevalence%2C+and+Years+Lived+with+Disability+for+328+Diseases+and+Injuries%0Afor+195+Countries%2C+1990%E2%80%932016%3A+A+Systematic+Analysis+for+the%0AGlobal+Burden+of+Disease+Study+2016&doi=10.1016%2FS0140-6736%2817%2932154-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2817%2932154-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252817%252932154-2%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DGlobal%252C%2520Regional%252C%2520and%2520National%2520Incidence%252C%250APrevalence%252C%2520and%2520Years%2520Lived%2520with%2520Disability%2520for%2520328%2520Diseases%2520and%2520Injuries%250Afor%2520195%2520Countries%252C%25201990%25E2%2580%25932016%253A%2520A%2520Systematic%2520Analysis%2520for%2520the%250AGlobal%2520Burden%2520of%2520Disease%2520Study%25202016%26jtitle%3DLancet%26date%3D2017%26volume%3D390%26spage%3D1211%26epage%3D1259%26doi%3D10.1016%2FS0140-6736%2817%2932154-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wardlaw, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berge, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Zoppo, G. J.</span></span> <span> </span><span class="NLM_article-title">Thrombolysis for Acute Ischaemic Stroke</span>. <i>Cochrane Database Syst. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">CD000213</span>, <span class="refDoi"> DOI: 10.1002/14651858.CD000213.pub3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1002%2F14651858.CD000213.pub3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=CD000213&author=J.+M.+Wardlawauthor=V.+Murrayauthor=E.+Bergeauthor=G.+J.+del+Zoppo&title=Thrombolysis+for+Acute+Ischaemic+Stroke&doi=10.1002%2F14651858.CD000213.pub3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD000213.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD000213.pub3%26sid%3Dliteratum%253Aachs%26aulast%3DWardlaw%26aufirst%3DJ.%2BM.%26aulast%3DMurray%26aufirst%3DV.%26aulast%3DBerge%26aufirst%3DE.%26aulast%3Ddel%2BZoppo%26aufirst%3DG.%2BJ.%26atitle%3DThrombolysis%2520for%2520Acute%2520Ischaemic%2520Stroke%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2014%26volume%3D7%26spage%3DCD000213%26doi%3D10.1002%2F14651858.CD000213.pub3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">(accessed July 21, 2019)</p></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zahuranec, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majersik, J. J.</span></span> <span> </span><span class="NLM_article-title">Percentage of Acute Stroke Patients Eligible for Endovascular Treatment</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">S22</span>– <span class="NLM_lpage">S25</span>, <span class="refDoi"> DOI: 10.1212/wnl.0b013e31826957cf</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1212%2Fwnl.0b013e31826957cf" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=23008402" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2012&pages=S22-S25&author=D.+B.+Zahuranecauthor=J.+J.+Majersik&title=Percentage+of+Acute+Stroke+Patients+Eligible+for+Endovascular+Treatment&doi=10.1212%2Fwnl.0b013e31826957cf"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1212%2Fwnl.0b013e31826957cf&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252Fwnl.0b013e31826957cf%26sid%3Dliteratum%253Aachs%26aulast%3DZahuranec%26aufirst%3DD.%2BB.%26aulast%3DMajersik%26aufirst%3DJ.%2BJ.%26atitle%3DPercentage%2520of%2520Acute%2520Stroke%2520Patients%2520Eligible%2520for%2520Endovascular%2520Treatment%26jtitle%3DNeurology%26date%3D2012%26volume%3D79%26spage%3DS22%26epage%3DS25%26doi%3D10.1212%2Fwnl.0b013e31826957cf" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Edaravone
Acute Infarction Study Group</span> <span> </span><span class="NLM_article-title">Effect of a Novel Free Radical Scavenger, Edaravone (MCI-186), on
Acute Brain Infarction. Randomized, Placebo-controlled, Double-blind
Study at Multicenters</span>. <i>Cerebrovasc. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">222</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1159/000069318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1159%2F000069318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=12715790" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=222-229&author=Edaravone%0AAcute+Infarction+Study+Group&title=Effect+of+a+Novel+Free+Radical+Scavenger%2C+Edaravone+%28MCI-186%29%2C+on%0AAcute+Brain+Infarction.+Randomized%2C+Placebo-controlled%2C+Double-blind%0AStudy+at+Multicenters&doi=10.1159%2F000069318"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1159%2F000069318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000069318%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DEffect%2520of%2520a%2520Novel%2520Free%2520Radical%2520Scavenger%252C%2520Edaravone%2520%2528MCI-186%2529%252C%2520on%250AAcute%2520Brain%2520Infarction.%2520Randomized%252C%2520Placebo-controlled%252C%2520Double-blind%250AStudy%2520at%2520Multicenters%26jtitle%3DCerebrovasc.%2520Dis.%26date%3D2003%26volume%3D15%26spage%3D222%26epage%3D229%26doi%3D10.1159%2F000069318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, M.</span></span> <span> </span><span class="NLM_article-title">Meta-analysis of Effect of dl-3-butylphthalide Injection on Neurological Function of Patients with Acute Cerebral Infarction</span>. <i>Chin. J. New Drugs Clin. Rem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=492-498&author=H.+Xieauthor=L.+Wangauthor=M.+Hanauthor=M.+Yao&title=Meta-analysis+of+Effect+of+dl-3-butylphthalide+Injection+on+Neurological+Function+of+Patients+with+Acute+Cerebral+Infarction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DM.%26atitle%3DMeta-analysis%2520of%2520Effect%2520of%2520dl-3-butylphthalide%2520Injection%2520on%2520Neurological%2520Function%2520of%2520Patients%2520with%2520Acute%2520Cerebral%2520Infarction%26jtitle%3DChin.%2520J.%2520New%2520Drugs%2520Clin.%2520Rem.%26date%3D2016%26volume%3D7%26spage%3D492%26epage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chavez, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barone, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feuerstein, G. Z.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic Interventions for Stroke</span>. <i>Stroke</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">e558</span>– <span class="NLM_lpage">e563</span>, <span class="refDoi"> DOI: 10.1161/strokeaha.109.559914</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1161%2Fstrokeaha.109.559914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=19745180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGjsb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2009&pages=e558-e563&author=J.+C.+Chavezauthor=O.+Hurkoauthor=F.+C.+Baroneauthor=G.+Z.+Feuerstein&title=Pharmacologic+Interventions+for+Stroke&doi=10.1161%2Fstrokeaha.109.559914"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic Interventions for Stroke: Looking Beyond the Thrombolysis Time Window into the Penumbra with Biomarkers, not a Stop Watch</span></div><div class="casAuthors">Chavez, Juan C.; Hurko, Orest; Barone, Frank C.; Feuerstein, Giora Z.</div><div class="citationInfo"><span class="NLM_cas:title">Stroke</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e558-e563</span>CODEN:
                <span class="NLM_cas:coden">SJCCA7</span>;
        ISSN:<span class="NLM_cas:issn">0039-2499</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Background and Purpose: The majority of pharmacol. agents for stroke were developed based on the assumption that neurol. deficits will be reduced upon the successful interruption of biochem. mechanisms leading to neuronal death.  Despite significant evidence of preclin. efficacy, none of these agents succeeded.  They either failed to demonstrate efficacy in the clinic or their development was halted for safety, strategic, or com. reasons.  Summary of Review: This "neuroprotection strategy" has focused primarily on targets in the neurotoxic environment that occurs under ischemic conditions.  In many cases, these agents were designed to tackle events that are known to start almost immediately after onset of ischemia, which is far before a realistic therapeutic time window opens for most, if not all, patients with stroke.  In other instances, they were evaluated beyond a realistic timeframe in which one could expect significant salvageable tissue or penumbra to exist.  Surprisingly, most of these agents were not evaluated in conjunction with strategies for improving perfusion to the affected tissue, indicating an overoptimistic assumption that neuroprotection alone could be sufficient to halt injury caused by an abrupt interruption of brain blood flow.  Conclusions: We provide a constructive translational medicine perspective about how one could improve the drug development process with the hope that the probability for success can increase in our quest to establish a novel therapy for stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUbehRObDyBrVg90H21EOLACvtfcHk0lj8p86QCCZRnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGjsb%252FJ&md5=db4161cadb475322fee461ce595de317</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1161%2Fstrokeaha.109.559914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252Fstrokeaha.109.559914%26sid%3Dliteratum%253Aachs%26aulast%3DChavez%26aufirst%3DJ.%2BC.%26aulast%3DHurko%26aufirst%3DO.%26aulast%3DBarone%26aufirst%3DF.%2BC.%26aulast%3DFeuerstein%26aufirst%3DG.%2BZ.%26atitle%3DPharmacologic%2520Interventions%2520for%2520Stroke%26jtitle%3DStroke%26date%3D2009%26volume%3D40%26spage%3De558%26epage%3De563%26doi%3D10.1161%2Fstrokeaha.109.559914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chioua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Alonso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalo-Gobernado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayuso, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escobar-Peso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infantes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadjipavlou-Litina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoya, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montaner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcázar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">New Quinolylnitrones for Stroke Therapy: Antioxidant and Neuroprotective. (Z)-N-t-Butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine Oxide as a New Lead-Compound for Ischemic Stroke Treatment</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2184</span>– <span class="NLM_lpage">2201</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01987</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01987" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVWjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2184-2201&author=M.+Chiouaauthor=E.+Mart%C3%ADnez-Alonsoauthor=R.+Gonzalo-Gobernadoauthor=M.+I.+Ayusoauthor=A.+Escobar-Pesoauthor=L.+Infantesauthor=D.+Hadjipavlou-Litinaauthor=J.+J.+Montoyaauthor=J.+Montanerauthor=A.+Alc%C3%A1zarauthor=J.+Marco-Contelles&title=New+Quinolylnitrones+for+Stroke+Therapy%3A+Antioxidant+and+Neuroprotective.+%28Z%29-N-t-Butyl-1-%282-chloro-6-methoxyquinolin-3-yl%29methanimine+Oxide+as+a+New+Lead-Compound+for+Ischemic+Stroke+Treatment&doi=10.1021%2Facs.jmedchem.8b01987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">New Quinolylnitrones for Stroke Therapy: Antioxidant and Neuroprotective (Z)-N-tert-Butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine Oxide as a New Lead-Compound for Ischemic Stroke Treatment</span></div><div class="casAuthors">Chioua, Mourad; Martinez-Alonso, Emma; Gonzalo-Gobernado, Rafael; Ayuso, Maria I.; Escobar-Peso, Alejandro; Infantes, Lourdes; Hadjipavlou-Litina, Dimitra; Montoya, Juan J.; Montaner, Joan; Alcazar, Alberto; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2184-2201</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe herein the synthesis and neuroprotective capacity of an array of 31 compds. comprising quinolyloximes, quinolylhydrazones, quinolylimines, QNs, and related heterocyclic azolylnitrones.  Neuronal cultures subjected to oxygen-glucose deprivation (OGD), as exptl. model for ischemic conditions, were treated with our mols. at the onset of recovery period after OGD and showed that most of these QNs, but not the azo mols., improved neuronal viability 24 h after recovery.  Esp., QN (Z)-N-tert-butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine oxide (I) was shown as a very potent neuroprotective agent.  Antioxidant anal. based on the ability of I to trap different types of toxic radical oxygenated species supported and confirmed its strong neuroprotective capacity.  Finally, I showed also neuroprotection induction in two in vivo models of cerebral ischemia, decreasing neuronal death and reducing infarct size, allowing us to conclude that I can be considered as new lead-compd. for ischemic stroke treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfCp1AW7e0XLVg90H21EOLACvtfcHk0lj8p86QCCZRnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVWjtbs%253D&md5=0f23023ae2328f11dab4bf332442d636</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01987%26sid%3Dliteratum%253Aachs%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DMart%25C3%25ADnez-Alonso%26aufirst%3DE.%26aulast%3DGonzalo-Gobernado%26aufirst%3DR.%26aulast%3DAyuso%26aufirst%3DM.%2BI.%26aulast%3DEscobar-Peso%26aufirst%3DA.%26aulast%3DInfantes%26aufirst%3DL.%26aulast%3DHadjipavlou-Litina%26aufirst%3DD.%26aulast%3DMontoya%26aufirst%3DJ.%2BJ.%26aulast%3DMontaner%26aufirst%3DJ.%26aulast%3DAlc%25C3%25A1zar%26aufirst%3DA.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DNew%2520Quinolylnitrones%2520for%2520Stroke%2520Therapy%253A%2520Antioxidant%2520and%2520Neuroprotective.%2520%2528Z%2529-N-t-Butyl-1-%25282-chloro-6-methoxyquinolin-3-yl%2529methanimine%2520Oxide%2520as%2520a%2520New%2520Lead-Compound%2520for%2520Ischemic%2520Stroke%2520Treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2184%26epage%3D2201%26doi%3D10.1021%2Facs.jmedchem.8b01987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arundine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tymianski, M.</span></span> <span> </span><span class="NLM_article-title">Molecular Mechanisms of Glutamate-dependent Neurodegeneration in Ischemia and Traumatic Brain Injury</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">668</span>, <span class="refDoi"> DOI: 10.1007/s00018-003-3319-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1007%2Fs00018-003-3319-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=15052409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsFyrtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2004&pages=657-668&author=M.+Arundineauthor=M.+Tymianski&title=Molecular+Mechanisms+of+Glutamate-dependent+Neurodegeneration+in+Ischemia+and+Traumatic+Brain+Injury&doi=10.1007%2Fs00018-003-3319-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury</span></div><div class="casAuthors">Arundine, M.; Tymianski, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">657-668</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Stroke and neuro trauma mediate neuronal death through a series of events that involve multiple interdependent mol. pathways.  It has been suggested that these pathways are triggered following elevations in extracellular excitatory amino acids, primarily glutamate.  This report outlines mechanisms involving glutamate-mediated excitotoxicity with specific focus on (i) the role of Ca2+ in neurotoxicity, (ii) the concept of "source specificity" of neurotoxicity, (iii) the role of the ionotropic N-methyl-D-aspartate (NMDA)-subtype glutamate receptor and its assocd. submembrane mols. that may give rise to signaling specificity in excitotoxicity and (iv) the role of glutamate-mediated free-radical generation and assocd. cell death pathways.  We also highlight a novel, peptide-based approach for uncoupling NMDA receptors from excitotoxicity in the rat central nervous system subjected to focal ischemia, thereby reducing stroke infarct vol. and improving neurol. functioning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz1t1bFIW-SrVg90H21EOLACvtfcHk0lgddiURP5IO7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsFyrtbo%253D&md5=33699e6badf3c87f2a6719d1e5731180</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00018-003-3319-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-003-3319-x%26sid%3Dliteratum%253Aachs%26aulast%3DArundine%26aufirst%3DM.%26aulast%3DTymianski%26aufirst%3DM.%26atitle%3DMolecular%2520Mechanisms%2520of%2520Glutamate-dependent%2520Neurodegeneration%2520in%2520Ischemia%2520and%2520Traumatic%2520Brain%2520Injury%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2004%26volume%3D61%26spage%3D657%26epage%3D668%26doi%3D10.1007%2Fs00018-003-3319-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span> <span> </span><span class="NLM_article-title">Role of Inflammation and Its Mediators in Acute Ischemic Stroke</span>. <i>J. Cardiovasc. Transl. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">834</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.1007/s12265-013-9508-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1007%2Fs12265-013-9508-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=24006091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A280%3ADC%252BC3sbltlGqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=834-851&author=R.+Jinauthor=L.+Liuauthor=S.+Zhangauthor=A.+Nandaauthor=G.+Li&title=Role+of+Inflammation+and+Its+Mediators+in+Acute+Ischemic+Stroke&doi=10.1007%2Fs12265-013-9508-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Role of inflammation and its mediators in acute ischemic stroke</span></div><div class="casAuthors">Jin Rong; Liu Lin; Zhang Shihao; Nanda Anil; Li Guohong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cardiovascular translational research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">834-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammation plays an important role in the pathogenesis of ischemic stroke and other forms of ischemic brain injury.  Increasing evidence suggests that inflammatory response is a double-edged sword, as it not only exacerbates secondary brain injury in the acute stage of stroke but also beneficially contributes to brain recovery after stroke.  In this article, we provide an overview on the role of inflammation and its mediators in acute ischemic stroke.  We discuss various pro-inflammatory and anti-inflammatory responses in different phases after ischemic stroke and the possible reasons for their failures in clinical trials.  Undoubtedly, there is still much to be done in order to translate promising pre-clinical findings into clinical practice.  A better understanding of the dynamic balance between pro- and anti-inflammatory responses and identifying the discrepancies between pre-clinical studies and clinical trials may serve as a basis for designing effective therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkoa7zhFP3lTjk2McQZ6XmfW6udTcc2eZHNMTmqXHXfrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbltlGqug%253D%253D&md5=6304a78caaf8d0514af563f73db5480f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs12265-013-9508-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12265-013-9508-6%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DNanda%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DG.%26atitle%3DRole%2520of%2520Inflammation%2520and%2520Its%2520Mediators%2520in%2520Acute%2520Ischemic%2520Stroke%26jtitle%3DJ.%2520Cardiovasc.%2520Transl.%2520Res.%26date%3D2013%26volume%3D6%26spage%3D834%26epage%3D851%26doi%3D10.1007%2Fs12265-013-9508-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-m.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-l.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, H.-x.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.-m.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-y.</span></span> <span> </span><span class="NLM_article-title">Dual Anti-ischemic Effects of Rosmarinic Acid n-Butyl Ester via Alleviation of DAPK-p53-mediated Neuronal Damage and Microglial Inflammation</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">468</span>, <span class="refDoi"> DOI: 10.1038/aps.2016.156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1038%2Faps.2016.156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=28216621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsV2qurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=459-468&author=L.+Wuauthor=H.-m.+Wangauthor=J.-l.+Liauthor=H.-x.+Fengauthor=W.-m.+Zhaoauthor=H.-y.+Zhang&title=Dual+Anti-ischemic+Effects+of+Rosmarinic+Acid+n-Butyl+Ester+via+Alleviation+of+DAPK-p53-mediated+Neuronal+Damage+and+Microglial+Inflammation&doi=10.1038%2Faps.2016.156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Dual anti-ischemic effects of rosmarinic acid n-butyl ester via alleviation of DAPK-p53-mediated neuronal damage and microglial inflammation</span></div><div class="casAuthors">Wu, Lei; Wang, Hong-min; Li, Jin-long; Feng, Hong-xuan; Zhao, Wei-min; Zhang, Hai-yan</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">459-468</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The discovery of efficacious anti-ischemic drugs remains a challenge.  Recently we have found that rosmarinic acid Bu ester (RABE), a deriv. of rosmarinic acid, significantly protects SH-SY5Y cells against oxygen glucose deprivation (OGD)-induced cell death.  In the present study we simultaneously investigated the effects of RABE on the two key players in the pathophysiol. of cerebral ischemia, ischemic neuronal damage and microglial inflammation.  Pretreatment with RABE (1, 10 μmol/L) dose-dependently attenuated OGD- or H2O2-induced redn. of the viability of SH-SY5Y neuroblastoma cells.  RABE pretreatment concurrently reduced the apoptotic cell rate, down-regulated the expression of the pro-apoptotic proteins Bax and p53, and up-regulated the expression of the anti-apoptotic protein phosphorylated death-assocd. protein kinase (DAPK).  Furthermore, pretreatment with RABE (3 μmol/L) markedly inhibited lipopolysaccharide (LPS)-induced increases in the release of TNF-α, IL-1β, NO and PGE2, and the expression levels of iNOS, and COX-2 in cultured rat microglial cells.  In conclusion, these results reveal for the first time the potential anti-ischemic effects of RABE on neuronal and glial cells and elucidate the mol. mechanisms involved in its dual beneficial profiles in vitro.  RABE may be a promising drug lead/candidate for the treatment of ischemic stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7dcgNIOLyhLVg90H21EOLACvtfcHk0ljZHf2nBIYYpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsV2qurc%253D&md5=ac8a694b16950a11c50ee0ca40511b8b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Faps.2016.156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2016.156%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.-m.%26aulast%3DLi%26aufirst%3DJ.-l.%26aulast%3DFeng%26aufirst%3DH.-x.%26aulast%3DZhao%26aufirst%3DW.-m.%26aulast%3DZhang%26aufirst%3DH.-y.%26atitle%3DDual%2520Anti-ischemic%2520Effects%2520of%2520Rosmarinic%2520Acid%2520n-Butyl%2520Ester%2520via%2520Alleviation%2520of%2520DAPK-p53-mediated%2520Neuronal%2520Damage%2520and%2520Microglial%2520Inflammation%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2017%26volume%3D38%26spage%3D459%26epage%3D468%26doi%3D10.1038%2Faps.2016.156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. Y.</span></span> <span> </span><span class="NLM_article-title">A Novel Caffeoyl Triterpene Attenuates Cerebral Ischemic Injury with Potent Anti-inflammatory and Hypothermic Effects</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1111/jnc.13046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1111%2Fjnc.13046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=25626516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVSmtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2015&pages=93-103&author=Z.+Ruanauthor=H.+M.+Wangauthor=X.+T.+Huangauthor=Y.+Fuauthor=J.+Wuauthor=C.+Y.+Yeauthor=J.+L.+Liauthor=L.+Wuauthor=Q.+Gongauthor=W.+M.+Zhaoauthor=H.+Y.+Zhang&title=A+Novel+Caffeoyl+Triterpene+Attenuates+Cerebral+Ischemic+Injury+with+Potent+Anti-inflammatory+and+Hypothermic+Effects&doi=10.1111%2Fjnc.13046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A novel caffeoyl triterpene attenuates cerebral ischemic injury with potent anti-inflammatory and hypothermic effects</span></div><div class="casAuthors">Ruan, Zhi; Wang, Hong Min; Huang, Xiao Tian; Fu, Yan; Wu, Jian; Ye, Chun Yan; Li, Jin Long; Wu, Lei; Gong, Qi; Zhao, Wei Min; Zhang, Hai Yan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-103</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Despite the intense efforts in searching for stroke therapies, an urgent need still exists to explore novel neuroprotective agents for ischemic stroke that have high efficacy and wide therapeutic time-window.  Here, we provide the first demonstration that 28-O-caffeoyl betulin (B-CA), a novel deriv. of naturally occurring caffeoyl triterpene, could significantly alleviate brain infarction and neurol. deficit when given as late as 6 h after transient middle cerebral artery occlusion in the rat.  Moreover, post-ischemia B-CA administration exhibited long-term (14 days post stroke) protective effects on both brain infarction and functional (i.e., motor and sensory) deficits.  Protective B-CA effects correlated with decreased inflammatory responses as indicated by inhibition of microglia and astrocyte activation [stained with ionized calcium-binding adapter mol. 1 (Iba-1) and glial fibrillary acidic protein (GFAP) antibody, resp.], as well as suppression of tumor necrosis factor-α, interleukin-1β, and cyclooxygenase-2 overprodn. in the ipsilateral cortex of ischemic rat.  B-CA administration caused significant hypothermia in the focal cerebral ischemic rat, which may contribute to its ameliorative effects on brain damage and inflammation.  In view of its potency in wide therapeutic time-window, robust anti-inflammatory and hypothermic effects, this novel caffeoyl triterpene deriv. may lead toward the development of effective therapeutic strategies for the treatment of ischemic stroke.  We documented for the first time that 28-O-caffeoyl betulin (B-CA), a novel synthetic caffeoyl triterpene inspired from active natural principles of Celastrus orbiculatus Thunb, possessed robust neuroprotection with a wide and clin. useful therapeutic time window against ischemic stroke, correlating with the anti-inflammatory and hypothermic effects.  Thus, this novel caffeoyl triterpene deriv. may lead toward the development of effective therapeutic strategies for the treatment of ischemic stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXEBFvuHBYv7Vg90H21EOLACvtfcHk0lgOVUdSKlXBOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVSmtb8%253D&md5=4fcfc14231aa604575f2d414209b837a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13046%26sid%3Dliteratum%253Aachs%26aulast%3DRuan%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DH.%2BM.%26aulast%3DHuang%26aufirst%3DX.%2BT.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DC.%2BY.%26aulast%3DLi%26aufirst%3DJ.%2BL.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DW.%2BM.%26aulast%3DZhang%26aufirst%3DH.%2BY.%26atitle%3DA%2520Novel%2520Caffeoyl%2520Triterpene%2520Attenuates%2520Cerebral%2520Ischemic%2520Injury%2520with%2520Potent%2520Anti-inflammatory%2520and%2520Hypothermic%2520Effects%26jtitle%3DJ.%2520Neurochem.%26date%3D2015%26volume%3D133%26spage%3D93%26epage%3D103%26doi%3D10.1111%2Fjnc.13046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potential Anti-Ischemic Stroke Agent: 3-Pentylbenzo[c]thiophen-1(3H)-one</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7173</span>– <span class="NLM_lpage">7181</span>, <span class="refDoi"> DOI: 10.1021/jm300681r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300681r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyns7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7173-7181&author=J.+Wuauthor=J.+Lingauthor=X.+Wangauthor=T.+Liauthor=J.+Liuauthor=Y.+Laiauthor=H.+Jiauthor=S.+Pengauthor=J.+Tianauthor=Y.+Zhang&title=Discovery+of+a+Potential+Anti-Ischemic+Stroke+Agent%3A+3-Pentylbenzo%5Bc%5Dthiophen-1%283H%29-one&doi=10.1021%2Fjm300681r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potential anti-ischemic stroke agent: 3-Pentylbenzo[c]thiophen-1(3H)-one</span></div><div class="casAuthors">Wu, Jing; Ling, Jingjing; Wang, Xuliang; Li, Tingting; Liu, Jingchao; Lai, Yisheng; Ji, Hui; Peng, Sixun; Tian, Jide; Zhang, Yihua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7173-7181</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of novel antithrombotic agents with strong free radical scavenging activity is of great significance for the treatment of ischemic stroke.  In the present study, 3-alkyl/arylalkyl-substituted benzo[c]thiophen-1(3H)-ones I(R = Et, nPr, Bu, pentyl,isopentyl, hexyl, heptyl, Bn) were designed and synthesized.  The most active compd. I(R = pentyl) significantly inhibited the ADP (ADP) induced and arachidonic acid (AA) induced in vitro platelet aggregation, superior to clin. used antiplatelet drug aspirin (ASP) and anti-ischemic stroke drugs 3-n-butylphthalide (NBP) and edaravone (Eda).  More importantly, in comparison with both NBP and Eda, I(R = pentyl) exhibited stronger antithrombotic and free radical scavenging activities and better or comparable neuroprotective effects against ischemia/reperfusion (I/R) in rats by ameliorating neurobehavioral function, reducing infarct size and brain-water content, attenuating cerebral damage, and normalizing the levels of oxidative enzymes.  Overall, our findings may provide an alternative strategy for the design of novel anti-ischemic stroke agents more potent than drugs like NBP and Eda.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpndCquiwopMbVg90H21EOLACvtfcHk0lgOVUdSKlXBOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyns7fN&md5=a9bda7b9ed49ebd198d52acb83c6fd57</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm300681r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300681r%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLing%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520a%2520Potential%2520Anti-Ischemic%2520Stroke%2520Agent%253A%25203-Pentylbenzo%255Bc%255Dthiophen-1%25283H%2529-one%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7173%26epage%3D7181%26doi%3D10.1021%2Fjm300681r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maples, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, R. A.</span></span> <span> </span><span class="NLM_article-title">Nitrone-Related Therapeutics</span>. <i>CNS Drugs</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1071</span>– <span class="NLM_lpage">1084</span>, <span class="refDoi"> DOI: 10.2165/00023210-200418150-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.2165%2F00023210-200418150-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=15581379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVSmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1071-1084&author=K.+R.+Maplesauthor=A.+R.+Greenauthor=R.+A.+Floyd&title=Nitrone-Related+Therapeutics&doi=10.2165%2F00023210-200418150-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Nitrone-related therapeutics: potential of NXY-059 for the treatment of acute ischaemic stroke</span></div><div class="casAuthors">Maples, Kirk R.; Green, A. Richard; Floyd, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1071-1084</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  At present, none of the neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease and stroke are treatable with compds. that slow or halt neuronal cell death.  However, the prototype nitrone radical trap α-phenyl-tert-butylnitrone (PBN) has been shown to be an effective neuroprotective agent in various models of neurodegeneration.  Some of these data are briefly reviewed as an introduction to an examn. of the effect of the novel nitrone radical trapping agent disodium 2,4-disulfophenyl-N-tert-butylnitrone (NXY-059) in various animal models of stroke.  NXY-059 has been shown to be an effective neuroprotective agent in both transient (reperfusion) and permanent focal ischemia models in rats.  In both types of model, NXY-059 has a large window of opportunity, providing effective neuroprotection when given up to 5 h after the start of the occlusion in transient ischemia and 4 h after the start of permanent ischemia.  The compd. is also effective in a marmoset permanent ischemia model when administered up to 4 h after the start of the occlusion.  In this model it has been found to attenuate the problem of spatial neglect and maintain function to the paretic arm.  NXY-059 administration also improves motor function in a rat hemorrhagic stroke model and has a neuroprotective effect in a rabbit thromboembolic stroke model.  The compd. is also well tolerated in stroke patients at plasma levels shown to provide a max. neuroprotective effect in animal models of stroke.  NXY-059, like PBN, is a nitrone with free radical trapping properties and this may be the basis of its neuroprotective action.  However, expts. with PBN and NXY-059 suggest the possibility of other mechanisms being involved and these are also reviewed.  Further expts. are required to fully elucidate the mechanism of action of these very effective neuroprotective agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV5lI5bUg1OrVg90H21EOLACvtfcHk0lgOVUdSKlXBOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVSmug%253D%253D&md5=3656154309f3ac81b5ef81add8c7ec78</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2165%2F00023210-200418150-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00023210-200418150-00003%26sid%3Dliteratum%253Aachs%26aulast%3DMaples%26aufirst%3DK.%2BR.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26aulast%3DFloyd%26aufirst%3DR.%2BA.%26atitle%3DNitrone-Related%2520Therapeutics%26jtitle%3DCNS%2520Drugs%26date%3D2004%26volume%3D18%26spage%3D1071%26epage%3D1084%26doi%3D10.2165%2F00023210-200418150-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lees, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zivin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashwood, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davalos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diener, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyden, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuaib, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hårdemark, H.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasiewski, W. W.</span></span> <span> </span><span class="NLM_article-title">NXY-059 for Acute Ischemic Stroke</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>354</i></span>,  <span class="NLM_fpage">588</span>– <span class="NLM_lpage">600</span>, <span class="refDoi"> DOI: 10.1056/nejmoa052980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1056%2Fnejmoa052980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=16467546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlKjt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2006&pages=588-600&author=K.+R.+Leesauthor=J.+A.+Zivinauthor=T.+Ashwoodauthor=A.+Davalosauthor=S.+M.+Davisauthor=H.-C.+Dienerauthor=J.+Grottaauthor=P.+Lydenauthor=A.+Shuaibauthor=H.-G.+H%C3%A5rdemarkauthor=W.+W.+Wasiewski&title=NXY-059+for+Acute+Ischemic+Stroke&doi=10.1056%2Fnejmoa052980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">NXY-059 for acute ischemic stroke</span></div><div class="casAuthors">Lees, Kennedy.; Zivin, Justin A.; Ashwood, Tim; Davalos, Antonio; Davis, Stephen M.; Diener, Hans-Christoph; Grotta, James; Lyden, Patrick; Shuaib, Ashfaq; Hardemark, Hans-Goran; Wasiewski, Warren W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">588-600</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">NXY-059 is a free-radical-trapping agent that is neuroprotective in animal models of stroke.  We tested whether it would reduce disability in humans after acute ischemic stroke.  We conducted a randomized, double-blind, placebo-controlled trial involving 1722 patients with acute ischemic stroke who were randomly assigned to receive a 72-h infusion of placebo or i.v. NXY-059 within 6 h after the onset of the stroke.  The primary outcome was disability at 90 days, as measured according to scores on the modified Rankin scale for disability (range, 0 to 5, with 0 indicating no residual symptoms and 5 indicating bed-bound, requiring const. care).  Among the 1699 subjects included in the efficacy anal., NXY-059 significantly improved the overall distribution of scores on the modified Rankin scale, as compared with placebo (P=0.038 by the Cochran-Mantel-Haenszel test).  The common odds ratio for improvement across all categories of the scale was 1.20 (95 % confidence interval, 1.01 to 1.42).  Mortality and rates of serious and nonserious adverse events were each similar in the two groups.  NXY-059 did not improve neurol. functioning as measured according to the National Institutes of Health Stroke Scale (NIHSS): the difference between the two groups in the change from baseline scores was 0.1 point (95 % confidence interval, -1.4 to 1.1; P = 0.86).  Likewise, no improvement was obsd. according to the Barthel index (P = 0.14).  In a post hoc anal. of patients who also received alteplase, NXY-059 was assocd. with a lower incidence of any hemorrhagic transformation (P=0.001) and symptomatic intracranial hemorrhage (P = 0.036).  The administration of NXY-059 within six hours after the onset of acute ischemic stroke significantly improved the primary outcome (reduced disability at 90 days), but it did not significantly improve other outcome measures, including neurol. functioning as measured by the NIHSS score.  Addnl. research is needed to confirm whether NXY-059 is beneficial in ischemic stroke. (ClinicalTrials.gov no., NCT00119626.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxgTdttmpFFLVg90H21EOLACvtfcHk0liVyFZBSdvdrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlKjt70%253D&md5=5f26d20befc4af0fadff81d820af489c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa052980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa052980%26sid%3Dliteratum%253Aachs%26aulast%3DLees%26aufirst%3DK.%2BR.%26aulast%3DZivin%26aufirst%3DJ.%2BA.%26aulast%3DAshwood%26aufirst%3DT.%26aulast%3DDavalos%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DS.%2BM.%26aulast%3DDiener%26aufirst%3DH.-C.%26aulast%3DGrotta%26aufirst%3DJ.%26aulast%3DLyden%26aufirst%3DP.%26aulast%3DShuaib%26aufirst%3DA.%26aulast%3DH%25C3%25A5rdemark%26aufirst%3DH.-G.%26aulast%3DWasiewski%26aufirst%3DW.%2BW.%26atitle%3DNXY-059%2520for%2520Acute%2520Ischemic%2520Stroke%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D354%26spage%3D588%26epage%3D600%26doi%3D10.1056%2Fnejmoa052980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zivin, J. A.</span></span> <span> </span><span class="NLM_article-title">Clinical Trials of Neuroprotective Therapies</span>. <i>Stroke</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">791</span>– <span class="NLM_lpage">793</span>, <span class="refDoi"> DOI: 10.1161/01.str.0000252090.44428.82</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1161%2F01.str.0000252090.44428.82" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=17261740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FlslCrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2007&pages=791-793&author=J.+A.+Zivin&title=Clinical+Trials+of+Neuroprotective+Therapies&doi=10.1161%2F01.str.0000252090.44428.82"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical trials of neuroprotective therapies</span></div><div class="casAuthors">Zivin Justin A</div><div class="citationInfo"><span class="NLM_cas:title">Stroke</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2 Suppl</span>),
    <span class="NLM_cas:pages">791-3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">There have been numerous failures in the field of acute stroke therapy over many years, but the first large clinical trial showing preliminary indications of efficacy and safety of a neuroprotective drug, NXY-059, has now been fully reported.  If confirmed, it will mean that a second therapy for acute stroke has been identified and neuroprotective drug development as a class can proceed.  Additionally, a new class of drugs, HMG CoA-reductase inhibitors (statins), specifically high-dose atorvastatin, has been shown to be safe and effective for secondary stroke prevention.  This drug should now become a regular part of stroke patient care.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQq3s1xqi4_THwOGIfWJ7-GfW6udTcc2eaZ6lSI28HFELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FlslCrsQ%253D%253D&md5=011cda0d2f75a5e8d1ea01837f792880</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1161%2F01.str.0000252090.44428.82&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.str.0000252090.44428.82%26sid%3Dliteratum%253Aachs%26aulast%3DZivin%26aufirst%3DJ.%2BA.%26atitle%3DClinical%2520Trials%2520of%2520Neuroprotective%2520Therapies%26jtitle%3DStroke%26date%3D2007%26volume%3D38%26spage%3D791%26epage%3D793%26doi%3D10.1161%2F01.str.0000252090.44428.82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lohaus, G.</span>; <span class="NLM_string-name">Dittmar, W.</span></span> <span> </span><span class="NLM_article-title">Antimycotic 1-hydroxy-2-pyridones</span>. <span class="NLM_patent">ZA 6906039</span>, March 2, <span class="NLM_year">1970</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1970&author=G.+Lohaus&author=W.+Dittmar&title=Antimycotic+1-hydroxy-2-pyridones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLohaus%26aufirst%3DG.%26atitle%3DAntimycotic%25201-hydroxy-2-pyridones%26date%3D1970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larchmont, L. A. G.</span>; <span class="NLM_string-name">Farinelli, S. E.</span></span> <span> </span><span class="NLM_article-title">Use of Ciclopirox or a Pharmaceutically Acceptable Salt Thereof for Inhibiting Neuronal Cell Damage or Neuronal Cell Death</span>. U.S. Patent <span class="NLM_patent">5,846,984A</span>, Dec 8, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=L.+A.+G.+Larchmont&author=S.+E.+Farinelli&title=Use+of+Ciclopirox+or+a+Pharmaceutically+Acceptable+Salt+Thereof+for+Inhibiting+Neuronal+Cell+Damage+or+Neuronal+Cell+Death"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLarchmont%26aufirst%3DL.%2BA.%2BG.%26atitle%3DUse%2520of%2520Ciclopirox%2520or%2520a%2520Pharmaceutically%2520Acceptable%2520Salt%2520Thereof%2520for%2520Inhibiting%2520Neuronal%2520Cell%2520Damage%2520or%2520Neuronal%2520Cell%2520Death%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Repurposing Antimycotic Ciclopirox Olamine as a Promising Anti-ischemic Stroke Agent</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, (in press) <span class="refDoi"> DOI: 10.1016/j.apsb.2019.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1016%2Fj.apsb.2019.08.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=H.+Fengauthor=L.+Huauthor=H.+Zhuauthor=L.+Taoauthor=L.+Wuauthor=Q.+Zhaoauthor=Y.+Gaoauthor=Q.+Gongauthor=F.+Maoauthor=X.+Liauthor=H.+Zhouauthor=J.+Liauthor=H.+Zhang&title=Repurposing+Antimycotic+Ciclopirox+Olamine+as+a+Promising+Anti-ischemic+Stroke+Agent&doi=10.1016%2Fj.apsb.2019.08.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2019.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2019.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DTao%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DRepurposing%2520Antimycotic%2520Ciclopirox%2520Olamine%2520as%2520a%2520Promising%2520Anti-ischemic%2520Stroke%2520Agent%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2019%26doi%3D10.1016%2Fj.apsb.2019.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ayuso, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chioua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Alonso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montaner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masjuán, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadjipavlou-Litina, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcázar, A.</span></span> <span> </span><span class="NLM_article-title">CholesteroNitrones for Stroke</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6704</span>– <span class="NLM_lpage">6709</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00755</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00755" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1OqsLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6704-6709&author=M.+I.+Ayusoauthor=M.+Chiouaauthor=E.+Mart%C3%ADnez-Alonsoauthor=E.+Sorianoauthor=J.+Montanerauthor=J.+Masju%C3%A1nauthor=D.+J.+Hadjipavlou-Litinaauthor=J.+Marco-Contellesauthor=A.+Alc%C3%A1zar&title=CholesteroNitrones+for+Stroke&doi=10.1021%2Facs.jmedchem.5b00755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">CholesteroNitrones for Stroke</span></div><div class="casAuthors">Ayuso, Maria I.; Chioua, Mourad; Martinez-Alonso, Emma; Soriano, Elena; Montaner, Joan; Masjuan, Jaime; Hadjipavlou-Litina, Dimitra J.; Marco-Contelles, Jose; Alcazar, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6704-6709</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This study describes CholesteroNitrone as an antioxidant and neuroprotective agent against ischemic injury.  Neuroprotection was assessed using in vitro and in vivo exptl. ischemia models.  The compd. significantly increased cell viability, induced neuroprotection following ischemic reperfusion, and decreased neurol. deficit scores in treated animals, supporting the next preclin. studies as a potential agent for the treatment of stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlFdwoZbvfw7Vg90H21EOLACvtfcHk0liVyFZBSdvdrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1OqsLjF&md5=a42e237f98c64f29033e9f9952cad984</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00755%26sid%3Dliteratum%253Aachs%26aulast%3DAyuso%26aufirst%3DM.%2BI.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DMart%25C3%25ADnez-Alonso%26aufirst%3DE.%26aulast%3DSoriano%26aufirst%3DE.%26aulast%3DMontaner%26aufirst%3DJ.%26aulast%3DMasju%25C3%25A1n%26aufirst%3DJ.%26aulast%3DHadjipavlou-Litina%26aufirst%3DD.%2BJ.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DAlc%25C3%25A1zar%26aufirst%3DA.%26atitle%3DCholesteroNitrones%2520for%2520Stroke%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6704%26epage%3D6709%26doi%3D10.1021%2Facs.jmedchem.5b00755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chioua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sucunza, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadjipavlou-Litina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcázar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayuso, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oset-Gasque, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monjas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samadi, A.</span></span> <span> </span><span class="NLM_article-title">α-Aryl-N-alkyl Nitrones, as Potential Agents for Stroke Treatment: Synthesis, Theoretical Calculations, Antioxidant, Anti-inflammatory, Neuroprotective, and Brain–Blood Barrier Permeability Properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1021/jm201105a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201105a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFCms73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=153-168&author=M.+Chiouaauthor=D.+Sucunzaauthor=E.+Sorianoauthor=D.+Hadjipavlou-Litinaauthor=A.+Alc%C3%A1zarauthor=I.+Ayusoauthor=M.+J.+Oset-Gasqueauthor=M.+P.+Gonz%C3%A1lezauthor=L.+Monjasauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=J.+Marco-Contellesauthor=A.+Samadi&title=%CE%B1-Aryl-N-alkyl+Nitrones%2C+as+Potential+Agents+for+Stroke+Treatment%3A+Synthesis%2C+Theoretical+Calculations%2C+Antioxidant%2C+Anti-inflammatory%2C+Neuroprotective%2C+and+Brain%E2%80%93Blood+Barrier+Permeability+Properties&doi=10.1021%2Fjm201105a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">α-Aryl-N-alkyl Nitrones, as Potential Agents for Stroke Treatment: Synthesis, Theoretical Calculations, Antioxidant, Anti-inflammatory, Neuroprotective, and Brain-Blood Barrier Permeability Properties</span></div><div class="casAuthors">Chioua, Mourad; Sucunza, David; Soriano, Elena; Hadjipavlou-Litina, Dimitra; Alcazar, Alberto; Ayuso, Irene; Oset-Gasque, Maria Jesus; Gonzalez, Maria Pilar; Monjas, Leticia; Rodriguez-Franco, Maria Isabel; Marco-Contelles, Jose; Samadi, Abdelouahid</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153-168</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the synthesis, theor. calcns., the antioxidant, anti-inflammatory, and neuroprotective properties, and the ability to cross the blood-brain barrier (BBB) of (Z)-α-aryl and heteroaryl-N-alkyl nitrones as potential agents for stroke treatment.  The majority of nitrones compete with DMSO for hydroxyl radicals, and most of them are potent lipoxygenase inhibitors.  Cell viability-related (MTT assay) studies clearly showed that some of these nitrones give rise to significant neuroprotection.  When the compds. were tested for necrotic cell death (LDH release test), several of the nitrones proved to be neuroprotective agents.  In vitro evaluation of the BBB penetration of selected nitrones using the PAMPA-BBB assay showed that all of them cross the BBB.  Two permeable quinoline nitrones show potent combined antioxidant and neuroprotective properties and, therefore, can be considered as new lead compds. for further development in specific tests for potential stroke treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT5WLMSQF7qLVg90H21EOLACvtfcHk0lgxa0FGi0Xa2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFCms73O&md5=731f2b2ae0945585e8e65a669a3a53a4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm201105a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201105a%26sid%3Dliteratum%253Aachs%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DSucunza%26aufirst%3DD.%26aulast%3DSoriano%26aufirst%3DE.%26aulast%3DHadjipavlou-Litina%26aufirst%3DD.%26aulast%3DAlc%25C3%25A1zar%26aufirst%3DA.%26aulast%3DAyuso%26aufirst%3DI.%26aulast%3DOset-Gasque%26aufirst%3DM.%2BJ.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DM.%2BP.%26aulast%3DMonjas%26aufirst%3DL.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DSamadi%26aufirst%3DA.%26atitle%3D%25CE%25B1-Aryl-N-alkyl%2520Nitrones%252C%2520as%2520Potential%2520Agents%2520for%2520Stroke%2520Treatment%253A%2520Synthesis%252C%2520Theoretical%2520Calculations%252C%2520Antioxidant%252C%2520Anti-inflammatory%252C%2520Neuroprotective%252C%2520and%2520Brain%25E2%2580%2593Blood%2520Barrier%2520Permeability%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D153%26epage%3D168%26doi%3D10.1021%2Fjm201105a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tenti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parada, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">León, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Revelles, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briones, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menéndez, J. C.</span></span> <span> </span><span class="NLM_article-title">New 5-Unsubstituted Dihydropyridines with Improved CaV1.3 Selectivity as Potential Neuroprotective Agents against Ischemic Injury</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4313</span>– <span class="NLM_lpage">4323</span>, <span class="refDoi"> DOI: 10.1021/jm500263v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500263v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFWns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4313-4323&author=G.+Tentiauthor=E.+Paradaauthor=R.+Le%C3%B3nauthor=J.+Egeaauthor=S.+Mart%C3%ADnez-Revellesauthor=A.+M.+Brionesauthor=V.+Sridharanauthor=M.+G.+L%C3%B3pezauthor=M.+T.+Ramosauthor=J.+C.+Men%C3%A9ndez&title=New+5-Unsubstituted+Dihydropyridines+with+Improved+CaV1.3+Selectivity+as+Potential+Neuroprotective+Agents+against+Ischemic+Injury&doi=10.1021%2Fjm500263v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">New 5-Unsubstituted Dihydropyridines with Improved CaV1.3 Selectivity as Potential Neuroprotective Agents against Ischemic Injury</span></div><div class="casAuthors">Tenti, Giammarco; Parada, Esther; Leon, Rafael; Egea, Javier; Martinez-Revelles, Sonia; Briones, Ana Maria; Sridharan, Vellaisamy; Lopez, Manuela G.; Ramos, Maria Teresa; Menendez, J. Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4313-4323</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">C5-unsubstituted-C6-aryl-1,4-dihydropyridines were prepd. by a CAN-catalyzed multicomponent reaction from chalcones, β-dicarbonyl compds., and ammonium acetate.  These compds. were able to block Ca2+ entry after a depolarizing stimulus and showed an improved Cav1.3/Cav1.2 selectivity in comparison with nifedipine.  Furthermore, they were able to protect neuroblastoma cells against Ca2+ overload and oxidative stress models.  Their selectivity ratio makes them highly interesting for the treatment of neurol. disorders where Ca2+ dyshomeostasis and high levels of oxidative stress have been demonstrated.  Furthermore, their low potency toward the cardiovascular channel subtype makes them safer by reducing their probable side effects, in comparison to classical 1,4-dihydropyridines.  Some compds. afforded good protective profile in a postincubation model that simulates the real clin. situation of ictus patients, offering a therapeutic window of opportunity of great interest for patient recovery after a brain ischemic episode.  Good activities were also found in acute ischemia/reperfusion models of oxygen and glucose deprivation.  Compds. I and II were found to be most active.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE2qOTrNT3NbVg90H21EOLACvtfcHk0lgxa0FGi0Xa2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFWns74%253D&md5=f9ed28bdea3ac4d3dda8e06159f6e4b5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm500263v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500263v%26sid%3Dliteratum%253Aachs%26aulast%3DTenti%26aufirst%3DG.%26aulast%3DParada%26aufirst%3DE.%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DMart%25C3%25ADnez-Revelles%26aufirst%3DS.%26aulast%3DBriones%26aufirst%3DA.%2BM.%26aulast%3DSridharan%26aufirst%3DV.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DRamos%26aufirst%3DM.%2BT.%26aulast%3DMen%25C3%25A9ndez%26aufirst%3DJ.%2BC.%26atitle%3DNew%25205-Unsubstituted%2520Dihydropyridines%2520with%2520Improved%2520CaV1.3%2520Selectivity%2520as%2520Potential%2520Neuroprotective%2520Agents%2520against%2520Ischemic%2520Injury%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4313%26epage%3D4323%26doi%3D10.1021%2Fjm500263v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghiselli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azzini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferro-Luzzi, A.</span></span> <span> </span><span class="NLM_article-title">A Fluorescence-Based Method for Measuring Total Plasma Antioxidant Capability</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1016/0891-5849(94)00102-p</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1016%2F0891-5849%2894%2900102-p" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=7896168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADyaK2MXjtVequrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1995&pages=29-36&author=A.+Ghiselliauthor=M.+Serafiniauthor=G.+Maianiauthor=E.+Azziniauthor=A.+Ferro-Luzzi&title=A+Fluorescence-Based+Method+for+Measuring+Total+Plasma+Antioxidant+Capability&doi=10.1016%2F0891-5849%2894%2900102-p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A fluorescence-based method for measuring total plasma antioxidant capability</span></div><div class="casAuthors">Ghiselli, Andrea; Serafini, Mauro; Maiani, Giuseppe; Azzini, Elena; Ferro-Luzzi, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-36</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The total Radical-Trapping Antioxidant Parameter (TRAP) of 10 freshly prepd. human plasmas was measured by a new fluorometric assay.  In this method, the rate of peroxidn. induced by 2,2'-diazobis (2-amidinopropane) dihydrochloride (ABAP) was monitored through the loss of fluorescence of the protein R-P phycoerythrin (R-PE).  The lag-phase induced by plasma was compared to that induced by 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox, a water-sol. analog of vitamin E).  Proteins (but not their sulphydryl groups) interfere with the anal., partially protecting R-PE when all plasma antioxidants are exhausted.  A Trolox-induced lag-phase must therefore be measured on each plasma sample.  We found that ascorbate (2.5-5.3%), α-tocopherol (2.9-8.5%), urate (19.6-61.0%), and thiol groups (17.3-42.3%) jointly explain up to 70% of TRAP.  Thus, either other compds. present in plasma are likely to exert antioxidant action, or a marked synergistic action between antioxidants should be postulated to exist.  This latter hypothesis is supported by the finding that the simultaneous inactivation of ascorbate and thiol groups produces a loss in antioxidant capacity of plasma greater (26%) than the sum of the decreases produced by the sep. inactivation of each of the two compds.  The proposed method appears simple, reliable, and allows the rapid handling of a reasonable no. of freshly prepd. plasma samples.  Given the rapid loss of TRAP upon storage, the latter characteristic is crucial in studies on humans, involving a large no. of subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopUf8A-YNPNbVg90H21EOLACvtfcHk0lgxa0FGi0Xa2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtVequrY%253D&md5=557ae0d6c94b5935b0c6e45f25514c68</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2F0891-5849%2894%2900102-p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0891-5849%252894%252900102-p%26sid%3Dliteratum%253Aachs%26aulast%3DGhiselli%26aufirst%3DA.%26aulast%3DSerafini%26aufirst%3DM.%26aulast%3DMaiani%26aufirst%3DG.%26aulast%3DAzzini%26aufirst%3DE.%26aulast%3DFerro-Luzzi%26aufirst%3DA.%26atitle%3DA%2520Fluorescence-Based%2520Method%2520for%2520Measuring%2520Total%2520Plasma%2520Antioxidant%2520Capability%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D1995%26volume%3D18%26spage%3D29%26epage%3D36%26doi%3D10.1016%2F0891-5849%2894%2900102-p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galili, S.</span>; <span class="NLM_string-name">Hovav, R.</span></span> <span> </span><span class="NLM_article-title">Chapter 16-Determination of Polyphenols, Flavonoids, and Antioxidant Capacity in Dry Seeds</span>. In  <i>Polyphenols in Plants</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, R. R.</span></span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">323</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1016%2FB978-0-12-397934-6.00016-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=305-323&author=S.+Galili&author=R.+Hovavauthor=R.+R.+Watson&title=Polyphenols+in+Plants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-397934-6.00016-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-397934-6.00016-4%26sid%3Dliteratum%253Aachs%26aulast%3DGalili%26aufirst%3DS.%26atitle%3DChapter%252016-Determination%2520of%2520Polyphenols%252C%2520Flavonoids%252C%2520and%2520Antioxidant%2520Capacity%2520in%2520Dry%2520Seeds%26btitle%3DPolyphenols%2520in%2520Plants%26aulast%3DWatson%26aufirst%3DR.%2BR.%26pub%3DAcademic%2520Press%26date%3D2014%26spage%3D305%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Piperlongumine Analogues and Discovery of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators as Potential Neuroprotective Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5242</span>– <span class="NLM_lpage">5255</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00410</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00410" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVansLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5242-5255&author=S.+Pengauthor=B.+Zhangauthor=X.+Mengauthor=J.+Yaoauthor=J.+Fang&title=Synthesis+of+Piperlongumine+Analogues+and+Discovery+of+Nuclear+Factor+Erythroid+2-Related+Factor+2+%28Nrf2%29+Activators+as+Potential+Neuroprotective+Agents&doi=10.1021%2Facs.jmedchem.5b00410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Piperlongumine Analogues and Discovery of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators as Potential Neuroprotective Agents</span></div><div class="casAuthors">Peng, Shoujiao; Zhang, Baoxin; Meng, Xianke; Yao, Juan; Fang, Jianguo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5242-5255</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cellular antioxidant system plays key roles in blocking or retarding the pathogenesis of adult neurodegenerative disorders as elevated oxidative stress has been implicated in the pathophysiol. of such diseases.  Mols. with the ability in enhancing the antioxidant defense thus are promising candidates as neuroprotective agents.  We reported herein the synthesis of piperlongumine analogs and evaluation of their cytoprotection against hydrogen peroxide- and 6-hydroxydopamine-induced neuronal cell oxidative damage in the neuron-like PC12 cells.  The structure-activity relationship was delineated after the cytotoxicity and protection screening.  Two compds., I and II, displayed low cytotoxicity and confer potent protection of PC12 cells from the oxidative injury via upregulation of a panel of cellular antioxidant mols.  Genetically silencing the transcription factor Nrf2, a master regulator of the cellular stress responses, suppresses the cytoprotection, indicating the crit. involvement of Nrf2 for the cellular action of compds. I and II in PC12 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3vh6ljVXbz7Vg90H21EOLACvtfcHk0ljFmC_aem4QlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVansLrF&md5=9bdbf8554832250c47056d352b1d42df</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00410%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520Piperlongumine%2520Analogues%2520and%2520Discovery%2520of%2520Nuclear%2520Factor%2520Erythroid%25202-Related%2520Factor%25202%2520%2528Nrf2%2529%2520Activators%2520as%2520Potential%2520Neuroprotective%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5242%26epage%3D5255%26doi%3D10.1021%2Facs.jmedchem.5b00410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasgar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenyon, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadhav, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Leyen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holman, T. R.</span></span> <span> </span><span class="NLM_article-title">Potent and Selective Inhibitors of Human Reticulocyte 12/15-Lipoxygenase as Anti-Stroke Therapies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4035</span>– <span class="NLM_lpage">4048</span>, <span class="refDoi"> DOI: 10.1021/jm401915r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401915r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFGmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4035-4048&author=G.+Raiauthor=N.+Joshiauthor=J.+E.+Jungauthor=Y.+Liuauthor=L.+Schultzauthor=A.+Yasgarauthor=S.+Perryauthor=G.+Diazauthor=Q.+Zhangauthor=V.+Kenyonauthor=A.+Jadhavauthor=A.+Simeonovauthor=E.+H.+Loauthor=K.+van+Leyenauthor=D.+J.+Maloneyauthor=T.+R.+Holman&title=Potent+and+Selective+Inhibitors+of+Human+Reticulocyte+12%2F15-Lipoxygenase+as+Anti-Stroke+Therapies&doi=10.1021%2Fjm401915r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and Selective Inhibitors of Human Reticulocyte 12/15-Lipoxygenase as Anti-Stroke Therapies</span></div><div class="casAuthors">Rai, Ganesha; Joshi, Netra; Jung, Joo Eun; Liu, Yu; Schultz, Lena; Yasgar, Adam; Perry, Steve; Diaz, Giovanni; Zhang, Qiangli; Kenyon, Victor; Jadhav, Ajit; Simeonov, Anton; Lo, Eng H.; van Leyen, Klaus; Maloney, David J.; Holman, Theodore R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4035-4048</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A key challenge facing drug discovery today is variability of the drug target between species, such as with 12/15-lipoxygenase (12/15-LOX), which contributes to ischemic brain injury, but its human and rodent isoenzymes have different inhibitor specificities.  In the current work, we have utilized a quant. high-throughput (qHTS) screen to identify compd. I (ML351), a novel chemotype for 12/15-LOX inhibition that has nanomolar potency (IC50 = 200 nM) against human 12/15-LOX and is protective against oxidative glutamate toxicity in mouse neuronal HT22 cells.  In addn., it exhibited greater than 250-fold selectivity vs. related LOX isoenzymes, was a mixed inhibitor, and did not reduce the active-site ferric ion.  Lastly, I significantly reduced infarct size following permanent focal ischemia in a mouse model of ischemic stroke.  As such, this represents the first report of a selective inhibitor of human 12/15-LOX with demonstrated in vivo activity in proof-of-concept mouse models of stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOKcxDniVzKrVg90H21EOLACvtfcHk0ljyBTPwKsT__w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFGmtb4%253D&md5=a7dbbc4bda0605ef1e2f44add66b6718</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm401915r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401915r%26sid%3Dliteratum%253Aachs%26aulast%3DRai%26aufirst%3DG.%26aulast%3DJoshi%26aufirst%3DN.%26aulast%3DJung%26aufirst%3DJ.%2BE.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSchultz%26aufirst%3DL.%26aulast%3DYasgar%26aufirst%3DA.%26aulast%3DPerry%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DKenyon%26aufirst%3DV.%26aulast%3DJadhav%26aufirst%3DA.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DLo%26aufirst%3DE.%2BH.%26aulast%3Dvan%2BLeyen%26aufirst%3DK.%26aulast%3DMaloney%26aufirst%3DD.%2BJ.%26aulast%3DHolman%26aufirst%3DT.%2BR.%26atitle%3DPotent%2520and%2520Selective%2520Inhibitors%2520of%2520Human%2520Reticulocyte%252012%252F15-Lipoxygenase%2520as%2520Anti-Stroke%2520Therapies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4035%26epage%3D4048%26doi%3D10.1021%2Fjm401915r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potential Anti-Ischemic Stroke Agent: 3-Pentylbenzo[c]thiophen-1(3H)-one</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7173</span>– <span class="NLM_lpage">7181</span>, <span class="refDoi"> DOI: 10.1021/jm300681r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300681r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyns7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7173-7181&author=J.+Wuauthor=J.+Lingauthor=X.+Wangauthor=T.+Liauthor=J.+Liuauthor=Y.+Laiauthor=H.+Jiauthor=S.+Pengauthor=J.+Tianauthor=Y.+Zhang&title=Discovery+of+a+Potential+Anti-Ischemic+Stroke+Agent%3A+3-Pentylbenzo%5Bc%5Dthiophen-1%283H%29-one&doi=10.1021%2Fjm300681r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potential anti-ischemic stroke agent: 3-Pentylbenzo[c]thiophen-1(3H)-one</span></div><div class="casAuthors">Wu, Jing; Ling, Jingjing; Wang, Xuliang; Li, Tingting; Liu, Jingchao; Lai, Yisheng; Ji, Hui; Peng, Sixun; Tian, Jide; Zhang, Yihua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7173-7181</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of novel antithrombotic agents with strong free radical scavenging activity is of great significance for the treatment of ischemic stroke.  In the present study, 3-alkyl/arylalkyl-substituted benzo[c]thiophen-1(3H)-ones I(R = Et, nPr, Bu, pentyl,isopentyl, hexyl, heptyl, Bn) were designed and synthesized.  The most active compd. I(R = pentyl) significantly inhibited the ADP (ADP) induced and arachidonic acid (AA) induced in vitro platelet aggregation, superior to clin. used antiplatelet drug aspirin (ASP) and anti-ischemic stroke drugs 3-n-butylphthalide (NBP) and edaravone (Eda).  More importantly, in comparison with both NBP and Eda, I(R = pentyl) exhibited stronger antithrombotic and free radical scavenging activities and better or comparable neuroprotective effects against ischemia/reperfusion (I/R) in rats by ameliorating neurobehavioral function, reducing infarct size and brain-water content, attenuating cerebral damage, and normalizing the levels of oxidative enzymes.  Overall, our findings may provide an alternative strategy for the design of novel anti-ischemic stroke agents more potent than drugs like NBP and Eda.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpndCquiwopMbVg90H21EOLACvtfcHk0lhJ8ucw4tu_GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyns7fN&md5=a9bda7b9ed49ebd198d52acb83c6fd57</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm300681r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300681r%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLing%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520a%2520Potential%2520Anti-Ischemic%2520Stroke%2520Agent%253A%25203-Pentylbenzo%255Bc%255Dthiophen-1%25283H%2529-one%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7173%26epage%3D7181%26doi%3D10.1021%2Fjm300681r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danino, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Förster, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenigsberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Major, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, B.</span></span> <span> </span><span class="NLM_article-title">Identification of Highly Promising Antioxidants/Neuroprotectants Based on Nucleoside 5′-Phosphorothioate Scaffold. Synthesis, Activity, and Mechanisms of Action</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8427</span>– <span class="NLM_lpage">8443</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00575</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00575" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1altLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8427-8443&author=S.+Azranauthor=O.+Daninoauthor=D.+F%C3%B6rsterauthor=S.+Kenigsbergauthor=G.+Reiserauthor=M.+Dixitauthor=V.+Singhauthor=D.+T.+Majorauthor=B.+Fischer&title=Identification+of+Highly+Promising+Antioxidants%2FNeuroprotectants+Based+on+Nucleoside+5%E2%80%B2-Phosphorothioate+Scaffold.+Synthesis%2C+Activity%2C+and+Mechanisms+of+Action&doi=10.1021%2Facs.jmedchem.5b00575"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Highly Promising Antioxidants/Neuroprotectants Based on Nucleoside 5'-Phosphorothioate Scaffold. Synthesis, Activity, and Mechanisms of Action</span></div><div class="casAuthors">Azran, Sagit; Danino, Ortal; Forster, Daniel; Kenigsberg, Sarah; Reiser, Georg; Dixit, Mudit; Singh, Vijay; Major, Dan T.; Fischer, Bilha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8427-8443</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">With a view to identify novel and biocompatible neuroprotectants, we designed nucleoside 5'-thiophosphate analogs, 6-11.  We identified 2-SMe-ADP(α-S), 7A, as a most promising neuroprotectant. 7A reduced ROS prodn. in PC12 cells under oxidizing conditions, IC50 of 0.08 vs 21 μM for ADP.  Furthermore, 7A rescued primary neurons subjected to oxidn., EC50 of 0.04 vs 19 μM for ADP. 7A is a most potent P2Y1-R agonist, EC50 of 0.0026 μM.  Activity of 7A in cells involved P2Y1/12-R as indicated by blocking P2Y12-R or P2Y1-R.  Compd. 7A inhibited Fenton reaction better than EDTA, IC50 of 37 vs 54 μM, due to radical scavenging, IC50 of 12.5 vs 30 μM for ADP, and Fe(II)-chelation, IC50 of 80 vs >200 μM for ADP (ferrozine assay).  In addn., 7A was stable in human blood serum, t1/2 of 15 vs 1.5 h for ADP, and resisted hydrolysis by NPP1/3, 2-fold vs ADP.  Hence, we propose 7A as a highly promising neuroprotectant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvBo7PyA9HOLVg90H21EOLACvtfcHk0lhJ8ucw4tu_GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1altLfK&md5=1611932aab3d86053cc23dfc9ba23593</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00575%26sid%3Dliteratum%253Aachs%26aulast%3DAzran%26aufirst%3DS.%26aulast%3DDanino%26aufirst%3DO.%26aulast%3DF%25C3%25B6rster%26aufirst%3DD.%26aulast%3DKenigsberg%26aufirst%3DS.%26aulast%3DReiser%26aufirst%3DG.%26aulast%3DDixit%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DV.%26aulast%3DMajor%26aufirst%3DD.%2BT.%26aulast%3DFischer%26aufirst%3DB.%26atitle%3DIdentification%2520of%2520Highly%2520Promising%2520Antioxidants%252FNeuroprotectants%2520Based%2520on%2520Nucleoside%25205%25E2%2580%25B2-Phosphorothioate%2520Scaffold.%2520Synthesis%252C%2520Activity%252C%2520and%2520Mechanisms%2520of%2520Action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8427%26epage%3D8443%26doi%3D10.1021%2Facs.jmedchem.5b00575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Förster, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danino, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, B.</span></span> <span> </span><span class="NLM_article-title">Highly Efficient Biocompatible Neuroprotectants with Dual Activity as Antioxidants and P2Y Receptor Agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4938</span>– <span class="NLM_lpage">4952</span>, <span class="refDoi"> DOI: 10.1021/jm400197m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400197m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFehsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4938-4952&author=S.+Azranauthor=D.+F%C3%B6rsterauthor=O.+Daninoauthor=Y.+Nadelauthor=G.+Reiserauthor=B.+Fischer&title=Highly+Efficient+Biocompatible+Neuroprotectants+with+Dual+Activity+as+Antioxidants+and+P2Y+Receptor+Agonists&doi=10.1021%2Fjm400197m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Efficient Biocompatible Neuroprotectants with Dual Activity as Antioxidants and P2Y Receptor Agonists</span></div><div class="casAuthors">Azran, Sagit; Forster, Daniel; Danino, Ortal; Nadel, Yael; Reiser, Georg; Fischer, Bilha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4938-4952</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Currently, there is a need for novel, biocompatible, and effective neuroprotectants for the treatment of neurodegenerative diseases and brain injury assocd. with oxidative damage.  Here, the authors developed nucleotide-based neuroprotectants acting dually as antioxidants and P2Y-R agonists.  To improve the potency, selectivity, and metabolic stability of ATP/ADP, the authors substituted adenine C2-position by Cl and Pα/Pβ position by borano group.  These substituted nucleotides inhibited oxidn. in cell-free systems (Fe(II)-H2O2), as detected by ESR (IC50 up to 175 μM), and ABTS assay (IC50 up to 40 μM).  They also inhibited FeSO4-induced oxidative stress in PC12 cells (IC50 of 80-200 nM).  2-Cl-ADP(α-BH3) was found to be the most potent P2Y1-R agonist currently known (EC50 7 nM) and protected primary cortical neurons from FeSO4 insult (EC50 170 nM).  In addn., it proved to be metabolically stable in human blood serum (t1/2 7 vs. 1.5 h for ADP).  Hence, the authors propose 2-Cl-ADP(α-BH3) as a highly promising neuroprotectant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0wqQCfTDBp7Vg90H21EOLACvtfcHk0ljPUeOXz9SWpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFehsr8%253D&md5=b6d078bca5a1fc44bde39883369cee48</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm400197m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400197m%26sid%3Dliteratum%253Aachs%26aulast%3DAzran%26aufirst%3DS.%26aulast%3DF%25C3%25B6rster%26aufirst%3DD.%26aulast%3DDanino%26aufirst%3DO.%26aulast%3DNadel%26aufirst%3DY.%26aulast%3DReiser%26aufirst%3DG.%26aulast%3DFischer%26aufirst%3DB.%26atitle%3DHighly%2520Efficient%2520Biocompatible%2520Neuroprotectants%2520with%2520Dual%2520Activity%2520as%2520Antioxidants%2520and%2520P2Y%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4938%26epage%3D4952%26doi%3D10.1021%2Fjm400197m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Hypoxia Inducible Factor 1alpha Promotes Endogenous Adaptive Response in Rat Model of Chronic Cerebral Hypoperfusion</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3</span>, <span class="refDoi"> DOI: 10.3390/ijms18010003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.3390%2Fijms18010003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFCnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=3&author=Y.+Yangauthor=J.+Juauthor=M.+Dengauthor=J.+Wangauthor=H.+Liuauthor=L.+Xiongauthor=J.+Zhang&title=Hypoxia+Inducible+Factor+1alpha+Promotes+Endogenous+Adaptive+Response+in+Rat+Model+of+Chronic+Cerebral+Hypoperfusion&doi=10.3390%2Fijms18010003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia inducible factor 1 promotes endogenous adaptive response in rat model of chronic cerebral hypoperfusion</span></div><div class="casAuthors">Yang, Ying; Ju, Jieyang; Deng, Min; Wang, Jing; Liu, Hui; Xiong, Li; Zhang, Junjian</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3/1-3/20</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Hypoxia inducible factor 1α (HIF-1α), a pivotal regulator of gene expression in response to hypoxia and ischemia, is now considered to regulate both pro-survival and pro-death responses depending on the duration and severity of the stress.  We previously showed that chronic global cerebral hypoperfusion (CCH) triggered long-lasting accumulation of HIF-1α protein in the hippocampus of rats.  However, the role of the stabilized HIF-1 in CCH is obscure.  Here, we knock down endogenous HIF-1α to det. whether and how HIF-1 affects the disease processes and phenotypes of CCH.  Lentivirus expressing HIF-1α small hairpin RNA was injected into the bilateral hippocampus and bilateral ventricles to knock down HIF-1α gene expression in the hippocampus and other brain areas.  Permanent bilateral common carotid artery occlusions, known as 2-vessel occlusions (2VOs), were used to induce CCH in rats.  Angiogenesis, oxidative stress, histopathol. changes of the brain, and cognitive function were tested.  Knockdown of HIF-1α prior to 2VO significantly exacerbates the impairment of learning and memory after four weeks of CCH.  Mech., reduced cerebral angiogenesis, increased oxidative damage, and increased d. of astrocytes and microglia in the cortex and some subregions of hippocampus are also shown after four weeks of CCH.  Furthermore, HIF-1α knockdown also disrupts upregulation of regulated downstream genes.  Our findings suggest that HIF-1α-protects the brain from oxidative stress and inflammation response in the disease process of CCH.  Accumulated HIF-1α during CCH mediates endogenous adaptive processes to defend against more severe hypoperfusion injury of the brain, which may provide a therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMlPwCddabT7Vg90H21EOLACvtfcHk0ljPUeOXz9SWpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFCnsLg%253D&md5=8ffc6b62c85b5143d68eedeca232af9b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3390%2Fijms18010003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18010003%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DJu%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DXiong%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DHypoxia%2520Inducible%2520Factor%25201alpha%2520Promotes%2520Endogenous%2520Adaptive%2520Response%2520in%2520Rat%2520Model%2520of%2520Chronic%2520Cerebral%2520Hypoperfusion%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26spage%3D3%26doi%3D10.3390%2Fijms18010003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadakis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyte, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallichan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibson, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchan, A. M.</span></span> <span> </span><span class="NLM_article-title">Neuroprotection by Dimethyloxalylglycine Following Permanent and Transient Focal Cerebral Ischemia in Rats</span>. <i>J. Cereb. Blood Flow Metab.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">143</span>, <span class="refDoi"> DOI: 10.1038/jcbfm.2010.60</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1038%2Fjcbfm.2010.60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=20407463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlequw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=132-143&author=S.+Nagelauthor=M.+Papadakisauthor=R.+Chenauthor=L.+C.+Hoyteauthor=K.+J.+Brooksauthor=D.+Gallichanauthor=N.+R.+Sibsonauthor=C.+Pughauthor=A.+M.+Buchan&title=Neuroprotection+by+Dimethyloxalylglycine+Following+Permanent+and+Transient+Focal+Cerebral+Ischemia+in+Rats&doi=10.1038%2Fjcbfm.2010.60"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats</span></div><div class="casAuthors">Nagel, Simon; Papadakis, Michalis; Chen, Ruoli; Hoyte, Lisa C.; Brooks, Keith J.; Gallichan, Daniel; Sibson, Nicola R.; Pugh, Chris; Buchan, Alastair M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">132-143</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Dimethyloxalylglycine (DMOG) is an inhibitor of prolyl-4-hydroxylase domain (PHD) enzymes that regulate the stability of hypoxia-inducible factor (HIF).  We investigated the effect of DMOG on the outcome after permanent and transient middle cerebral artery occlusion (p/tMCAO) in the rat.  Before and after pMCAO, rats were treated with 40 mg/kg, 200 mg/kg DMOG, or vehicle, and with 40 mg/kg or vehicle after tMCAO.  Serial magnetic resonance imaging (MRI) was performed to assess infarct evolution and regional cerebral blood flow (rCBF).  Both doses significantly reduced infarct vols., but only 40 mg/kg improved the behavior after 24 h of pMCAO.  Animals receiving 40 mg/kg were more likely to maintain rCBF values above 30% from the contralateral hemisphere within 24 h of pMCAO.  DMOG after tMCAO significantly reduced the infarct vols. and improved behavior at 24 h and 8 days and also improved the rCBF after 24 h.  A consistent and significant upregulation of both mRNA and protein levels of vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (eNOS) was assocd. with the obsd. neuroprotection, although this was not consistently related to HIF-1α levels at 24 h and 8 days.  Thus, DMOG afforded neuroprotection both at 24 h after pMCAO and at 24 h and 8 days after tMCAO.  This effect was assocd. with an increase of VEGF and eNOS and was mediated by improved rCBF after DMOG treatment.  Journal of Cerebral Blood Flow & Metab. (2011) 31, 132-143; doi:10.1038/jcbfm.2010.60; published online 21 Apr. 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn5j8hu4vDY7Vg90H21EOLACvtfcHk0ljPUeOXz9SWpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlequw%253D%253D&md5=f7318845f27e741c82b46f4fde000e4f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2010.60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2010.60%26sid%3Dliteratum%253Aachs%26aulast%3DNagel%26aufirst%3DS.%26aulast%3DPapadakis%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DHoyte%26aufirst%3DL.%2BC.%26aulast%3DBrooks%26aufirst%3DK.%2BJ.%26aulast%3DGallichan%26aufirst%3DD.%26aulast%3DSibson%26aufirst%3DN.%2BR.%26aulast%3DPugh%26aufirst%3DC.%26aulast%3DBuchan%26aufirst%3DA.%2BM.%26atitle%3DNeuroprotection%2520by%2520Dimethyloxalylglycine%2520Following%2520Permanent%2520and%2520Transient%2520Focal%2520Cerebral%2520Ischemia%2520in%2520Rats%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2011%26volume%3D31%26spage%3D132%26epage%3D143%26doi%3D10.1038%2Fjcbfm.2010.60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katschinski, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhardt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheid, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenger, R. H.</span></span> <span> </span><span class="NLM_article-title">The Antimycotic Ciclopirox Olamine Induces HIF-1alpha Stability, VEGF expression, and Angiogenesis</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">763</span>, <span class="refDoi"> DOI: 10.1096/fj.02-0586fje</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1096%2Ffj.02-0586fje" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=12594177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislGlt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=761-763&author=T.+Lindenauthor=D.+M.+Katschinskiauthor=K.+Eckhardtauthor=A.+Scheidauthor=H.+Pagelauthor=R.+H.+Wenger&title=The+Antimycotic+Ciclopirox+Olamine+Induces+HIF-1alpha+Stability%2C+VEGF+expression%2C+and+Angiogenesis&doi=10.1096%2Ffj.02-0586fje"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The antimycotic ciclopirox olamine induces HIF-1α stability, VEGF expression, and angiogenesis</span></div><div class="casAuthors">Linden, Tobias; Katschinski, Dorthe M.; Eckhardt, Katrin; Scheid, Annette; Pagel, Horst; Wenger, Roland H.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">761-763, 10.1096/fj.0586fje</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">The heterodimeric hypoxia-inducible factor (HIF)-1 is a master regulator of oxygen homeostasis.  Protein stability and transactivation function of the a subunit are controlled by iron- and oxygen-dependent hydroxylation of proline and asparagine residues.  The anti-mycotic ciclopirox olamine (CPX) is a lipophilic bidentate iron chelator that stabilizes HIF-1α under normoxic conditions at lower concns. than other iron chelators, probably by inhibiting HIF-1α hydroxylation.  As shown by the inhibition of iron-dependent quenching of FITC-labeled deferoxamine (DFX) fluorescence, CPX appears to have an even higher affinity for iron than DFX.  Initial observations that treatment with 1% CPX, but not with placebo, occasionally caused reddening of wound margins in a mouse skin wound model prompted us to investigate the capability of CPX to induce angiogenesis.  CPX-induced HIF-1-mediated reporter gene activity and endogenous HIF-1 target gene expression, including elevation of transcription, mRNA, and protein levels of the vascular endothelial growth factor (VEGF).  In the chick chorioallantoic membrane assay, inert polymer disks contg. CPX but not the solvent alone induced angiogenesis.  In summary, these results suggest that CPX induces angiogenesis in vivo via HIF-1 and VEGF induction.  Therefore, CPX might serve as an alternative to recombinant VEGF treatment or to VEGF gene therapy for therapeutic angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEvhtlKtKalbVg90H21EOLACvtfcHk0liQU74rVmgiPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislGlt70%253D&md5=dd39c593d247c43036f591011d5b308a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1096%2Ffj.02-0586fje&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.02-0586fje%26sid%3Dliteratum%253Aachs%26aulast%3DLinden%26aufirst%3DT.%26aulast%3DKatschinski%26aufirst%3DD.%2BM.%26aulast%3DEckhardt%26aufirst%3DK.%26aulast%3DScheid%26aufirst%3DA.%26aulast%3DPagel%26aufirst%3DH.%26aulast%3DWenger%26aufirst%3DR.%2BH.%26atitle%3DThe%2520Antimycotic%2520Ciclopirox%2520Olamine%2520Induces%2520HIF-1alpha%2520Stability%252C%2520VEGF%2520expression%252C%2520and%2520Angiogenesis%26jtitle%3DFASEB%2520J.%26date%3D2003%26volume%3D17%26spage%3D761%26epage%3D763%26doi%3D10.1096%2Ffj.02-0586fje" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span> <span> </span><span class="NLM_article-title">SDTNBI: an Integrated Network and Chemoinformatics Tool For Systematic Prediction of Drug–target Interactions and Drug Repositioning</span>. <i>Briefings Bioinf.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">347</span>, <span class="refDoi"> DOI: 10.1093/bib/bbw012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1093%2Fbib%2Fbbw012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=26944082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivVaqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=333-347&author=Z.+Wuauthor=F.+Chengauthor=J.+Liauthor=W.+Liauthor=G.+Liuauthor=Y.+Tang&title=SDTNBI%3A+an+Integrated+Network+and+Chemoinformatics+Tool+For+Systematic+Prediction+of+Drug%E2%80%93target+Interactions+and+Drug+Repositioning&doi=10.1093%2Fbib%2Fbbw012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">SDTNBI: an integrated network and chemoinformatics tool for systematic prediction of drug-target interactions and drug repositioning</span></div><div class="casAuthors">Wu, Zengrui; Cheng, Feixiong; Li, Jie; Li, Weihua; Liu, Guixia; Tang, Yun</div><div class="citationInfo"><span class="NLM_cas:title">Briefings in Bioinformatics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">333-347</span>CODEN:
                <span class="NLM_cas:coden">BBIMFX</span>;
        ISSN:<span class="NLM_cas:issn">1477-4054</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Computational prediction of drug-target interactions (DTIs) and drug repositioning provides a low-cost and high-efficiency approach for drug discovery and development.  The traditional social network-derived methods based on the na.ovrddot.ive DTI topol. information cannot predict potential targets for new chem. entities or failed drugs in clin. trials.  There are currently millions of com. available mols. with biol. relevant representations in chem. databases.  It is urgent to develop novel computational approaches to predict targets for new chem. entities and failed drugs on a large scale.  In this study, we developed a useful tool, namely substructure-drug-target network-based inference (SDTNBI), to prioritize potential targets for old drugs, failed drugs and new chem. entities.  SDTNBI incorporates network and chemoinformatics to bridge the gap between new chem. entities and known DTI network.  High performance was yielded in 10-fold and leave-one-out cross validations using four benchmark data sets, covering G protein-coupled receptors, kinases, ion channels and nuclear receptors.  Furthermore, the highest areas under the receiver operating characteristic curve were 0.797 and 0.863 for two external validation sets, resp.  Finally, we identified thousands of new potential DTIs via implementing SDTNBI on a global network.  As a proof-of-principle, we showcased the use of SDTNBI to identify novel anticancer indications for nonsteroidal anti-inflammatory drugs by inhibiting AKR1C3, CA9 or CA12.  In summary, SDTNBI is a powerful network-based approach that predicts potential targets for new chem. entities on a large scale and will provide a new tool for DTI prediction and drug repositioning.  The program and predicted DTIs are available on request.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwVHm2U7tYlLVg90H21EOLACvtfcHk0liQU74rVmgiPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivVaqurY%253D&md5=0520946f0d2be84fdad7173a04fb9fc0</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1093%2Fbib%2Fbbw012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbib%252Fbbw012%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DY.%26atitle%3DSDTNBI%253A%2520an%2520Integrated%2520Network%2520and%2520Chemoinformatics%2520Tool%2520For%2520Systematic%2520Prediction%2520of%2520Drug%25E2%2580%2593target%2520Interactions%2520and%2520Drug%2520Repositioning%26jtitle%3DBriefings%2520Bioinf.%26date%3D2017%26volume%3D18%26spage%3D333%26epage%3D347%26doi%3D10.1093%2Fbib%2Fbbw012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marco, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valhondo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martín-Fontecha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Villa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Río, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagredo, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrecillas, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frechilla, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benhamú, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Rodríguez, M. L.</span></span> <span> </span><span class="NLM_article-title">New Serotonin 5-HT1A Receptor Agonists with Neuroprotective Effect against Ischemic Cell Damage</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7986</span>– <span class="NLM_lpage">7999</span>, <span class="refDoi"> DOI: 10.1021/jm2007886</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2007886" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOgu73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7986-7999&author=I.+Marcoauthor=M.+Valhondoauthor=M.+Mart%C3%ADn-Fontechaauthor=H.+V%C3%A1zquez-Villaauthor=J.+Del+R%C3%ADoauthor=A.+Planasauthor=O.+Sagredoauthor=J.+A.+Ramosauthor=I.+R.+Torrecillasauthor=L.+Pardoauthor=D.+Frechillaauthor=B.+Benham%C3%BAauthor=M.+L.+L%C3%B3pez-Rodr%C3%ADguez&title=New+Serotonin+5-HT1A+Receptor+Agonists+with+Neuroprotective+Effect+against+Ischemic+Cell+Damage&doi=10.1021%2Fjm2007886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">New Serotonin 5-HT1A Receptor Agonists with Neuroprotective Effect against Ischemic Cell Damage</span></div><div class="casAuthors">Marco, Isabel; Valhondo, Margarita; Martin-Fontecha, Mar; Vazquez-Villa, Henar; Del Rio, Joaquin; Planas, Anna; Sagredo, Onintza; Ramos, Jose A.; Torrecillas, Ivan R.; Pardo, Leonardo; Frechilla, Diana; Benhamu, Bellindo; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7986-7999</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the synthesis of 32 new compds. based on structural modifications of different moieties of previously described lead UCM-2550.  The new nonpiperazine derivs., representing second-generation agonists, were assessed for binding affinity, selectivity, and functional activity at the 5-HT1A receptor (5-HT1AR).  Computational β2-based homol. models of the ligand-receptor complexes were used to explain the obsd. structure-affinity relationships.  Selected candidates were also evaluated for their potential in vitro and in vivo neuroprotective properties.  Interestingly, (2-{6-[(3,4-dihydro-2H-chromen-2-ylmethyl)amino]hexyl}tetrahydro-1H-pyrrolo[1,2-c]imidazole-1,3(2H)-dione) has been characterized as a high-affinity and potent 5-HT1AR agonist (Ki = 5.9 nM, EC50 = 21.8 nM) and exhibits neuroprotective effect in neurotoxicity assays in primary cell cultures from rat hippocampus and in the MCAO model of focal cerebral ischemia in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplOiTkeejxUbVg90H21EOLACvtfcHk0liQU74rVmgiPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOgu73L&md5=65f3249c302236c9be04cf1bb99f8e91</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm2007886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007886%26sid%3Dliteratum%253Aachs%26aulast%3DMarco%26aufirst%3DI.%26aulast%3DValhondo%26aufirst%3DM.%26aulast%3DMart%25C3%25ADn-Fontecha%26aufirst%3DM.%26aulast%3DV%25C3%25A1zquez-Villa%26aufirst%3DH.%26aulast%3DDel%2BR%25C3%25ADo%26aufirst%3DJ.%26aulast%3DPlanas%26aufirst%3DA.%26aulast%3DSagredo%26aufirst%3DO.%26aulast%3DRamos%26aufirst%3DJ.%2BA.%26aulast%3DTorrecillas%26aufirst%3DI.%2BR.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DFrechilla%26aufirst%3DD.%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DNew%2520Serotonin%25205-HT1A%2520Receptor%2520Agonists%2520with%2520Neuroprotective%2520Effect%2520against%2520Ischemic%2520Cell%2520Damage%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7986%26epage%3D7999%26doi%3D10.1021%2Fjm2007886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Novel Hybrids of Optically Active Ring-Opened 3-n-Butylphthalide Derivative and Isosorbide as Potential Anti-Ischemic Stroke Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3078</span>– <span class="NLM_lpage">3089</span>, <span class="refDoi"> DOI: 10.1021/jm4001693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4001693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlersr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3078-3089&author=X.+Wangauthor=L.+Wangauthor=T.+Liauthor=Z.+Huangauthor=Y.+Laiauthor=H.+Jiauthor=X.+Wanauthor=J.+Xuauthor=J.+Tianauthor=Y.+Zhang&title=Novel+Hybrids+of+Optically+Active+Ring-Opened+3-n-Butylphthalide+Derivative+and+Isosorbide+as+Potential+Anti-Ischemic+Stroke+Agents&doi=10.1021%2Fjm4001693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Hybrids of Optically Active Ring-Opened 3-n-Butylphthalide Derivative and Isosorbide as Potential Anti-Ischemic Stroke Agents</span></div><div class="casAuthors">Wang, Xiaoli; Wang, Linna; Li, Tingting; Huang, Zhangjian; Lai, Yisheng; Ji, Hui; Wan, Xiaolong; Xu, Jinyi; Tian, Jide; Zhang, Yihua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3078-3089</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In search of novel anti-ischemic stroke agents with higher potency than a known drug 3-n-butylphthalide (NBP), a series of glycoside hybrids, e.g. I, from optically active ring-opened NBP deriv. and isosorbide were synthesized for evaluating their anti-ischemic stroke activity.  Compd. I displayed the strongest activity in inhibiting the ADP and arachidonic acid (AA)-induced platelet aggregation in vitro, with 10.0- and 8.4-fold more effectiveness than (S)-NBP, resp.  Furthermore, I was stable in artificial gastrointestinal fluids and could penetrate the blood-brain barrier (BBB) with an appreciate lipid/water partition coeff. relative to (S)-NBP.  More importantly, oral treatment with I protected from acute thrombosis and inhibited the ischemia/reperfusion-related brain injury in animals.  Our findings suggest that I may be promising for further evaluation for the intervention of ischemic stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2jxmyrF5QhrVg90H21EOLACvtfcHk0lhHUlrNA8ZsfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlersr8%253D&md5=0c4aec09a2a24f7948a28339463fccc5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm4001693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4001693%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DWan%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DNovel%2520Hybrids%2520of%2520Optically%2520Active%2520Ring-Opened%25203-n-Butylphthalide%2520Derivative%2520and%2520Isosorbide%2520as%2520Potential%2520Anti-Ischemic%2520Stroke%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3078%26epage%3D3089%26doi%3D10.1021%2Fjm4001693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babcock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.-q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.-b.</span></span> <span> </span><span class="NLM_article-title">Activation of Human Ether-a-go-go Related Gene (hERG) Potassium Channels by Small Molecules</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">781</span>– <span class="NLM_lpage">788</span>, <span class="refDoi"> DOI: 10.1038/aps.2011.70</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1038%2Faps.2011.70" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=21623390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFyjur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=781-788&author=P.-z.+Zhouauthor=J.+Babcockauthor=L.-q.+Liuauthor=M.+Liauthor=Z.-b.+Gao&title=Activation+of+Human+Ether-a-go-go+Related+Gene+%28hERG%29+Potassium+Channels+by+Small+Molecules&doi=10.1038%2Faps.2011.70"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of human ether-a-go-go related gene (hERG) potassium channels by small molecules</span></div><div class="casAuthors">Zhou, Ping-zheng; Babcock, Joseph; Liu, Lian-qing; Li, Min; Gao, Zhao-bing</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">781-788</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Human ether-a-go-go related gene (hERG) potassium (K+) channels play a crit. role in cardiac action potential repolarization.  Mutations that reduce hERG conductance or surface expression may cause congenital long QT syndrome (LQTS).  However, the channels can be inhibited by structurally diverse small mols., resulting in an acquired form of LQTS.  Consequently, small mols. that increase the hERG current may be of value for treatment for LQTS.  So far, 9 hERG activators were reported.  The aim of this review is to discuss recent advances concerning the identification and action mechanism of hERG activators.  Acta Pharmacologica Sinica (2011) 32: 781-788; doi: 10.1038/aps.2011.70; published online 30 May 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEvf2nAFthM7Vg90H21EOLACvtfcHk0lhHUlrNA8ZsfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFyjur8%253D&md5=72e6fdcc441a14a1a8f0ef86e52d2b9c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Faps.2011.70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2011.70%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DP.-z.%26aulast%3DBabcock%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.-q.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DZ.-b.%26atitle%3DActivation%2520of%2520Human%2520Ether-a-go-go%2520Related%2520Gene%2520%2528hERG%2529%2520Potassium%2520Channels%2520by%2520Small%2520Molecules%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2011%26volume%3D32%26spage%3D781%26epage%3D788%26doi%3D10.1038%2Faps.2011.70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delarue, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girault, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debreu-Fontaine, M.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaeïd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grellier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sergheraert, C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in Vitro and in Vivo Antimalarial Activity of New 4-Anilinoquinolines</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">2827</span>– <span class="NLM_lpage">2833</span>, <span class="refDoi"> DOI: 10.1021/jm010842o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010842o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltlClsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2827-2833&author=S.+Delarueauthor=S.+Giraultauthor=L.+Maesauthor=M.-A.+Debreu-Fontaineauthor=M.+Labae%C3%AFdauthor=P.+Grellierauthor=C.+Sergheraert&title=Synthesis+and+in+Vitro+and+in+Vivo+Antimalarial+Activity+of+New+4-Anilinoquinolines&doi=10.1021%2Fjm010842o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro and in vivo antimalarial activity of new 4-anilinoquinolines</span></div><div class="casAuthors">Delarue, Sandrine; Girault, Sophie; Maes, Louis; Debreu-Fontaine, Marie-Ange; Labaeied, Mehdi; Grellier, Philippe; Sergheraert, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2827-2833</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of 4-anilinoquinolines, e.g., I, with two proton-accepting side chains has been synthesized.  Antimalarial activity and levels of cytotoxicity upon both MRC-5 cells and macrophages were found to be highly dependent upon the features of these side chains.  Several compds. were found to be active in the low nanomolar range, against both chloroquine-sensitive and -resistant strains of Plasmodium falciparum in vitro.  From among them, a morpholino deriv. cured mice infected by Plasmodium berghei and displayed a lower toxicity than amodiaquine upon mouse macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFBF8Weq9xkbVg90H21EOLACvtfcHk0lhHUlrNA8ZsfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltlClsrk%253D&md5=f986f00d19c5902faeaf1b22ca929209</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm010842o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010842o%26sid%3Dliteratum%253Aachs%26aulast%3DDelarue%26aufirst%3DS.%26aulast%3DGirault%26aufirst%3DS.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DDebreu-Fontaine%26aufirst%3DM.-A.%26aulast%3DLabae%25C3%25AFd%26aufirst%3DM.%26aulast%3DGrellier%26aufirst%3DP.%26aulast%3DSergheraert%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Antimalarial%2520Activity%2520of%2520New%25204-Anilinoquinolines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2827%26epage%3D2833%26doi%3D10.1021%2Fjm010842o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingram, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierroz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spingler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keiser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Ferrocenyl Derivatives of the Anthelmintic Praziquantel: Design, Synthesis, and Biological Evaluation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8790</span>– <span class="NLM_lpage">8798</span>, <span class="refDoi"> DOI: 10.1021/jm301077m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301077m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8790-8798&author=M.+Patraauthor=K.+Ingramauthor=V.+Pierrozauthor=S.+Ferrariauthor=B.+Spinglerauthor=J.+Keiserauthor=G.+Gasser&title=Ferrocenyl+Derivatives+of+the+Anthelmintic+Praziquantel%3A+Design%2C+Synthesis%2C+and+Biological+Evaluation&doi=10.1021%2Fjm301077m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Ferrocenyl derivatives of the anthelmintic praziquantel: design, synthesis, and biological evaluation</span></div><div class="casAuthors">Patra, Malay; Ingram, Katrin; Pierroz, Vanessa; Ferrari, Stefano; Spingler, Bernhard; Keiser, Jennifer; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8790-8798</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design, synthesis, and biol. evaluation of 18 ferrocenyl derivs. I [Fc = ferrocenyl, 1/2(1,1'-ferrocenediyl), bis(ferrocenylcarbonyl)methyl; 4A-12A, X = CO, bond; n = 1-4; Y = bond; 4B-12B, X = 4-piperidinylcarbonyl; Y = CO, bond; n = 1-4] of the most well-known drug against schistosomiasis, namely praziquantel (PZQ), are reported.  These compds., which have been all isolated as racemates, were unambiguously characterized by 1H and 13C NMR spectroscopy, mass spectrometry, and elemental anal. as well as by x-ray crystallog. for 4A, 5A, and 7A.  Cytotoxicity studies revealed that the complexes were moderately toxic toward a cervical cancer cell line (HeLa) and, importantly, significantly less active toward a noncancerous cell line (MRC-5).  The in vitro anthelmintic activity of the 18 ferrocenyl PZQ derivs. was tested against adult Schistosoma mansoni, and values in the micromolar range (26-68 μM) were detd. for the four most active compds.  It was also demonstrated using two compds. of the series as models (8A and 8B) that the complexes were stable when incubated for 24 h at 37° in human plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW9b3zQZLtAbVg90H21EOLACvtfcHk0lj6c7wzEs3VZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsr7I&md5=cba4112ec4d7d52681cff4366970c890</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm301077m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301077m%26sid%3Dliteratum%253Aachs%26aulast%3DPatra%26aufirst%3DM.%26aulast%3DIngram%26aufirst%3DK.%26aulast%3DPierroz%26aufirst%3DV.%26aulast%3DFerrari%26aufirst%3DS.%26aulast%3DSpingler%26aufirst%3DB.%26aulast%3DKeiser%26aufirst%3DJ.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DFerrocenyl%2520Derivatives%2520of%2520the%2520Anthelmintic%2520Praziquantel%253A%2520Design%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8790%26epage%3D8798%26doi%3D10.1021%2Fjm301077m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anglin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, B. V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span> <span> </span><span class="NLM_article-title">Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">542</span>– <span class="NLM_lpage">546</span>, <span class="refDoi"> DOI: 10.1021/ml400036z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400036z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=542-546&author=B.+Zhengauthor=Y.+Yaoauthor=Z.+Liuauthor=L.+Dengauthor=J.+L.+Anglinauthor=H.+Jiangauthor=B.+V.+V.+Prasadauthor=Y.+Song&title=Crystallographic+Investigation+and+Selective+Inhibition+of+Mutant+Isocitrate+Dehydrogenase&doi=10.1021%2Fml400036z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase</span></div><div class="casAuthors">Zheng, Baisong; Yao, Yuan; Liu, Zhen; Deng, Lisheng; Anglin, Justin L.; Jiang, Hong; Prasad, B. V. Venkataram; Song, Yongcheng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">542-546</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutations in isocitrate dehydrogenase (IDH), a key enzyme in the tricarboxylic acid cycle, have recently been found in ∼75% glioma and ∼20% acute myeloid leukemia.  Different from the wild-type enzyme, mutant IDH1 catalyzes the redn. of α-ketoglutaric acid to D-2-hydroxyglutaric acid.  Strong evidence has shown mutant IDH1 represents a novel target for this type of cancer.  We found two 1-hydroxypyridin-2-one compds. that are potent inhibitors of R132H and R132C IDH1 mutants with Ki values as low as 120 nM.  These compds. exhibit >60-fold selectivity against wild-type IDH1 and can inhibit the prodn. of D-2-hydroxyglutaric acid in IDH1 mutated cells, representing novel chem. probes for cancer biol. studies.  We also report the first inhibitor-bound crystal structures of IDH1(R132H), showing these inhibitors have H-bond, electrostatic, and hydrophobic interactions with the mutant enzyme.  Comparison with the substrate-bound IDH1 structures revealed the structural basis for the high enzyme selectivity of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH0vzVLGCPZLVg90H21EOLACvtfcHk0lj6c7wzEs3VZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWrtLg%253D&md5=c34c67949fe816bdf151525a578535f3</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fml400036z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400036z%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DAnglin%26aufirst%3DJ.%2BL.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DPrasad%26aufirst%3DB.%2BV.%2BV.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DCrystallographic%2520Investigation%2520and%2520Selective%2520Inhibition%2520of%2520Mutant%2520Isocitrate%2520Dehydrogenase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D542%26epage%3D546%26doi%3D10.1021%2Fml400036z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kogiso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases: Synthesis, Structure–Activity Relationship, and Selective Antitumor Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8307</span>– <span class="NLM_lpage">8318</span>, <span class="refDoi"> DOI: 10.1021/jm500660f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500660f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Khu7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8307-8318&author=Z.+Liuauthor=Y.+Yaoauthor=M.+Kogisoauthor=B.+Zhengauthor=L.+Dengauthor=J.+J.+Qiuauthor=S.+Dongauthor=H.+Lvauthor=J.+M.+Galloauthor=X.-N.+Liauthor=Y.+Song&title=Inhibition+of+Cancer-Associated+Mutant+Isocitrate+Dehydrogenases%3A+Synthesis%2C+Structure%E2%80%93Activity+Relationship%2C+and+Selective+Antitumor+Activity&doi=10.1021%2Fjm500660f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases: Synthesis, Structure-Activity Relationship, and Selective Antitumor Activity</span></div><div class="casAuthors">Liu, Zhen; Yao, Yuan; Kogiso, Mari; Zheng, Baisong; Deng, Lisheng; Qiu, Jihui J.; Dong, Shuo; Lv, Hua; Gallo, James M.; Li, Xiao-Nan; Song, Yongcheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8307-8318</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutations of isocitrate dehydrogenase 1 (IDH1) are frequently found in certain cancers such as glioma.  Different from the wild-type (WT) IDH1, the mutant enzymes catalyze the redn. of α-ketoglutaric acid to D-2-hydroxyglutaric acid (D2HG), leading to cancer initiation.  Several 1-hydroxypyridin-2-one compds. were identified to be inhibitors of IDH1(R132H).  A total of 61 derivs. were synthesized, and their structure-activity relationships were investigated.  Potent IDH1(R132H) inhibitors were identified with Ki values as low as 140 nM, while they possess weak or no activity against WT IDH1.  Activities of selected compds. against IDH1(R132C) were found to be correlated with their inhibitory activities against IDH1(R132H), as well as cellular prodn. of D2HG, with R2 of 0.83 and 0.73, resp.  Several inhibitors, e.g., I, were found to be permeable through the blood-brain barrier in a cell-based model assay and exhibit potent and selective activity (EC50 = 0.26-1.8 μM) against glioma cells with the IDH1 R132H mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNdW-Y0b-flbVg90H21EOLACvtfcHk0lj6c7wzEs3VZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Khu7nF&md5=a348026146bbdeca471b0277fff0fd93</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm500660f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500660f%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DKogiso%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DJ.%2BJ.%26aulast%3DDong%26aufirst%3DS.%26aulast%3DLv%26aufirst%3DH.%26aulast%3DGallo%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DX.-N.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520Cancer-Associated%2520Mutant%2520Isocitrate%2520Dehydrogenases%253A%2520Synthesis%252C%2520Structure%25E2%2580%2593Activity%2520Relationship%252C%2520and%2520Selective%2520Antitumor%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8307%26epage%3D8318%26doi%3D10.1021%2Fjm500660f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shangguan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joullié, M.</span></span> <span> </span><span class="NLM_article-title">A Copper-Carbodiimide Approach to the Phomopsin Tripeptide Side Chain</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">6748</span>– <span class="NLM_lpage">6750</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2009.09.072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1016%2Fj.tetlet.2009.09.072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=20802791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWlsrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=6748-6750&author=N.+Shangguanauthor=M.+Joulli%C3%A9&title=A+Copper-Carbodiimide+Approach+to+the+Phomopsin+Tripeptide+Side+Chain&doi=10.1016%2Fj.tetlet.2009.09.072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A copper-carbodiimide approach to the phomopsin tripeptide side chain</span></div><div class="casAuthors">Shangguan, Ning; Joullie, Madeleine</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">6748-6750</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A one-step copper-carbodiimide elimination was used to provide the (E)-dehydroisoleucine moiety in the phomopsin side chain stereoselectively.  An efficient approach to the phomopsin tripeptide side chain was developed to be used in the total syntheses of phomopsins A and B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbaQci2taEVrVg90H21EOLACvtfcHk0ljcqlHyuhDnYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWlsrzE&md5=7e6d176f5da15fd2d86ec3cfa84c1991</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2009.09.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2009.09.072%26sid%3Dliteratum%253Aachs%26aulast%3DShangguan%26aufirst%3DN.%26aulast%3DJoulli%25C3%25A9%26aufirst%3DM.%26atitle%3DA%2520Copper-Carbodiimide%2520Approach%2520to%2520the%2520Phomopsin%2520Tripeptide%2520Side%2520Chain%26jtitle%3DTetrahedron%2520Lett.%26date%3D2009%26volume%3D50%26spage%3D6748%26epage%3D6750%26doi%3D10.1016%2Fj.tetlet.2009.09.072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brandel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartigny, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couvrat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eusébio, M. E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canotilho, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petit, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coquerel, G.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Reversible Phase Transitions in Molecular Crystals: Case of Ciclopirox</span>. <i>Chem. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">6360</span>– <span class="NLM_lpage">6373</span>, <span class="refDoi"> DOI: 10.1021/acs.chemmater.5b02389</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemmater.5b02389" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVWntLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=6360-6373&author=C.+Brandelauthor=Y.+Cartignyauthor=N.+Couvratauthor=M.+E.+S.+Eus%C3%A9bioauthor=J.+Canotilhoauthor=S.+Petitauthor=G.+Coquerel&title=Mechanisms+of+Reversible+Phase+Transitions+in+Molecular+Crystals%3A+Case+of+Ciclopirox&doi=10.1021%2Facs.chemmater.5b02389"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of Reversible Phase Transitions in Molecular Crystals: Case of Ciclopirox</span></div><div class="casAuthors">Brandel, Clement; Cartigny, Yohann; Couvrat, Nicolas; Eusebio, M. Ermelinda S.; Canotilho, Joao; Petit, Samuel; Coquerel, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry of Materials</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6360-6373</span>CODEN:
                <span class="NLM_cas:coden">CMATEX</span>;
        ISSN:<span class="NLM_cas:issn">0897-4756</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The detailed characterization of several subambient solid state transitions occurring in the pharmaceutical ingredient Ciclopirox between -20° and -85° was performed by using a combination of DSC, cold-stage optical microscopy, vibrational spectroscopies, solid state NMR at controlled temp., structural analyses by single crystal x-ray diffraction, and temp.-resolved X-ray powder diffraction.  The global anal. of the available data reveals that the mechanisms of these reversible transitions involve a subtle compromise between phenomena related to mol. disorder, cooperative release of strains induced by cooling, and structural reorganization assocd. with topotactic changes in crystal lattice and symmetry.  However, no major change in the main features of crystal packings is obsd. during the successive single crystal-to-single crystal transitions, which highlights the difficulty to classify such transitions in the frame of conventional theor. frameworks.  The successive thermal events and related structural changes or relaxations can be seen as the consequences of a deconvolution phenomenon for the global phase transition between the dynamically disordered room temp. form (space group C2/c, Z = 8, Z' = 1) and the ordered low-temp. form (space group P21/c, Z = 48, Z' = 12).  In this respect, the intermediate form(s) can be seen as transient states of kinetic origin with a questionable genuine crystallog. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLP7mFOQyt8bVg90H21EOLACvtfcHk0ljcqlHyuhDnYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVWntLvI&md5=e7df5c8e9e68025e30cbe3460896c91b</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.chemmater.5b02389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemmater.5b02389%26sid%3Dliteratum%253Aachs%26aulast%3DBrandel%26aufirst%3DC.%26aulast%3DCartigny%26aufirst%3DY.%26aulast%3DCouvrat%26aufirst%3DN.%26aulast%3DEus%25C3%25A9bio%26aufirst%3DM.%2BE.%2BS.%26aulast%3DCanotilho%26aufirst%3DJ.%26aulast%3DPetit%26aufirst%3DS.%26aulast%3DCoquerel%26aufirst%3DG.%26atitle%3DMechanisms%2520of%2520Reversible%2520Phase%2520Transitions%2520in%2520Molecular%2520Crystals%253A%2520Case%2520of%2520Ciclopirox%26jtitle%3DChem.%2520Mater.%26date%3D2015%26volume%3D27%26spage%3D6360%26epage%3D6373%26doi%3D10.1021%2Facs.chemmater.5b02389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Longa, E. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, R.</span></span> <span> </span><span class="NLM_article-title">Reversible Middle Cerebral Artery Occlusion without Craniotomy in Rats</span>. <i>Stroke</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1161/01.str.20.1.84</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1161%2F01.str.20.1.84" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=2643202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A280%3ADyaL1M7gtFWhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1989&pages=84-91&author=E.+Z.+Longaauthor=P.+R.+Weinsteinauthor=S.+Carlsonauthor=R.+Cummins&title=Reversible+Middle+Cerebral+Artery+Occlusion+without+Craniotomy+in+Rats&doi=10.1161%2F01.str.20.1.84"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible middle cerebral artery occlusion without craniectomy in rats</span></div><div class="casAuthors">Longa E Z; Weinstein P R; Carlson S; Cummins R</div><div class="citationInfo"><span class="NLM_cas:title">Stroke</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-91</span>
        ISSN:<span class="NLM_cas:issn">0039-2499</span>.
    </div><div class="casAbstract">To develop a simple, relatively noninvasive small-animal model of reversible regional cerebral ischemia, we tested various methods of inducing infarction in the territory of the right middle cerebral artery (MCA) by extracranial vascular occlusion in rats.  In preliminary studies, 60 rats were anesthetized with ketamine and different combinations of vessels were occluded; blood pressure and arterial blood gases were monitored.  Neurologic deficit, mortality rate, gross pathology, and in some instances, electroencephalogram and histochemical staining results were evaluated in all surviving rats.  The principal procedure consisted of introducing a 4-0 nylon intraluminal suture into the cervical internal carotid artery (ICA) and advancing it intracranially to block blood flow into the MCA; collateral blood flow was reduced by interrupting all branches of the external carotid artery (ECA) and all extracranial branches of the ICA.  In some groups of rats, bilateral vertebral or contralateral carotid artery occlusion was also performed.  India ink perfusion studies in 20 rats documented blockage of MCA blood flow in 14 rats subjected to permanent occlusion and the restoration of blood flow to the MCA territory in six rats after withdrawal of the suture from the ICA.  The best method of MCA occlusion was then selected for further confirmatory studies, including histologic examination, in five additional groups of rats anesthetized with halothane.  Seven of eight rats that underwent permanent occlusion of the MCA had resolving moderately severe neurologic deficits (Grade 2 of 4) and unilateral infarcts averaging 37.6 +/- 5.5% of the coronal sectional area at 72 hours after the onset of occlusion.(ABSTRACT TRUNCATED AT 250 WORDS)</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-hfBvofz-K_tos8R3JUhXfW6udTcc2eZtn8GfumyZVrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M7gtFWhuw%253D%253D&md5=299efbee4d90d6aee124ca4167210ceb</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1161%2F01.str.20.1.84&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.str.20.1.84%26sid%3Dliteratum%253Aachs%26aulast%3DLonga%26aufirst%3DE.%2BZ.%26aulast%3DWeinstein%26aufirst%3DP.%2BR.%26aulast%3DCarlson%26aufirst%3DS.%26aulast%3DCummins%26aufirst%3DR.%26atitle%3DReversible%2520Middle%2520Cerebral%2520Artery%2520Occlusion%2520without%2520Craniotomy%2520in%2520Rats%26jtitle%3DStroke%26date%3D1989%26volume%3D20%26spage%3D84%26epage%3D91%26doi%3D10.1161%2F01.str.20.1.84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanberg, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willing, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Ramos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chopp, M.</span></span> <span> </span><span class="NLM_article-title">Intravenous Administration of Human Umbilical Cord Blood Reduces Behavioral Deficits after Stroke in Rats</span>. <i>Stroke</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">2682</span>– <span class="NLM_lpage">2688</span>, <span class="refDoi"> DOI: 10.1161/hs1101.098367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=10.1161%2Fhs1101.098367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=11692034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;key=1%3ACAS%3A280%3ADC%252BD3MnktFemsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2001&pages=2682-2688&author=J.+Chenauthor=P.+R.+Sanbergauthor=Y.+Liauthor=L.+Wangauthor=M.+Luauthor=A.+E.+Willingauthor=J.+Sanchez-Ramosauthor=M.+Chopp&title=Intravenous+Administration+of+Human+Umbilical+Cord+Blood+Reduces+Behavioral+Deficits+after+Stroke+in+Rats&doi=10.1161%2Fhs1101.098367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats</span></div><div class="casAuthors">Chen J; Sanberg P R; Li Y; Wang L; Lu M; Willing A E; Sanchez-Ramos J; Chopp M</div><div class="citationInfo"><span class="NLM_cas:title">Stroke</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2682-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Human umbilical cord blood cells (HUCBC) are rich in stem and progenitor cells.  In this study we tested whether intravenously infused HUCBC enter brain, survive, differentiate, and improve neurological functional recovery after stroke in rats.  In addition, we tested whether ischemic brain tissue extract selectively induces chemotaxis of HUCBC in vitro.  METHODS:  Adult male Wistar rats were subjected to transient (2-hour) middle cerebral artery occlusion (MCAO).  Experimental groups were as follows: group 1, MCAO alone (n=5); group 2, 3x10(6) HUCBC injected into tail vein at 24 hours after MCAO (n=6) (animals of groups 1 and 2 were killed at 14 days after MCAO); group 3, MCAO alone (n=5); group 4, MCAO injected with PBS at 1 day after stroke (n=8); and group 5, 3x10(6) HUCBC injected into tail vein at 7 days after MCAO (n=5).  Rats of groups 3, 4, and 5 were killed at 35 days after MCAO.  Behavioral tests (rotarod and Modified Neurological Severity Score [mNSS]) were performed.  Immunohistochemical staining was used to identify cells derived from HUCBC.  Chemotactic activity of ischemia brain tissue extracts toward HUCBC at different time points was evaluated in vitro.  RESULTS:  Treatment at 24 hours after MCAO with HUCBC significantly improved functional recovery, as evidenced by the rotarod test and mNSS (P<0.05).  Treatment at 7 days after MCAO with HUCBC significantly improved function only on the mNSS (P<0.05).  Some HUCBC were reactive for the astrocyte marker glial fibrillary acidic protein and the neuronal markers NeuN and microtubule-associated protein 2.  In vitro, significant HUCBC migration activity was present at 24 hours after MCAO (P<0.01) compared with normal brain tissue.  CONCLUSIONS:  Intravenously administered HUCBC enter brain, survive, migrate, and improve functional recovery after stroke.  HUCBC transplantation may provide a cell source to treat stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ22Smdbsm0SMrRqEXsZufAfW6udTcc2ebJgfnEQv7VC7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MnktFemsw%253D%253D&md5=d91929883c97c51bcc90235902e672b9</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1161%2Fhs1101.098367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252Fhs1101.098367%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DSanberg%26aufirst%3DP.%2BR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DWilling%26aufirst%3DA.%2BE.%26aulast%3DSanchez-Ramos%26aufirst%3DJ.%26aulast%3DChopp%26aufirst%3DM.%26atitle%3DIntravenous%2520Administration%2520of%2520Human%2520Umbilical%2520Cord%2520Blood%2520Reduces%2520Behavioral%2520Deficits%2520after%2520Stroke%2520in%2520Rats%26jtitle%3DStroke%26date%3D2001%26volume%3D32%26spage%3D2682%26epage%3D2688%26doi%3D10.1161%2Fhs1101.098367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i73"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01338">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_11572"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01338?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01338</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">NMR multiplet reports and synthetic methods of the intermediates, HPLC reports for the purity check of compounds <b>1–31</b>, in vitro BBB permeation assay, oxygen radical absorbance capacity (ORAC-FL) assay, hERG cardiac toxicity assay, determination of metabolic stability in liver microsomes, bSDTNBI in silico prediction results, Fe-ion chelation experiment, effects of compounds on the viability of cells without insult, comparison of protective effects between compounds <b>11</b> and <b>16</b>, <sup>1</sup>H/<sup>13</sup>C NMR, MASS spectra and HPLC traces of compounds <b>1–31</b> and the intermediates, determination of the blood plasma concentrations of <b>11·Ola</b> and CPX olamine after intravenous administration in rats (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01338/suppl_file/jm9b01338_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01338/suppl_file/jm9b01338_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01338/suppl_file/jm9b01338_si_001.pdf">jm9b01338_si_001.pdf (11.97 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01338/suppl_file/jm9b01338_si_002.csv">jm9b01338_si_002.csv (2.94 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01338&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-3%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01338" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01338" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679995f1cd96221c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
